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The two primary predictors of cycling performance are maximal oxygen consumption and 
lactate threshold. However, several physiological and biomechanical factors influence 
these variables. The purpose of study one was to investigate relative joint contribution, 
muscle activation, and muscle oxygenation differences between high (HLT) and low (LLT) 
lactate threshold cyclists with similar maximal oxygen consumption capabilities (VO2max). 
While there were no differences in muscle oxygenation, the HLT group had greater relative 
hip contribution at 90% of VO2max compared to the LLT group, as well as decreased vastus 
medialis EMG activation during exercise at 60 and 70% of VO2max (p<0.05). These 
findings suggesting the HLT cyclists place a greater emphasis on the hip compared to the 
knee joint to generate power while cycling. The purpose of study two was to investigate 
the effects of short-term maximal power training on cycling peak oxygen consumption 
(VO2peak-cycling) in non-cyclists. Over the course of 5 days, the training group performed 10 
maximal sprints a day each lasting ~4 seconds with two-minutes rest between each sprint. 
This protocol was designed to maximize recruitment of muscles involved in cycling while 
 vii 
minimizing cardiovascular stress during training. Following training, absolute and relative 
VO2peak-cycling was 5.9 ± 1.6% and 5.6 ± 1.9% greater compared to pre-training (p<0.05), 
while in the control group VO2peak-cycling did not change (p>0.05). The improvement in 
VO2peak-cycling was accompanied by a 6.3 ± 2.5% increase (Pre: 228 ± 18 W vs. Post: 242 ± 
19 W) in peak work rate achieved during post-testing in the training group (p<0.05). This 
suggests that VO2peak-cycling can be increased through maximal power training in non-
cyclists likely as a result of increased ability to recruit additional muscle mass during 
intense cycling exercise. Taken together, these studies indicate that biomechanical muscle 
recruitment ‘strategies’ can influence both submaximal (i.e. LTVO2) and peak oxygen 
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Chapter I: General Introduction 
Human endurance performance is governed by the highest rate of oxygen consumption that 
can be maintained for the duration of exertion. The upper limit to this rate of oxygen consumption 
is dictated by maximum oxygen consumption (VO2max), and is a function of the exercise intensity 
at which lactate begins to accumulate in the muscle and then blood (i.e. lactate threshold). 
Improvements in oxygen delivery and muscle oxygen utilization allow athletes to exercise at 
higher rates of oxygen consumption at lactate threshold (LTVO2).  
Chronic endurance training elicits improvements in skeletal muscle oxidative capacity (Chi 
et al. 1983, Holloszy et al. 1984) which increases the relative and absolute exercise intensity at 
which lactate threshold occurs (Ivy et al. 1980). Although a majority of the increases in lactate 
threshold result from improved oxygen delivery and  muscle oxidative capacity, previous research 
has suggested that lactate threshold may also be improved by distributing power production to a 
greater amount of active muscle (Coyle et al. 1988). In theory, by spreading the work to more 
muscle mass, the work performed by any individual muscle would be reduced thereby delaying 
the onset of lactate production and lactate threshold.  
Active muscle mass plays an important role in achieving VO2max while cycling. For 
example, individuals without cycling experience demonstrate ~10% lower VO2max values while 
cycling (i.e. VO2peak) than those achieved during treadmill VO2max testing (Tanaka 1994). This 
lower VO2peak-cycling has been attributed to lower muscle mass recruitment in untrained individuals 
(Tanaka et al. 1987, Tanaka 1994, Sloniger et al. 1997, Sloniger et al. 1997). Greater active muscle 
mass during exercise is related to greater maximal oxygen consumption (Sloniger et al. 1997). 
Having subjects stand up towards the end of maximal exercise cycling results in higher values of 
maximal oxygen consumption compared to seated cycling which can be attributed to an increased 
 2 
recruitment of active muscle mass (Tanaka et al. 1987).  The mechanism driving this relationship 
has been attributed to increases in peak cardiac output from more active muscle tissues receiving 
oxygenated blood (Reybrouck et al. 1975). Therefore, we sought to determine whether VO2peak-
cycling could be improved in non-cyclists, specifically through short-term inertial load training 
designed to elicit maximal muscle recruitment and neuromuscular power while minimizing 
cardiovascular stress.  
Muscle deoxygenation is reflective of the metabolic stress of a particular muscle group 
during exercise (Ryan et al. 2014, Skovereng et al. 2016, Skovereng et al. 2016). Previous research 
has shown reduced stress, as reflected by less glycogen depletion, on the vastus lateralis of well-
trained cyclists with high lactate thresholds compared with equally well-trained cyclists with 
relatively low lactate thresholds during submaximal cycling (Coyle et al. 1988). Accompanying 
this reduced stress was an estimated ~2kg increase in the estimated total muscle mass used during 
cycling in the high lactate threshold cyclists. Authors attributed the reduction in knee extensor 
glycogen utilization to a better spreading of the metabolic work across more muscle mass and 
multiple power generating joints (i.e. hip and knee), however, direct investigations are needed to 
test this hypothesis. 
Therefore, the primary objectives of this dissertation are to determine 1) whether 
biomechanical differences occur between highly trained cyclists with high and low LT and if these 
differences are associated with changes in deoxygenation of the vastus lateralis during submaximal 
cycling and 2) whether short-term inertial load power training increases VO2peak-cycling and reduces 
stress on the vastus lateralis during submaximal exercise reflective of a possible ‘learned ability’ 
to recruit additional muscle while cycling.  
A variety of biomechanical and physiological techniques were implemented to investigate 
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the cycling strategy used by well-trained cyclists. Techniques included electromyography (EMG) 
to determine relative muscle activation and near-infrared spectroscopy (NIRS) to assess changes 
in deoxygenation of the vastus lateralis during submaximal cycling in HLT and LLT cyclists. 
Kinematics (i.e. motion analysis) and kinetics (i.e. pedal forces) were used to determine the relative 
contribution of the hip, knee, and ankle joints to the cycling movement. The unique combination 
of local physiological stress (i.e. NIRS) and biomechanical data will provide a detailed description 
of the cycling stress and technique in well-trained cyclists (HLT) and whether it reduces the 
deoxygenation of knee extensors. These data will describe the cycling biomechanics of athletes 
with high lactate thresholds who are capable of exercising at higher steady state rates of energy 
expenditure.  
Furthermore, short-term inertial-load power training designed to elicit maximal 
neuromuscular improvement was used to investigate whether improvements in VO2peak-cycling, 
LTVO2-cycling, and muscle oxygenation can be made without significant cardiovascular stress during 
training. By utilizing this training technique on subjects who fail to achieve VO2max when cycling 
but rather only obtain VO2peak-cycling, elicited improvements to cycling maximal and submaximal 
performance can occur independent of aerobic exercise training or possible changes in the maximal 
values of cardiac output and/or A-VO2diff. We hypothesize that inertial-load power training will 
increase VO2peak-cycling, LTVO2-cycling, and lower deoxygenation of the vastus lateralis.  
Together, these two studies attempt to investigate the adaptations other than cardiovascular 
or mitochondrial function of cycling performance, specifically, those possible biomechanical 




Chapter II: Statement of Problem 
 Classically, the limiting factors of VO2max and LTVO2 have been examined from a systems 
physiology perspective with an emphasis on the relationship between the maximal capabilities of 
cardiac output and skeletal muscle oxidative capacity. However, the variation in both VO2max and 
LTVO2 in cyclists can be attributed to other factors other than oxygen delivery and oxidative 
capacity. Therefore, the following studies were designed to determine novel determinants of 
cycling endurance performance (i.e. VO2max and LTVO2). This series of studies answers the 
following specific questions: 
1. Do individuals with similar VO2max, but differing cycling LTVO2 (i.e. high and low lactate 
threshold) differ in relative joint contribution, muscle oxygenation, and muscle activation 
during submaximal cycling?  
2. Does short-term inertial-load power training lead to improvements in VO2peak-cycling, LTVO2-




Chapter III: Purpose and Hypothesis 
Study #1: The purpose of this study was to examine the physiological (as assessed by NIRS) and 
biomechanical (as assessed by absolute/relative joint power contributions) differences between 
high LTVO2 (HLT) and low LTVO2 (LLT) cyclists across work rates in competitive cycling. We 
hypothesized that compared with LLT cyclists, HLT cyclists will exhibit greater relative power 
contribution from the hip and lower relative contribution from the knee during submaximal cycling 
resulting in lower physiological stress as evidenced by lower deoxygenation and EMG activation 
on the knee extensors. 
 
Study #2: The purpose of this study was to examine changes in VO2peak-cycling and LTVO2-cycling after 
a short-term, inertial-load maximal power cycling training program that maximized neuromuscular 
power and minimized cardiovascular stress. We hypothesized that recreationally trained 
individuals would demonstrate improved cycling VO2peak-cycling, LTVO2-cycling, and reduced muscle 




Chapter IV: Study #1  
RELATIVE LOWER EXTREMITY JOINT POWER AND MUSCLE DEOXYGENATION IN HIGH AND 
LOW LACTATE THRESHOLD CYCLISTS 
Abstract 
 
Background: The physiological and biomechanical differences between high LTVO2 (HLT) and 
low LTVO2 (LLT) cyclists have yet to be completely described. Therefore, the objective of the 
present study is to investigate whether, compared with low LTVO2 cyclists, high LTVO2 cyclists are 
able to reduce the stress on the knee extensor muscles and relative joint contribution by increasing 
the relative contribution of the hip extensor muscles during high intensity cycling.  
Methods: Sixteen well-trained endurance athletes completed cycling and running VO2max and 
cycling and running lactate threshold (LTVO2) testing, and were separated into two groups based 
on cycling LTVO2 (HLT: n=8) and (LLT: n=8). During submaximal cycling (60-90% VO2max), 
near-infrared spectroscopy (NIRS) measured oxygenated hemoglobin (O2Hb), deoxygenated 
hemoglobin (HHb), %saturation, and total hemoglobin (THb) in the vastus lateralis; EMG 
measured activity of muscles in the lower extremity; and hip, knee, and ankle absolute and relative 
joint powers (the percent contribution to total joint powers) were compared between groups.  
Results: Sixteen subjects were separated into two groups based on cycling LTVO2: HLT (n=8) and 
LLT (n=8) with similar VO2max between groups. Blood lactate concentration increased with work 
rate and was lower in the HLT group at 80 and 90% of VO2max (p<0.05). Groups did not differ in 
O2Hb, HHb, or THb (p>0.05). Vastus medialis activation was higher in the LLT group at 60 and 
70% VO2max (p<0.05). There were no differences between groups in either hip, knee, or ankle 
absolute joint specific power across work rates (p>0.05), but relative hip contribution was 
significantly greater in the HLT group at 90% VO2max compared to the LLT group (p<0.05).  
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Conclusion: HLT cyclists have a greater relative hip contribution during submaximal cycling and 





The mechanisms surrounding maximal aerobic capacity (VO2max) and lactate threshold 
(LTVO2) are a complex combination of cardiovascular, muscular, and neural adaptations that 
improve oxygen delivery and muscle oxidative capacity (Holloszy et al. 1984, Bassett et al. 2000). 
Typically, VO2max and LTVO2 are specific to the mode of exercise used in training (Millet et al. 
2009). For example, well-trained cyclists have high LTVO2 capabilities while cycling (Coyle et al. 
1988), but runners and triathletes typically have lower LTVO2 while cycling compared with running 
uphill (Millet et al. 2009).  
When comparing cycling and inclined treadmill running in well-trained cyclists, two 
groups have emerged in prior research: 1) those cyclists with equally high LTVO2 while cycling 
and running uphill and 2) cyclists with low LTVO2 while cycling, but high LTVO2 while running 
uphill (closely matching those of the high LTVO2 cyclists) (Coyle et al. 1988). Traditionally, 
mitochondrial enzyme activity/skeletal muscle oxidative capacity would explain differences in 
LTVO2 between groups of cyclists; however, mitochondrial enzyme activity was found to be similar 
between these two groups suggesting the low LTVO2 cyclists have a capacity for high LTVO2 that 
is not attained during cycling. Previous research investigating physiological measures as possible 
causes found no evidence of glucose or glycogen utilization nor oxidative metabolism as the 
driving mechanism for these differences. Moreover, the high LTVO2 used approximately 1.8 kg 
more calculated muscle mass during cycling compared with low LTVO2 cyclists despite having 
similar VO2max (Coyle et al. 1988, Coyle 1995). The authors attributed the higher LTVO2 to the 
improved ability to spread the metabolic work to a greater amount of muscle mass effectively 
increasing the number of mitochondria sharing in the metabolic work. Others have speculated this 
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could be accomplished, at least in part, by specific technical adaptations, such cycling skill and/or 
muscle utilization patterns (Millet et al. 2009).  
Experienced cyclists tend to reduce the stress on their knee extensors and generate more 
force on the down-stroke of pedaling, presumably through increased joint contribution from the 
hip extensors (Coyle et al. 1988, Coyle et al. 1991, Takaishi et al. 1998). Direct comparisons of 
relative joint contribution between experienced and novice cyclists (Hoshikawa 2007, Bini et al. 
2014, Aasvold 2017) have found inconsistent results, with some studies finding higher (Aasvold 
2017), lower (Hoshikawa 2007), or no difference in relative hip contribution (Bini et al. 2014). 
The discrepancy in these results are likely a result of the work rates chosen for comparison, as 
prior studies have made relative joint contribution comparisons at different absolute and relative 
work rates and/or relative exercise intensities. To date no study has compared, between high and 
low LTVO2 cyclists with similar VO2max, the relative joint contribution at similar absolute and 
relative work rates commonly attained during high level competitive cycling. 
Although absolute and relative joint powers calculated through inverse dynamics have 
often been used interchangeably to describe muscular power, these joint power calculations are 
independent of the mechanical energy expenditure of working skeletal muscle during exercise and 
differ from individual muscle contribution (Kautz et al. 1994, Neptune et al. 1998, Kautz et al. 
2002). Electromyography (EMG) allows for the assessment of muscle activation and can be used 
to determine relative intensity of muscle activation and patterns of muscle recruitment. Prior 
research has shown increased muscle EMG activation of the vastus lateralis in novice compared 
with experienced cyclists (Takaishi et al. 1998). Additionally, near-infrared spectroscopy (NIRS) 
can assess the oxygenation of working muscle by calculating oxygenated (O2Hb) and 
deoxygenated (HHb) hemoglobin. Changes in HHb in response to changes in work rate and 
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cadence during cycling have been used as indicators of local muscle stress (Boone et al. 2015, 
Skovereng et al. 2016, Skovereng et al. 2016)and, in healthy adults, decreased relative knee 
contribution at higher work rates is accompanied by a plateau in deoxygenation of the vastus 
lateralis. However, changes in deoxygenation have not been used to compare the physiological 
stress of the working muscle between low and high LTVO2 cyclists.  
Therefore, the objective of the present study is to investigate whether, compared with low 
LTVO2 cyclists, high LTVO2 cyclists are able to reduce the stress on the knee extensor muscles and 
relative joint contribution by increasing the relative contribution of the hip extensor muscles during 
high intensity cycling. We propose to examine the physiological (as assessed by NIRS and EMG) 
and biomechanical (as assessed by absolute/relative joint contributions) differences between high 
LTVO2 (HLT) and low LTVO2 (LLT) cyclists. We hypothesized that compared with LLT cyclists, 
HLT cyclists will exhibit greater relative hip power contribution and lower relative knee power 
contribution during submaximal cycling resulting in lower physiological stress as evidenced by 
lower deoxygenation and EMG activation of the knee extensors. 
Methods 
Fifty-two well-trained endurance athletes were originally recruited to take part in this 
research study. Those who did not obtain similar running and cycling VO2max values were excluded 
(cycling VO2max no less than 0.2 L/min compared with treadmill VO2max). The remaining 16 well-
trained endurance athletes were separated into two groups: High LTVO2 (HLT, n=8) and Low 
LTVO2 (LLT, n=8) based on cycling LTVO2 (HLT: cycling LTVO2 no less than 0.2L/min compared 
with treadmill LTVO2) while controlling for cycling VO2max to ensure no differences between 
groups in maximal oxygen consumption capabilities. 
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A total of 6 testing visits were required. Visit 1 measured VO2max while cycling and Visit 
2 measured VO2max while running uphill. Visit 3 was used to determine LTVO2 while cycling and 
Visit 4 was used to determine LTVO2 while running. Visit 5 and 6 measured muscle deoxygenation, 
muscle activation, and joint specific power during submaximal cycling.  
Maximal Oxygen Consumption While Cycling and Running 
Subjects exercised for 8-12 minutes with increasing intensity until exhaustion, as described 
previously (Costill 1970). Briefly, subjects exercised for four minutes at a moderate intensity 
(~75% VO2max) and thereafter work rate was progressively increased every two minutes until 
exhaustion. During the cycling test, wattage was increased on the cycle ergometer (Excaliber 
Sport, Lode, Groningen, The Netherlands). During the treadmill test, subjects ran at a constant, 
speed which elicited ~75% of VO2max. After 4 minutes, grade was increased to 4% and increased 
2% every 2 minutes thereafter. Subjects typically reached VO2max at a grade of 8-10%. For both 
cycling and running, a successful VO2max test was determine based on ACSM criteria: RER>1.1, 
Max Heart Rate ± 10 bpm of predicted max heart rate (Tanaka et al. 2001), plateau of ≤ 150 
mL/min VO2, and an RPE >17 (Pescatello et al. 2014). Heart rate was measured continuously by 
a monitor worn around the chest (Suunto, Vantaa, Finland). 
Respiratory analyses were determined using oxygen and carbon dioxide analyzers (Applied 
Electrochemistry, Models S-3A/I and CD-3A, respectively) while the participants breathed 
through a one-way valve (Hans Rudolph, Kansas City, MO). Ventilation was measured via an 
inspiratory pneumotachometer (Hans Rudolph, Kansas City, MO). VO2, VCO2, and RER was 
continuously monitored throughout the exercise test. The highest 30 second average of VO2 was 
used as the measurement of VO2max.  
Lactate Threshold Testing 
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This protocol required 30 minutes of continuous exercise at submaximal intensities (5 min 
at each stage of approximately 40, 50, 60, 70, 80, 90% of maximal oxygen consumption). During 
cycling test, wattage was adjusted to increase work rate and cadence was maintained at 80-100 
RPM. However, during treadmill testing subjects ran at a constant 10% grade and speed was 
increased (from a walk ~80 m/min to a jog/run ~215 m/min) to increase work rate as uphill running 
has been shown to use similar muscles as cycling (Costill et al. 1974). Lactate threshold was 
determined from analysis of a series of blood samples obtained between minutes 4 and 5 in each 
stage. Blood samples were immediately deproteinized by placing in a 10% perchloric acid solution 
and lactic acid levels were measured on the supernatant. Enzymatic analysis was used to determine 
blood lactate concentration, as described previously (Farrell et al. 1979, Coyle et al. 1988). The 
lactate threshold was defined as the exercise intensity that elicits a 1mM increase above baseline 
in blood lactate concentration (Coyle et al. 1988, Coyle et al. 1991). VO2, VCO2, and RER were 
continuously monitored throughout the exercise test and were averaged over the final 4 and 5 
minutes of each stage. Heart rate was measured continuously by a monitor worn around the chest 
and taken as the average during minutes 4 and 5 of each stage (Suunto, Vantaa, Finland), during 
this time subjects were also asked to report RPE. 
Muscle Deoxygenation 
 
Near-infrared spectroscopy (OxiplexTS, ISS, Champaign, IL) was used to measure 
oxygenated hemoglobin [O2Hb] and deoxygenated hemoglobin [HHb] in the vastus lateralis. NIRS 
uses the feature that the chromophores of O2Hb and HHb have different optical properties of 
absorbing near-infrared (wave length: 690 nm, 830 nm). This enabled NIRS to measure the 
absolute concentrations of O2Hb and HHb in µM in real-time in a noninvasive manner (Ryan et 
al. 2012, Boone et al. 2015, Skovereng et al. 2016). O2Hb and HHb serve as markers of 
 13 
‘physiological stress’ and were compared between groups. The O2Hb and HHb data during the last 
1 minute of each stage were averaged and compared as a %change from resting values. 
Electromyography 
 
Bagnoli™ Desktop EMG system (Delsys INC., Natick, MA) was used to determine muscle 
activity of the: gluteus maximus (Gmax), rectus femoris (RF), vastus lateralis (VL), vastus 
medialis (VM), biceps femoris (BF), gastrocnemius (Gast), soleus (Sol), and tibialis anterior (TA). 
Skin sites were cleaned and shaved with an alcoholic prep wipe and disposable razor. Electrodes 
were placed along the skin surface to run in parallel with the skeletal muscle fibers, and secured 
with double sided tape and athletic wrap. Raw EMG signals were smoothed using a fourth-order, 
band-pass Butterworth filter with a frequency range set between 20 and 500Hz. Onset and offset 
of EMG activity were determined when the signal with an amplitude above two standard 
deviations beyond the mean of the quiescent phase between EMG bursts (Diefenthaeler et al. 
2012). All EMG data were visually inspected and data manually selected to determine periods of 
quiescence before and after EMG bursts. EMG data were normalized as the percentage of the 
highest value which occurred during testing. 
Joint Specific Powers 
 
Subjects exercised on a stationary cycle ergometer while wearing 3M reflective markers. 
The markers were secured to the subjects using double-sided tape and placed on 9 sites (acromion 
process, mid-axillary, greater trochanter, mid-femur, lateral epicondyle of knee, mid-shank, lateral 
malleolus, toe of shoe, and heel of shoe). The Vicon Nexus motion analysis system uses infrared 
technology to collect data on the position of the markers in a 3-dimensional space and provides 
coordinates that can later be used for data processing and analysis (Vicon Motion Systems Ltd., 
Lake Forest, CA). Normal and tangential components of force applied to the pedal were collected 
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using a custom-designed force pedal with two piezo electric force transducers (Kistler, model 
9251AQ01) at a sampling rate of 1200Hz. Pedal forces were filtered by a third-order low-pass 
Butterworth filter with a cutoff frequency of 10Hz (Coyle et al. 1991, Diefenthaeler et al. 2012). 
Data were paired to match the kinematic data obtained through motion analysis. Using the pedal 
angle obtained in the coordinate data, forces were transformed from the reference frame of the 
pedal into the inertial reference frame. Data were used for inverse dynamics calculations that 
determined the joint moments/power from the hip, knee, and ankle (Hull et al. 1985, Skovereng et 
al. 2016, Skovereng et al. 2016). Data were processed using a custom MatLab (MathWorks Inc., 
Natick, MA, USA) program. 
Joint powers at the hip, knee, and ankle were derived using standard inverse dynamics 
techniques (Hull et al. 1985). Rigid segment models of the crank, foot, leg, and thigh were 
generated. Hip position was determined based on the location of the anterior superior iliac spine 
assuming constant offset measured during the static trials (Neptune et al. 1995). Linear and angular 
velocities and accelerations of the limb segments were determined by finite differentiation of 
position data with respect to time. Segmental mass proportions, center of mass locations, and radii 
of gyration were estimated from anthropometric tables (de Leva 1996). Joint moments of the ankle, 
knee, and hip were calculated through use of angular accelerations of the segments, normal and 
tangential pedal forces, and acceleration of segmental center of gravity. Joint powers were then 
calculated by the product of joint angular velocities and joint moments. Relative joint contribution 
was then calculated as the percentage contribution to the total joint powers.  
Statistical Analysis 
 15 
 Descriptive statistics are reported as Mean ± SE. Descriptive statistics were compared 
using Students t-test (α= 0.05). Between group differences in VO2max and lactate threshold were 
determined by Two-Way ANOVA (Group X Exercise Mode). Differences in muscle oxygenation, 
muscle activation, and joint contribution during submaximal cycling were determined through 
two-way repeated measures ANOVA (Group X Work Rate). Least Significant Difference post hoc 
comparison were performed for all significant main effects (α= 0.05). 
Results 
Subject Characteristics 
There was no difference in age (HLT: 30.3 ± 1.0 yrs.; LLT: 26.3 ± 3.0 yrs.), height (HLT: 
175.4 ± 1.5 cm; LLT: 176.0 ± 2.7 cm) or weight (HLT: 76.1 ± 3.2 kg; LLT: 67.9 ± 2.4 kg) 
between groups (p>0.05). 
Within Group Differences in VO2max (i.e. Ergometer vs. Treadmill) 
During maximal exercise, there were no differences in absolute or relative oxygen 
consumption, HR, RER, or RPE between cycling and running in the HLT group (p>0.05). 
Similarly, the LLT group did not differ in absolute or relative maximal oxygen consumption, RER, 
or RPE on the cycle ergometer compared with treadmill running (p>0.05); However, HRmax was 
significantly higher while cycling compared with treadmill running in the HLT group (Table 1).  
Between Group Differences in VO2max (i.e. HLT vs LLT) 
During cycling VO2max testing there were no differences between groups in absolute 
(L/min) or relative (mL/kg/min) oxygen consumption, RER, Watts, or RPE (p>0.05). However, 
cycling HRmax was higher in the HLT group compared with the LLT group (p<0.05). During 
treadmill VO2max testing absolute oxygen consumption (L/min), HRmax, RER, or RPE did not differ 
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between groups. However, treadmill relative oxygen consumption (mL/kg/min) was lower in the 
HLT group compared with the LLT group (p<0.05) (Table 1).  
Within Group Differences in LTVO2 and LTHR (i.e. Bike vs Treadmill) 
Within the HLT group there were no differences in LTVO2 or LTHR while cycling compared 
with uphill running (p>0.05). However, in the LLT group, LTVO2 and LTHR were significantly 
lower while cycling compared with uphill running (p<0.05) (Table 2).  
Between Group Differences in LTVO2 and LTHR (i.e. HLT vs LLT) 
Oxygen consumption and work rate at lactate threshold were significantly higher in the 
HLT group compared with the LLT group (p<0.05) (Table 2 and Figure 1). However, there was 
no difference in cycling or running LTHR between the HLT and LLT groups (p>0.05). Furthermore, 
no differences between groups were found for uphill running LTVO2 or LTHR (p>0.05) (Table 2).  
Submaximal Measures During Lactate Threshold Testing 
Cycling 
Blood lactate concentration increased with increasing work rate in both groups, with the 
HHLT group having lower blood lactate concentration while cycling at 80 and 90% of VO2max 
compared with the LLT group (p<0.05) (Figure 1). Additionally, as work rate progressively 
increased oxygen consumption, HR, RPE, RER in both groups (p<0.05) with each successive 
increase in intensity (p<0.05). However, there were no differences between groups (p>0.05) 
(Figure 2).  
Uphill Running 
As work rate increased all physiological measures (i.e. blood lactate, oxygen consumption, 
HR, RPE, and RER) increased for both groups (p<0.05), with each successive increase in exercise 
 17 
intensity. (p<0.05). However, there was no difference between groups in any measure (p>0.05) 
(Figure 3). 
 NIRS, EMG, and Joint Powers 
Near-Infrared Spectroscopy 
Percent change (%∆) in %Saturation of oxygen within the vastus lateralis was not 
statistically different across work rates or between groups (p>0.05). However, difference in %∆ in 
THB, O2Hb, and HHb increased with work rates (p<0.05) with no differences between groups 
(p>0.05) (Figure 4). 
 Electromyography 
A summary of the EMG results can be found in Table 3. Briefly, there were no differences 
between LLT and HLT across work rates for the RF, BF, Gast, or TA in % Activation (p>0.05). 
However, VM activation was lower in the HLT group compared with the LLT group at 60 and 
70% VO2max with no differences at higher work rates (p<0.05). VL and Gmax activation increased 
with work rate (p<0.05). In addition, the average Sol activation was higher in the HLT group 
compared with the LLT group (p<0.05). 
Joint Power 
 There were no significant differences between the HLT and LLT groups in either Hip or 
Knee joint specific power at any work rate (p>0.05) (Figure 4). However, in both the HLT and 
LLT groups, absolute hip joint specific power increased with increases in work rate (p<0.05). Knee 
joint specific power increased with increases in work rate in the LLT group (p<0.05), but did not 
change in the HLT group (p>0.05). Ankle joint specific power did not differ between groups 
(p>0.05). 
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Relative hip contribution was significantly greater in the HLT group at 90% VO2max 
compared with the LLT group (p<0.05). Relative knee contribution was not significantly different 
between groups or across work rates (p>0.05). In addition, relative ankle contribution was not 
different in the HLT group compared with the LLT group (Figure 5). 
Discussion 
 
The present study sought to determine the physiological and biomechanical differences 
between high LTVO2 (HLT) and low LTVO2 (LLT) cyclists. In well-trained cyclists with equally 
high VO2max, those with low LTVO2 during cycling can sometimes achieve a higher LTVO2 during 
uphill treadmill running which suggests that the reduced LTVO2 is cycling-specific in some highly 
trained cyclists (Coyle et al. 1988). Prior research has shown HLT cyclists have reduced glycogen 
utilization of the knee extensors which was speculated to be due to shifts in biomechanical 
strategies during submaximal cycling (Coyle et al. 1988); specifically, the authors hypothesized 
that HLT cyclists distribute power production across multiple joints which reduces stress on the 
knee extensors. Therefore, we hypothesized that compared with LLT cyclists, HLT cyclists would 
exhibit greater relative hip power contribution and lower relative knee power contribution during 
submaximal cycling resulting in lower physiological stress as evidenced by lower deoxygenation 
and EMG activation of the knee extensors. In the present study, we observed that HLT cyclists 
have a greater contribution from the hip joint when cycling at 90% VO2max and lower EMG 
activation of the VM compared with LLT cyclists.  
Differences between groups in relative hip joint contribution emerged at 80% (p=0.07) and 
90% of VO2max (p<0.05): the HLT group had greater relative contribution of power from the hip 
joint compared with the LLT cyclists. For knee joint power there was a cross-over effect: with 
increases in work rate the LLT group significantly increased knee joint power, but there were no 
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changes in knee joint power in the HLT group (Figure 5). In the LLT group, since both the absolute 
hip joint and knee joint power increased with increasing work rates, there were no changes in 
relative hip joint or knee joint contribution over time. However, absolute hip joint power increased 
at 80 & 90% of VO2max in the HLT group without changes in knee power leading to greater relative 
hip joint contribution at 90% of VO2max in the HLT group compared with the LLT group. This 
finding suggests the HLT group relies more on increasing hip joint power to accommodate 
increases in work rate and provides further evidence that HLT cyclists have adapted a 
biomechanical strategy to rely more on their hip for power production during submaximal cycling 
(Coyle et al. 1988, Coyle et al. 1991). 
The higher relative hip joint contribution in HLT compared with LLT cyclists supports the 
work of Aasvold et al. (2017) who compared elite cyclists with amateur recreational cyclists 
(Aasvold 2017). However, other studies which have attempted to compare joint powers between 
groups of cyclists have found inconsistent results (Hoshikawa 2007, Bini et al. 2014), likely due 
to the subject population and work rates chosen for comparison. As such, prior research has found 
greater relative knee contribution and lower relative hip contribution in cyclists compared with 
recreationally active adults (Hoshikawa 2007) as well as no differences in relative hip or knee joint 
contribution between well-trained cyclists and triathletes (Bini et al. 2014). Prior studies have used 
groups which differed in both maximal oxygen consumption and lactate threshold (Aasvold 2017) 
or failed to report either (Hoshikawa 2007, Bini et al. 2014). Therefore, subjects either exercised 
at different absolute workloads  (Aasvold 2017) or potentially different relative oxygen 
consumptions (Hoshikawa 2007, Bini et al. 2014). In the current study, and in the work by Aasvold 
et al. 2017, subjects were compared at work rates relative to maximal oxygen consumption or 
lactate threshold and both found greater relative hip joint contribution in the more ‘experience’ 
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cyclists. Conversely, when studies compared experienced and novice cyclists at the same absolute 
work rates the experienced cyclists had a higher relative knee joint contribution and lower relative 
hip joint contribution (Hoshikawa 2007). However, when using absolute work rates the relative 
exercise intensity would be lower for trained cyclists and therefore, a higher relative hip joint 
contribution may not have been necessary to accomplish the given task. By controlling for 
maximal oxygen consumption, the current study allowed direct comparisons between groups at 
the same submaximal work rates thereby limiting the confounding effects absolute work rate can 
have on joint powers (Ericson 1986, Ericson 1988). The present study adds to the current literature 
examining joint power differences among individuals who vary in cycling ability and is unique its 
ability to: 1) compare groups of cyclists that differ in lactate threshold (which is cycling specific) 
rather than cycling experience and 2) control for relative exercise intensity (%VO2max)/absolute 
work rate (W).  
No differences were found in muscle deoxygenation between the HLT and LLT groups 
suggesting no significant differences between groups in the oxidative stress placed on the knee 
extensors during submaximal cycling. However, differences in hip and knee joint contribution can 
have direct effects on deoxygenation of the knee extensors while cycling (Skovereng et al. 2016). 
Previous work has shown that knee extensors’ muscle oxygen consumption, assessed by the 
vascular occlusion technique using near-infrared spectroscopy, is related to absolute and relative 
knee joint specific power during submaximal cycling (Skovereng et al. 2016). Therefore, lower 
relative stress, assessed by higher muscle oxygenation, could be reflective of lower relative knee 
joint contributions. The lack of differences between groups in muscle oxygenation could be due to 
the variations in muscle oxygenation in response to changes in work rate (Chin et al. 2011) or the 
location (proximal versus distal) of sensor placement on a given muscle (Spencer et al. 2014). The 
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oxygenation of the VL may not be truly reflective of the combined effect of the muscles crossing 
the knee joint which could partially explain the discrepancies between the present study and prior 
investigations.  
 In addition to muscle oxygenation status, the present study assessed muscle activation with 
electromyography to determine relative intensity of muscle activation and patterns of muscle 
recruitment. While prior research has shown increased muscle activation of the vastus lateralis in 
novice compared with experienced cyclists (Takaishi et al. 1998), the present study found little 
difference in vastus lateralis muscle activation between groups. These discrepancies could be 
attributed to the relatively low work rate chosen by Takaishi et al. 1998 or the differences in cycling 
experience between novice and experienced cyclists which highlighted differences in VL muscle 
activation. By including only experienced cyclists the present study restricted the range of ‘cycling 
skill’ and perhaps the ability to detect differences in VL activation between groups. Importantly, 
in the present study, the HLT group did have lower activation of another knee extensor, the vastus 
medialis (VM), suggesting a reduced stress on the vastii group. Additionally, the HLT group 
demonstrated increased SOL activation compared with the LLT group which is consistent with 
fine wire EMG studies on lower extremity muscle activation in experienced and novice cyclists 
(Chapman et al. 2006, Chapman et al. 2008) and may reflect a less skilled pattern of SOL 
recruitment during cycling in the LLT group. The Gmax and vastii muscle groups account for 
~80% of the power production during cycling; however, only approximately 55% of that power 
production is transferred directly to the pedal while the rest (45%) is transferred to the limb 
segments (Raasch et al. 1997, Neptune et al. 2000). Therefore, plantar flexion muscle activation is 
necessary to ensure the remaining 45% of the power going to the limbs can assist in the 
acceleration of the crank, rather than transfer to knee extension and dorsiflexion (Raasch et al. 
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1997). Thus, the greater SOL activation in the HLT cyclists may assist in the transfer of hip power 
towards crank acceleration, and agrees with prior studies which suggest triathletes and novice 
cyclists differ in muscle recruitment of the plantar/dorsi flexors and pedaling technique compared 
with experienced cyclists (Chapman et al. 2006, Chapman et al. 2008, Chapman et al. 2009).   
 This is the first study to compare relative joint contribution, muscle deoxygenation, and 
muscle activation, differences among high and low LTVO2 cyclists with similar VO2max. Therefore, 
the confounding effects of different work rates on relative joint contributions were eliminated 
allowing physiological and biomechanical measures to be compared at the same absolute and 
relative submaximal work rates. Prior research has hypothesized that an increased ability to recruit 
additional muscle mass during submaximal cycling can increase LTVO2, and total active muscle 
mass explains ~20% of the variance in LTVO2 (Coyle et al. 1988, Coyle 1995). As more muscle 
mass is recruited, there is a larger amount of muscle mass able to share in the metabolic work 
which equates to lower oxygen demand per mitochondria, lesser reliance on glycogenolysis, and 
a lower overall lactate production during submaximal exercise (Holloszy et al. 1984, Coyle et al. 
1988). Therefore, the higher relative hip joint contribution at 80% (p=0.07) and 90% of VO2max 
(p<0.05) in the HLT cyclists could be reflective of an increased ability to ‘spread the metabolic 
work’ by increasing the contribution of the hip to power production leading the lower blood lactate 
concentrations in the HLT group at 80 and 90% of VO2max compared with the LLT cyclists. 
Without a direct measure of total active muscle mass, we are unable to determine whether the HLT 
group’s lower blood lactate concentrations while cycling was due to their ability to spread the work 
to more active muscle.  
The present study is unique in its ability to determine whether HLT group exhibits greater 
relative contribution from the hip during submaximal cycling and whether these differences are 
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associated with lower physiological stress of the knee extensors (assessed by muscle 
deoxygenation and EMG activation). The HLT cyclists exhibited lower EMG activation of knee 
extensors (i.e. VM) and increased relative power production from their hip. Therefore, it appears 
that HLT cyclists rely more on their hip to produce power during submaximal cycling compared 
with LLT cyclists, which is reflected in higher relative hip power and lower knee extensor 
activation during submaximal cycling. These results add to the growing evidence suggesting the 
traditional limiters of endurance performance (i.e. VO2max and LTVO2) can be influenced by cycling 




Tables and Figures 
 
Table 1. Results of maximal oxygen consumption testing between High Lactate Threshold 
(HLT) and Low Lactate Threshold (LLT) groups during cycling and treadmill 
running. 
 HLT LLT 
 Cycling Treadmill Cycling Treadmill 
Absolute VO2max (L/min) 4.57 ± 0.17 4.47 ± 0.13 4.42 ± 0.15 4.49 ± 0.16 
Relative VO2max (mL•kg-1min-1) 60.3 ± 2.0 58.7 ± 1.3* 64.9 ± 1.6 65.9 ± 2.2 
Heart Rate Max (beats/min) 189 ± 2*† 184 ± 3 179 ± 3 179 ± 3 
Maximal RER 1.10 ± 0.01 1.09 ± 0.02 1.10 ± 0.01 1.07 ± 0.02 
Maximal RPE 18 ± 1 18 ± 1 18 ± 1 18 ± 1 
Work Rate at VO2max (W) 359 ± 16 ------ 326 ± 17 ------ 
*significant difference between HLT & LLT within same exercise mode. †significant difference 
between Cycling and Treadmill within same group. RER: respiratory exchange ratio; RPE: rating 






Table 2. Results of lactate threshold testing between High Lactate Threshold (HLT) and Low 
Lactate Threshold (LLT) groups during both cycling and uphill running. 
 HLT LLT 
 Cycling Treadmill Cycling Treadmill 
LT Threshold VO2 (L/min) 3.68 ± 0.21* 3.73 ± 0.18 3.10 ± 0.15† 3.71 ± 0.13 
LT Threshold %VO2max 80.2 ± 2.1 82.3 ± 2.5  70.3 ± 2.9*† 82.8 ± 2.3 
LT Threshold Heart Rate 
(beats/min) 162 ± 4 164 ± 3 152 ± 7† 168 ± 4 
LT Threshold Work Rate (W) 263 ± 9* ------ 221 ± 14 ------ 
*significant difference between HLT & LLT within same exercise mode. 










Table 3. Electromyography (EMG) results. Between group differences in percent activation (% 
Act) of lower extremity muscles during submaximal cycling of increasing work rate 
in the High (HLT) and Low (LLT) threshold cyclists (Mean ± SE). 
 
  %VO2max 
  60 70 80 90  
Vastus Lateralis (% Act) HLT 37.4 ± 2.5
 39.5 ± 2.2 41.4 ± 2.9 47.1 ± 2.7a,b.c  
LLT 36.7 ± 2.2 35.8 ± 1.5 45.5 ±4.7b 44.6 ± 6.3a,b  
Rectus Femoris (% Act) HLT 29.3 ± 5.1 32.7 ± 5.2 30.6 ± 2.5 35.8 ± 2.4 
 
LLT 24.3 ± 0.9 23.2 ± 1.1 26.7 ± 3.2 33.2 ± 7.8  
Vastus Medialis (% Act) HLT 29.6 ± 1.5* 32.5 ± 1.9* 33.2 ± 3.1 38.8 ± 2.7  LLT 50.3 ± 8.5 52.0 ± 9.6 41.4 ± 4.0 40.8 ± 2.5  
Biceps Femoris (% Act) HLT 40.9 ± 3.5 41.7 ± 4.1 41.7 ± 2.5 43.9 ± 2.9  LLT 35.2 ± 3.4 36.6 ± 2.5 35.9 ± 2.5 39.1 ± 1.8  
Gluteus Maximus (% Act) HLT 49.3 ± 3.7 55.4 ± 3.7 66.2 ± 4.9
a 69.8 ± 1.8a  
LLT 41.6 ± 5.9 46.9 ± 5.4 50.1 ± 6.4 49.4 ± 5.8  
Soleus (% Act) HLT 52.5 ± 7.5* 54.2 ± 5.3 51.5 ± 2.0 50.4 ± 2.4  LLT 40.8 ± 3.7 40.3 ± 3.3 44.4 ± 4.8 42.4 ± 2.5  
Gastrocnemius (% Act) HLT 36.7 ± 4.5 35.8 ± 2.9 36.1 ± 2.1 34.3 ± 1.8  LLT 29.3 ± 5.5 26.6 ± 3.8 27.4 ± 4.3 27.1 ± 3.1  
Tibialis Anterior (% Act) 
HLT 54.6 ± 7.4 48.4 ± 3.8 40.1 ± 3.6 48.7 ± 3.9  
LLT 33.3 ± 8.1 23.1 ± 6.5 34.1 ± 11.4 36.1 ± 6.3  
 
 
*=significant difference between the HLT and LLT group, a=significant difference compared 




   
Figure 1. Blood lactate concentration during lactate threshold testing during A) Cycling and B) 
Uphill Running (Mean ± SE). Solid lines with closed symbols represent the High 
Lactate Threshold (HLT) group and dashed lines with open symbols represent the 
Low Lactate Threshold (LLT) group. Blue arrows indicate LTVO2. *significant 




Figure 2. Physiological measurement during the cycling LTVO2 testing in both the High Lactate 
Threshold (HLT) and Low Lactate Threshold (LLT) groups (Mean ± SE). Solid 
lines with closed bars represent the HLT group and dashed line with open symbols 
represent the LLT group. There were no significant differences between groups at 





Figure 3. Physiological measurement during the uphill running LTVO2 testing in both the High 
Lactate Threshold (HLT) and Low Lactate Threshold (LLT) groups (Mean ± SE). 
Solid lines with closed symbols represent the HLT group and dashed line with open 
symbols represent the LLT group. There were no significant differences between 




Figure 4. Near-infrared spectroscopy (NIRS) measurements of the vastus lateralis during 
submaximal cycling between High Lactate Threshold (HLT) and Low Lactate 
Threshold (LLT) groups. Calculated as the percent change from resting 
oxygenation. Solid lines with closed symbols represent the HLT group and dashed 
lines with open symbols represent the LLT group. There were no significant 
differences between groups (p>0.05); however, there were significant differences 
across work rates (p<0.05). asignificant difference compared with the 60% VO2max 
work rate within that group. bsignificant difference compared with the 70% VO2max 




Figure 5. Between group comparison of joint powers and relative joint contribution with 
increases in work rate (Mean ± SE). A&B) Hip, C&D) Knee, E&F) Ankle. Solid 
lines with closed symbols represent the High Lactate Threshold (HLT) group and 
dashed line with open symbols represent the Low Lactate Threshold (LLT) group. 
*between group differences at that work rate. asignificant difference between 60% 
VO2max work rate, bsignificant difference compared with the 70% VO2max work rate.  
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Chapter V: Study #2 
EFFECTS OF SHORT-TERM MAXIMAL POWER TRAINING ON VO2PEAK AND LACTATE 
THRESHOLD IN NON-CYCLISTS 
Abstract 
Background: The present study tested whether short-term inertial-load training, designed to 
achieve maximal neuromuscular recruitment with minimal aerobic stress, could improve measures 
of aerobic metabolism while cycling using measures of VO2peak-cycling, lactate threshold and 
oxygenation (NIRS) of the vastus lateralis (VL) in individuals without cycling experience. 
Methods: Twenty subjects (9 males) completed pre-assessments (Day 1: VO2max-treadmill; Day 2: 
VO2peak-cycling and LT+NIRS) assessments and were randomly allocated into a Training (n=10) 
group or Control group (n=10). Training group performed 10 bouts of maximal acceleration for 4 
seconds with 2 minutes rest between bouts each day of training. Control group received no 
intervention. All subjects completed post-assessments (VO2peak-cycling; LT+NIRS) on Day 9. 
Results: Groups did not differ in absolute or relative VO2max-treadmill or cycling VO2peak-cycling 
(p>0.05). Maximal power or RPM @ maximal power did not differ across training days (p>0.05). 
Training group absolute VO2peak-cycling, relative VO2peak-cycling, peak work rate increased following 
training (p<0.05) without differences (pre to post-training) in maximal RER, heart rate, or RPE 
(p>0.05). Groups did not differ in pre and post-intervention regarding VO2peak-cycling (p>0.05) or 
other variables. Post training LTVO2-cycling did not differ from pre-training in the Control or Training 
groups (p>0.05). Muscle oxygenation (NIRS) did not differ pre-training vs post-training (p>0.05). 
Conclusion: VO2peak-cycling can be improved through maximal power cycling training over a 5-day 




Maximal oxygen uptake (VO2max) and lactate threshold oxygen consumption (LTVO2) are 
predictors of endurance performance among athletes (Tanaka et al. 1993, Coyle 1995, Coyle 1999, 
Bassett et al. 2000, Joyner et al. 2008). Adaptations to endurance training that lead to 
improvements in VO2max are primarily central in nature (i.e. increases in stroke volume and cardiac 
output) which effect the delivery of blood and, more specifically, oxygen to the working muscles 
(Ekblom et al. 1968, Saltin et al. 1968). Peripheral adaptations (i.e. mitochondrial density and 
increased capillarization) with endurance training play a smaller role in influencing VO2max, but 
are still significant determinants of submaximal performance (i.e. LTVO2) (Holloszy et al. 1984, 
Saltin 1985, Bassett et al. 2000). While VO2max sets the upper limit of submaximal endurance 
performance, the determinants of LTVO2 are complex and represent a combination of central and 
peripheral adaptations that lead to improvements in oxygen delivery and muscle oxidative capacity 
(Holloszy et al. 1984, Coyle 1995, Bassett et al. 2000).  
VO2max is specific to the mode of exercise used in training and the recruitment of a large 
enough quantity of muscle to surpass the ability of the cardiovascular system to deliver blood and 
oxygen to the working muscles (Tanaka 1994, Millet et al. 2009). Untrained individuals and 
experienced runners have values ~10% lower on a cycle ergometer (i.e. VO2peak-cycling) compared 
with treadmill running (Astrand et al. 1961, Withers et al. 1981, Mikesell et al. 1984). Compared 
with running, the lower VO2peak-cycling has been attributed to lower cardiac output and/or lower 
arteriovenous oxygen difference (A-VO2difference) (Hermansen et al. 1969, Hermansen et al. 1970, 
Faulkner et al. 1971). However, VO2peak-cycling values may also be due to lower total muscle mass 
used while cycling compared with running and thus a less than maximal stress on cardiac output 
(Faulkner et al. 1971). In support of this, VO2peak-cycling has been shown to be higher when untrained 
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men perform maximal testing on a cycle ergometer while standing as compared with sitting, which 
was attributed to greater total active muscle mass (Tanaka et al. 1987).  
Non-cyclists can have a relatively low LTVO2-cycling compared with running, suggesting that 
test specificity or prior experience in the exercise modality plays an important role in determining 
LTVO2 (Mazzeo et al. 1989, Bouckaert et al. 1990). Some high LTVO2-cycling cyclists display less 
vastus lateralis glycogen depletion during exercise compared with low LTVO2-cycling cyclists. This 
has been attributed to differences in cycling technique, specifically, that high LTvo2-cycling cyclists 
are theorized to place less stress on knee extensors (Coyle et al. 1988). Recently, near-infrared 
spectroscopy has been used to determine muscle oxygenation and deoxygenation of the vastus 
lateralis (Skovereng et al. 2016, Skovereng et al. 2016), which has served as an indicator of the 
physiological stress placed on the working muscle during exercise. With this method, the 
breakpoint in muscle deoxygenation has been shown to correspond with LTVO2-cycling  (Wang et al. 
2012). Therefore, in addition to the typical predictors of LTVO2 (i.e. mitochondrial 
number/activity), LTVO2-cycling might be partially explained by cycling experience and learning 
which could allow for increased amount of active muscle mass during cycling. This suggests that 
untrained individuals might improve LTVO2-cycling, and VO2peak-cycling without traditional 
physiological adaptations (i.e. increases in mitochondrial number/activity), but simply by gaining 
cycling experience. However, to date, no study has yet examined whether maximal neuromuscular 
power training increases VO2peak-cycling and LTVO2-cycling by reducing stress (i.e. HHb) on the vastii 
muscles during cycling exercise. 
 Inertial-load cycling elicits maximal neuromuscular power production in a 4 second bout 
of sprinting (Martin et al. 1997, Martin et al. 2000, McLean et al. 2012). This type of exercise 
maximally activates the muscles necessary for cycling with only small increases in oxygen 
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consumption when adequate rest is given between bouts. Recreationally active individuals 
demonstrate ~7% increases in maximal power production over ~3 training sessions performing 
repeated sprint bouts with 1-2 min rest using the inertial load method (Martin et al. 2000). This 
suggests that maximal power production while cycling is, in part, a partially learned skill that can 
be acquired relatively quickly (Martin et al. 2000). Heavy strength training has been shown to 
increase VO2peak-cycling, but this study was prolonged (10 weeks), and was accompanied by 
increases in lean body mass (Hickson et al. 1980). Therefore, it cannot be determined whether the 
increases in absolute VO2peak-cycling are attributed to increased total body mass or an improved 
ability to recruit additional muscle mass while cycling. Therefore, the present study employed a 
training protocol that would maximize neuromuscular power, minimize cardiovascular stress, and 
determine whether maximal neuromuscular power training can lead to improvements in VO2peak-
cycling and LTVO2-cycling through the improved ability to recruit additional muscle mass.  
Currently, it is unknown whether maximal power training elicits improvements in VO2peak-
cycling or LTVO2-cycling. Therefore, we propose to examine changes in VO2peak-cycling and LTVO2-cycling 
and after a short-term, inertial-load maximal power cycling training program. We hypothesize that 
recreationally trained individuals will demonstrate improved cycling VO2peak-cycling, LTVO2-cycling, 
and reduced muscle deoxygenation on their knee extensors. 
Methods 
Study Overview 
 Twenty recreationally-active, college-aged men and women without cycling experience 
were recruited to participate in this study. Subjects were randomly allocated into either a Training 
group (n=10) or a Control group (n=10) and, over a one week period, visited the laboratory either 
three (Control) or eight (Training) times. The study timeline can be found below (Figure 6).  
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Day 1,3&10: Treadmill Maximal Oxygen Consumption and Cycling Peak Oxygen Consumption 
On the first day of testing (Day 1) subjects performed an incremental treadmill VO2max-
treadmill test lasting 8-12 minutes during which time, incline was increased by 2% every 2 minutes 
(Costill 1970). VO2, VCO2, and heart rate (HR) was monitored throughout the test, and the highest 
30 second VO2 average was recorded for maximal oxygen consumption. ACSM criteria for VO2max 
was used to determine a successful VO2max-treadmill test; these criteria are: respiratory exchange ratio 
(RER) >1.1, Max Heart Rate (HRmax) ± 10 bpm of predicted maximal heart rate (Tanaka et al. 
2001), oxygen consumption plateau of £ 150 mL/min, and rating of perceived exertion (RPE) >17 
(Pescatello et al. 2014). The values for treadmill VO2max-treadmill served two purposes: 1) to confirm 
subjects have no cycling experience (compared with cycling VO2peak-cycling) 2) to determine 
workloads for the cycling lactate threshold and VO2peak-cycling testing procedures. On Day 3 & 10 
subjects performed a peak oxygen consumption test on the cycle ergometer, initial workloads were 
estimated from the results of the treadmill VO2max-treadmill test. The cycling VO2peak-cycling test on 
Day 10 used the same protocol as used during Day 3 of testing.  
Day 3&10: Lactate Threshold Testing and Muscle Deoxygenation 
 On Day 3, subjects performed a 25-minute submaximal cycling test consisting of five 5-
minute stages of progressive intensities (40,50,60,70, & 80% of VO2peak) estimated from treadmill 
VO2max-treadmilltesting. VO2, VCO2, and HR were monitored throughout the test, and averaged over 
the final minute of each stage. During the final minute of each stage approximately 1mL of blood 
was drawn from a venous catheter and used later for plasma lactate analysis. When subjects 
returned for Day 10 of testing they performed the same submaximal cycling protocol utilizing the 
workloads of Day 3.  
 37 
Respiratory and Cardiovascular Measurements During Maximal Exercise 
During exercise the participants breathed through a two-way non-rebreathing valve (Hans 
Rudolph, Kansas City, MO). Ventilation was measured via an inspiratory pneumotachometer 
attached to the two-way valve (Hans Rudolph, Kansas City, MO). Expired gas samples were taken 
from a mixing chamber which was directly connected via capillary tubing to oxygen and carbon 
dioxide analyzers (Applied Electrochemistry, Models S-3A/I and CD-3A, respectively). MOXUS 
metabolic software (Applied Electrochemistry) was then used to continuously analyze VO2, VCO2, 
and RER throughout the exercise trials. Gross efficiency was calculated as the ratio of the energy 
produced on the ergometer to the rate of caloric expenditure as previously described (Coyle et al. 
1992, Horowitz et al. 1994).  
Near-Infrared Spectroscopy (Muscle Deoxygenation) 
 Near-infrared spectroscopy (OxiplexTS TS, ISS, Champaign, IL) was used to measure 
oxygenated hemoglobin [O2Hb] and deoxygenated hemoglobin [HHb] in the vastus lateralis 
during the lactate threshold testing procedure. The chromophores of O2Hb and HHb have different 
optical properties of absorbing near-infrared light (wave length: 690 nm, 830 nm). This enables 
NIRS to measure the absolute concentrations of O2Hb and HHb in µM in real-time noninvasively 
(Ryan et al. 2012, Boone et al. 2015, Skovereng et al. 2016, Skovereng et al. 2016). NIRS serves 
as a marker of ‘physiological stress’ and was compared between testing sessions. The NIRS data 
during the last 1 minute of each stage were averaged and recorded.   
Days 4-8: Control or Training Intervention 
Control Intervention 
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Subjects in the Control group were instructed to maintain their normal diet and exercise 
programs over the course of Days 5-9. Subjects were instructed to refrain from vigorous activity 
on Day 2 and 9 of testing to minimize effects of fatigue on VO2peak-cycling testing on Days 3 and 10.  
Training Intervention 
Subjects in the Training group visited the lab on 5 successive days to perform maximal 
inertial-load cycling training (i.e.; days 5-9). For the training program, subjects performed 10 bouts 
of maximal acceleration on the Inertial Load Ergometer with 2-minutes resting recovery between 
trials. Subjects started from a resting crank angle of approximately 45° from top dead center (0°), 
and accelerated maximally for approximately 3-4 s with standardized verbal encouragement. Seat 
height was self-selected by each subject, and the same height was used for all trials. Subjects were 
instructed to remain seated throughout the duration of each bout (Martin et al. 1997). All trials 
were analyzed for absolute and relative maximal power as well as maximum pedal revolutions, 
and RPM at max power. Subjects in the Training group were instructed to maintain their normal 
diet and exercise programs in addition to completing the inertial-load training program. 
Statistical Measures 
Descriptive statistics are reported as Mean ± SE. Between group differences pre and post 
training on cycling VO2peak-cycling testing measures were compared with two-way repeated measures 
ANOVA (Treatment x Time). In order to determine differences in subject characteristics pre-
intervention, two-tailed unpaired t-tests were performed (α=0.05). Within and between group 
differences in submaximal cycling measures were compared through multiple two-way repeated 
measures ANOVA (Treatment x Work Rate). Tukey’s least significant difference test were used 




 Twenty recreationally active individuals (9 males; 11 females) were recruited to participate 
in this research study. There were no significant differences between groups in subject 
characteristics including: age, height, or weight pre-intervention (See Table 4) (p>0.05).  
Treadmill Results 
The groups were similar in absolute and relative maximal oxygen consumption during pre-
training treadmill testing (Table 4). Additionally, there were no differences in maximal heart rate 
or RPE during the treadmill test (p>0.05). However, pooled subject data revealed treadmill 
absolute VO2max-treadmill (3.47 ± 0.26 L/min) was 11.2 ± 2.9% higher than cycling VO2peak-cycling 
(3.06 ± 0.19 L/min) (p<0.05) and maximal heart rate during treadmill testing (190 ± 2 bpm) was 
4.9 ± 1.1 % higher compared with cycling peak heart rate (180 ± 2 bpm) (p<0.05). 
Inertial-Load Training Results 
In the training group, there was no treatment effect for maximal power, relative maximal 
power, or RPM @ peak power (p>0.05) (Table 5). In addition, there were no differences in average 
heart rate, average peak heart rate, or resting heart rate across days of the training protocol 
(p>0.05). The daily average heart rate during training ranged from the lowest daily average of (93 
± 8 bpm) to a high of (98 ± 2 bpm) (p>0.05. While the average peak heart rate during training 
ranged from 121 ± 3 bpm to 123 ±2 bpm (p>0.05). 
Cycling VO2peak Results 
Pre-training measures of cycling absolute VO2peak-cycling (L/min), relative VO2peak-cycling 
(mL/kg/min), RER, heart rate, work rate, or RPE did not differ between the Control and Training 
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group (Table 3) (p>0.05). The Control group did not differ in pre and post training measures during 
cycling VO2peak-cycling testing (Table 6) (p>0.05). However, in the training group, compared with 
pre, post intervention, absolute VO2peak-cycling and relative VO2peak-cycling increased by 5.9 ± 1.6% 
and 5.6 ± 1.9%, respectively (p<0.05) (Table 6). Additionally, in the training group, the maximal 
work-rate achieved during the cycling peak VO2 test increased by 6.3 ± 2.5 % (Pre: 228 ± 18 W 
vs Post: 242 ± 19W) following training (p<0.05) (ES: 0.23, p<0.05) without differences (pre to 
post-training) in maximal RER, heart rate, or RPE (p>0.05) (Table 6).  
Cycling Submaximal Responses 
Post-training LTVO2-cycling did not differ from pre-training in the Control or Training groups 
(p>0.05) (Figure 7 and Figure 8A, B). The average heart rate during LTVO2-cycling testing was not 
significantly different pre vs post-training in either the Control (Pre: 150 ± 4 vs Post: 148 ± 4, 
p>0.05) or Training groups (Pre: 144 ± 4 vs Post: 141 ± 4, p=0.07). In addition, heart rate at lactate 
threshold did not change following the intervention in either the Control (Pre: 149 ± 5 bpm; Post: 
151 ± 3 bpm) or Training group (Pre: 146 ± 5 bpm; Post: 139 ± 4bpm) (p>0.05). There was no 
significant main effect for TREATMENT in either the Control or Training group (Pre vs Post-
training) for VO2, RER, lactate, heart rate, or RPE (p>0.05) (Table 7). 
 There were no main effects for either WORKRATE or TREATMENT (pre-training vs. 
post-training) for % Sat for the Control group (p>0.05). There was a significant main effect for 
WORKRATE (p<0.05) for [total Hb], [HHb], and [O2Hb] in the Control Group(p<0.05) (Figure 9 
A-D). For the Training group, there was a significant main effect for WORKRATE for % 
Saturation, [total Hb], and [HHb](p<0.05). However, there was no significant main effect for 
WORKRATE with [O2Hb] (p>0.05). There were no significant main effects for TREATMENT 
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(pre-training vs. post-training) or significant interaction (TREATMENT x WORKRATE) for any 
of the NIRS measures (p>0.05) (Figure 10 A-D).  
Discussion 
The present study tested whether short-term inertial-load training for maximal power could 
improve measures of aerobic metabolism while cycling using measures of VO2peak-cycling, lactate 
threshold and oxygenation of the vastus lateralis. The training protocol allowed subjects to achieve 
maximal neuromuscular recruitment with minimal aerobic stress in order to determine the 
independent effects of muscle recruitment on VO2peak-cycling, lactate threshold, and oxygenation of 
the vastus lateralis. The primary findings of this study were that VO2peak-cycling (absolute and 
relative) and peak work rate were significantly improved by ~5% and ~6%, respectively, following 
short-term maximal power training. Inertial-load training had no effect on LTVO2-cycling or the 
muscle oxygenation responses to matched-work rate submaximal cycling.  
In the present study, peak oxygen consumption and peak work rate while cycling increased 
following the training intervention without measurable differences in lactate threshold or muscle 
oxygenation. In agreement with previous findings, during the pre-measurements our subjects had 
~10% lower cycling VO2peak-cycling compared with treadmill running. These differences might be 
attributed to lower total muscle mass recruitment while cycling (Tanaka et al. 1987, Tanaka 1994). 
VO2peak-cycling has previously been improved by having subjects stand during maximal cycling 
testing, likely as a result of increased muscle mass recruitment while standing compared to seated 
cycling (Tanaka et al. 1987). Additionally, prior research utilizing heavy resistance training over 
a period of 10 weeks has shown improvements in cycling VO2peak-cycling which was attributed to an 
improved ability to recruit additional muscle mass following training (Hickson et al. 1980).  
However due to the study design the subjects also increased lean body mass which could have led 
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to the improvements in VO2peak-cycling. In the current study, it is likely that the increases in cycling 
VO2peak-cycling following only 5 days of maximal power training resulted in were due to an improved 
ability to recruit additional muscle mass while cycling.  
Studies which have examined the effects of active muscle mass on VO2peak-cycling have done 
so by adding arm cycling with maximal leg cycling. Some (Gleser et al. 1974, Reybrouck et al. 
1975), but not all (Astrand et al. 1961) studies using this approach have found increases in cycling 
VO2peak-cycling from the addition of arm cycling to maximal leg cycling above that achieved with 
maximal leg cycling alone. The cycling VO2peak-cycling increase found with the addition of arm 
muscles has been attributed to increases in cardiac output (Reybrouck et al. 1975). Traditionally, 
VO2max values while cycling and running have been used to differentiate cyclists from runners and 
recreationally active individuals: well-trained cyclists can attain similar maximal oxygen 
consumptions while cycling and running while runners and recreationally active individuals have 
higher maximal oxygen consumptions while running compared with cycling. Importantly,  
Reybrouck et al. 1975 noted that VO2peak-cycling  did not increase acutely with the addition of arm 
cycling in subjects who were “conditioned for leg ergometry” (Reybrouck et al. 1975). Since our 
subjects had no cycling experience and were capable of achieving ~10% higher values of oxygen 
consumptions while running compared with cycling, it is likely the increases in cycling specific 
VO2peak-cycling following maximal power training were a result of increased muscle mass 
recruitment. However, data from the current study cannot conclusively determine if the 
improvements in VO2peak-cycling is a result of increased muscle mass recruitment attributed to 
neuromuscular training.  
 Since cardiac output was not measured in the present study, we cannot determine whether 
increases in cardiac output or A-V O2difference are responsible for the increase in cycling VO2peak-
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cycling. As previously mentioned, increasing muscle mass while cycling leads to increases in 
VO2peak-cycling  through increases in cardiac output (Reybrouck et al. 1975). However, other 
potential factors can lead to increases in cardiac output following short-term training, with the 
primary factor being plasma volume expansion. Plasma volume expansion has been shown to 
increase VO2max and time to fatigue in untrained individuals (Coyle et al. 1990). However, those 
studies which have shown increases in plasma volume following short-term endurance training 
have typically used moderate intensity exercise (60-80% VO2max) for long durations 30-120 
minutes (Convertino et al. 1980, Convertino et al. 1980, Green et al. 1991, Luetkemeier et al. 
1994). In the present study, the average heart rate while training was ~93-98 bpm suggesting that 
the cardiovascular stress during the training protocol was low. Indeed, average peak heart rate 
during the training protocol was 121-123 bpm, corresponding to 65% of maximal heart rate for 
this population. While it is unlikely that 4 second intervals with the highest heart rate at 65% heart 
rate max for a few seconds would be sufficient to generate increases in plasma volume and cardiac 
output, it cannot be ruled out.  
Previous research has suggested that in addition to VO2peak-cycling, LTVO2-cycling is also 
influenced, at least in part, by the total amount of active muscle mass while cycling (Coyle et al. 
1988). Since the inertial-load training protocol was designed to elicit maximal neuromuscular 
recruitment while cycling, we hypothesized that the duty cycle of a given motor unit would be 
reduced during submaximal exercise by having a larger pool of potential motor units following 
training. Therefore, we theorized that potential increases in the total active muscle mass 
recruitment might allow for reductions in blood lactate for a given workload as well as reductions 
in the physiological stress of the vastus lateralis, as assessed by HHb of the VL, at given 
submaximal work rate. Potential mechanisms leading to improvements in lactate threshold and 
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endurance performance are through reductions in the physiological stress placed on the vastii for 
a given absolute workload (Coyle et al. 1988). Muscle oxygenation of the vastii is related to total 
external work (watts) as well as joint specific work of the knee extensors (Skovereng et al. 2016, 
Skovereng et al. 2016). Therefore, we expected to find reduced HHb following training reflecting 
reduced physiological stress on the vastii and increased recruitment of additional muscle mass. 
Prior research utilizing heavy progressive resistance strength training alone or concurrently with 
endurance training over a period of a few weeks has found improvements in short-duration and 
long-duration cycling endurance performance in untrained and well-trained cyclists (Hickson et 
al. 1988, Marcinik et al. 1991, Vikmoen et al. 2016). This is usually, but not always, accompanied 
by improvements in lactate threshold (Marcinik et al. 1991, Vikmoen et al. 2016). Therefore, it is 
possible that the lack of training effect on lactate threshold and the NIRS responses during 
submaximal testing could be explained by the short nature of our protocol.  
Interestingly, during the inertial-load training protocol maximal power and RPM at 
maximal power remained constant across training days. Prior research from our laboratory using 
a similar subject group found improvements of ~4% in relative maximal power after only one day 
of inertial load training and another 2.5% by the third day. However, in the present study there 
were increases within the first day of testing for maximal power (W/kg) with all but the 4th and 
6th bouts having higher maximal power compared with the 1st bout. This is in accordance with 
prior research using inertial-load maximal power training which found increases in maximal power 
over the course of the first day of testing (Martin et al. 2000).  consider 
The increases in cycling VO2peak-cycling following power training were likely the result of an 
improved ability to recruit additional muscle mass, leading to greater cardiac output and oxygen 
consumption. However, the current study had no direct measure of total active muscle mass 
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limiting the ability to confirm muscle mass recruitment as the source of VO2peak-cycling 
improvements. Additionally, with no direct measure of cardiac output, we lack the ability to 
discern whether cycling VO2peak-cycling increased as a result of changes in maximal cardiac output 
or A-VO2difference. However, a strength of the present study was the low peak and average heart rate 
during maximal power training which likely minimized other training induced adaptations 
including plasma volume expansion which has been shown to increase cardiac output and VO2max 
(Coyle et al. 1990); while maximal power training still allowed for neuromuscular adaptations and 
subsequent improvements in VO2peak-cycling through increases in muscle mass recruitment. Future 
research is still necessary to determine if short-term maximal neuromuscular power training has 
the ability to increase the physiological maximum of cardiac output and/or A-V O2difference, or if 
the early changes in VO2peak-cycling following maximal power training can be attributed to a learning 
effect which increases the peak cardiac output during maximal cycling exercise as we suspect.  
To date, differences in cycling VO2peak-cycling and treadmill VO2max in individuals without 
cycling experience have been attributed to decreased muscle mass recruitment and reductions in 
cardiac outputs during cycling (Hermansen et al. 1969, Hermansen et al. 1970, Faulkner et al. 
1971). The present study demonstrates that cycling VO2peak-cycling and cycling performance can be 
improved through maximal power cycling training over a 5-day period in individuals without 
cycling experience.  
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Tables and Figures 
    
 
Figure 6. Study design. Subjects were separated into two groups (Control or Training) and 
compared during treadmill maximal and cycling lactate threshold and peak testing.  
 
 
Table 4. Descriptive statistics and treadmill VO2max testing results of the two groups (i.e. Control 
and Training) at the beginning of the study. All data are reported as Mean ± SE.  
 
Control Training Descriptives 
Age (yrs) 26 ± 1 27 ± 2 
Height (cm) 171.0 ± 4.0 171.5 ± 4.0  
Weight (kg) 76.4 ± 7.2 72.1 ± 5.5 
Sex (N) 
 
M: 4; F: 6 M: 5; F: 5 
Treadmill Running   
Absolute VO2max(L/min) 3.52 ± 0.31 3.44 ± 0.32 
Relative VO2max (mL/kg/min) 46.4 ± 2.0 48.8 ± 4.8 
Heart Rate Max (bpm) 192 ± 3 188 ± 4 






Training Group: Inertial-Load Training
Control Group: No Training Intervention
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10
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Table 5. Power and heart rate measure during the inertial-load training intervention for the 
Training group over the course of the 5 training days. All data reported as Mean ± 
SE.  
 Day 1 Day 2 Day 3 Day 4 Day 5 
Peak Power (Watts) 984 ± 121 1005 ± 114 987 ± 124 993 ± 122 994 ± 118 
Relative Max Power 
(W/kg) 
13.4 ± 0.9 13.7 ± 1.0 13.4± 1.0 13.5 ± 1.0 13.5 ± 0.9 
RPM @ Max Power 125 ± 4 128 ± 4 127 ± 3 124 ± 4 127 ± 4 
Average Heart Rate 
(bpm) 
93 ± 3 96 ± 3 95 ± 4 97 ± 2 98 ± 2 
Average Peak Heart 
Rate (bpm) 
121 ± 3 121 ± 3 122 ± 4 121 ± 3 123 ± 2 
Average Resting Heart 
Rate (bpm) 




Table 6. Cycling VO2peak testing results in both groups (i.e. Control and Training) both before 
(Pre) and after intervention (Post). All results are reported Mean ± SE.  
 Control Training 
 Pre Post Pre Post 
Absolute VO2peak-cycling 
(L/min) 2.97 ± 0.27 2.99 ± 0.27 3.16 ± 0.28 3.32 ± 0.27* 
Relative VO2peak-cycling  
(mL/kg/min) 39.2 ± 2.1 39.3 ± 2.0 44.1 ± 3.3 46.4 ± 3.3* 
RER 1.10 ± 0.02 1.10 ± 0.01 1.10 ± 0.01 1.10 ± 0.01 
Heart Rate (bpm) 182 ± 2 183 ± 1 179 ± 3 181 ± 3 
Work Rate (W) 217 ± 19 224 ± 20 228 ± 18 242 ± 19* 
RPE 18 ± 0 18 ± 0 18 ± 0 18 ± 0 
 




Figure 7. Lactate threshold oxygen consumption (LTVO2) while cycling in the A) Control and B) 
Training groups before and after the intervention. Open bar represents group mean 
and lines represent individual subject data. No significant difference in LTVO2 



































































Figure 8. Mean blood lactate concentration during the cycling LTVO2 test in both A) Control and 
B) Training groups (Mean ± SE). Solid lines and closed symbols represent pre-
training values. Dashed line with open symbols represent post-training values. 
Blood lactate concentration generally increased with increases in work rates 
(p<0.05): a>40%; b>50%; c>60%; d>70%.
 
Table 7. Group comparisons of physiological measurements during the cycling LTVO2 test both pre and post-training (Mean ± SE).  
 Work Rate (%VO2peak-cycling)  
 40 50 60 70 80 
 Pre Post Pre Post Pre Post Pre Post Pre Post 
VO2 (L/min)           
Control 1.52 ± 0.18 1.51 ± 0.16 1.80 ± 0.21a 1.76 ± 0.19a 2.07± 0.24a,b 2.03 ± 0.22a,b 2.40 ± 0.29a,b,c 2.35 ± 0.27a,b,c 2.64 ± 0.33a,b,c,d 2.61 ± 0.29a,b,c,d 
Training 1.43 ± 0.12 1.41 ± 0.13 1.69 ± 0.15a 1.65 ± 0.16a 1.95 ± 0.17a,b 1.87 ± 0.19a,b 2.31 ± 0.22a,b,c 2.18 ± 0.24a,b,c 2.69 ± 0.27a,b,c,d 2.53 ± 0.28a,b,c,d 
Gross Efficiency (%)           
Control 13.7 ± 0.8 13.0 ± 1.1 15.6 ± 0.8 15.0 ± 1.1 17.1 ± 1.0a 16.5 ± 1.1a 18.1 ± 1.1a,b 17.4 ± 1.3a,b 19.8 ± 1.4a,b,c 18.4 ± 1.2a,b 
Training 13.6 ± 1.0 13.5 ± 0.9 15.3 ± 1.0 15.2 ± 0.9 16.7 ± 0.9a 16.6 ± 0.9a 17.2 ± 0.6a,b 17.5 ± 0.7a,b 17.3 ± 0.6a,b 17.9 ± 0.7a,b 
RER           
Control 0.93 ± 0.02 0.93 ± 0.02 0.95 ± 0.01a 0.96 ± 0.01a 0.97 ± 0.02a,b 0.98 ± 0.01a,b 0.98 ± 0.02a,b,c 0.99 ± 0.01a,b,c 1.00 ± 0.02a,b,c,d 1.00 ± 0.01a,b,c,d 
Training 0.96 ± 0.02 0.94 ± 0.02 0.97 ± 0.02 0.97 ± 0.01a 0.98 ± 0.02a 0.99 ± 0.01a,b 1.00 ± 0.02a,b,c 1.00 ± 0.01a,b,c 1.00 ± 0.02a,b,c 1.00 ± 0.01a,b,c 
Heart Rate           
Control  123 ± 4 119 ± 4 137 ± 4a 136 ± 4a 150 ± 4a,b 149 ± 4a,b 163 ± 4a,b,c 163 ± 4a,b,c 175 ± 4a,b,c,d 175 ± 5a,b,c,d 
Training 116 ± 5 113 ± 4 132 ± 5a 127 ±4a 145 ± 4a,b 141 ±4a,b 158 ± 4a,b,c 154 ± 4a,b,c 171 ± 4a,b,c,d 168 ± 4a,b,c,d 
RPE           
Control 10 ± 1 10 ± 1 12 ± 1a 12 ± 1a 14 ± 1a,b 14 ± 1a,b 16 ± 1a,b,c 16 ± 1a,b,c 17 ± 1a,b,c,d 17 ± 1a,b,c,d 
Training 9 ± 1 9 ± 1 11 ± 1a 11 ± 1a 13 ± 1a,b 13 ± 1a,b 15 ± 1a,b,c 15 ± 1a,b,c 16 ± 1a,b,c,d 16 ± 1a,b,c,d 
 
 
a=significant difference compared with 40% work rate, b=significant difference compared with 50% work rate, c=significant difference compared with 60% work rate, d= 








Figure 9. Near-Infrared Spectroscopy (NIRS) measurements pre vs post-intervention in the 
Control group (Mean ± SE). Solid lines with closed symbols represent pre-
intervention. Dashed lines with open symbols represent post-intervention. There 
were no differences pre vs post-intervention (p>0.05). However, there were 
significant differences across work rates (p<0.05) a>40%; b>50%; c>60%; d>70% 
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Figure 10. Near-Infrared Spectroscopy (NIRS) measurements pre vs post-intervention in the 
Training group (Mean ± SE). Solid lines with closed symbols represent pre-
intervention. Dashed lines with open symbols represent post-intervention. There 
were no differences pre vs post-intervention (p>0.05). However, there were 
significant differences across work rates (p<0.05) a>40%; b>50%; c>60%; d>70% 
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Chapter VI: General Summary 
The purpose of this dissertation was to identify novel factors that influence cycling lactate 
threshold (LTVO2) and peak oxygen consumption (VO2peak-cycling) in well-trained cyclists as well as 
non-cyclists. The specific aims were to determine: 1) the relative joint power contribution, muscle 
activation, and muscle oxygenation differences between high (HLT) and low (LLT) LTVO2 cyclists 
and 2) the effect of short-term (5 days) maximal power training on VO2peak-cycling in non-cyclists.  
In study 1, it was shown HLT cyclists have an increased relative hip joint power 
contribution and decreased EMG activation of the knee extensors. This agrees with the idea that 
spreading the metabolic work rate reduces lactate production because recruiting a larger mass of 
muscle for a given work rate reduces the stress per kg of muscle activated in HLT compared with 
LLT cyclists. In study 2, it was demonstrated that non-cyclists have a lower maximal oxygen 
consumption while cycling (i.e. VO2peak-cycling) compared with treadmill running (i.e. VO2max) and 
maximal-power training effectively increased VO2peak-cycling. This type of training required 
maximal neuromuscular recruitment while limiting the cardiovascular training stimulus, and 
therefore any changes found in VO2peak-cycling following the training program were likely a result of 
an increased ability to recruit additional muscle mass while cycling. Taken together these studies 
suggest both submaximal LTVO2 in trained cyclists and peak oxygen consumption (VO2peak-cycling) 
in non-cyclists can be influenced by ‘cycling strategy’ of muscle recruitment. Future studies should 
directly assess the changes in relative joint power contribution and active muscle mass recruitment 
following traditional aerobic exercise regimens and the role they play in LTVO2 and VO2max. This 
is especially important in studies which have non-cyclists begin a cycling aerobic training 






In summary, in well-trained and non-cyclists, both LTVO2 and VO2peak are influenced by 
the cycling strategy. These findings provide guidance for future research integrating physiological 







Chapter VII: Review of Literature 
DETERMINANTS OF CYCLING ENDURANCE PERFORMANCE 
Endurance cycling performance is primarily determined by the oxygen consumption at 
lactate threshold (LTVO2) which is largely a function of maximal oxygen uptake (VO2max) and 
skeletal muscle oxidative capacity. The power/velocity that an athlete maintains during 
competition is influenced by the integration of physiological and biomechanical factors. 
Identifying novel factors that determine an individual's VO2max and LTVO2 has wide-ranging 
implications for cycling performance (Coyle 1995, Joyner et al. 2008). 
Maximal aerobic capacity sets the upper limit of endurance performance. Endurance 
performance can be predicted by an individual’s VO2max in a heterogeneous group of athletes 
(Farrell et al. 1979). However, a weak relationship between VO2max and endurance performance 
exists when VO2max is homogenous among subjects (Coyle et al. 1991). Instead, the LTVO2 that 
can be sustained for the duration of the endurance event dictates performance when VO2max is 
homogenous across subjects (Coyle et al. 1991).  
For endurance events lasting longer than five minute the majority of the race is performed 
below an individual's VO2max. Endurance athletes can exercise for long periods of time at a steady 
state value of oxygen consumption with little accumulation of blood lactate so long as the intensity 
remains low (i.e. below 70% of VO2max) (Costill et al. 1973). It has been previously shown that 
LTVO2 is significantly related to endurance performance, and is a better indicator of endurance 
performance when the VO2max of a group of  athletes becomes more homogeneous (Coyle et al. 
1991). As endurance athletes progress through training they can improve VO2max and LTVO2 
(Hickson et al. 1977, Hickson et al. 1981); these improvements are a result of cardiovascular and 






Maximal oxygen consumption (VO2max) is the highest rate at which the body can use 
oxygen during intense, whole body exercise, and is frequently used as an indicator of 
cardiorespiratory fitness(Astrand et al. 1961). Factors central (i.e. pulmonary diffusing capacity, 
cardiac output, and oxygen carrying capacity of the blood) and peripheral (i.e. skeletal muscle 
oxidative capacity) in nature determine VO2max (Bassett et al. 2000). This review will discuss those 
factors limiting VO2max in apparently healthy individuals exercising at sea level, as well as the 
ability of VO2max to determine endurance performance.  
Cardiac Output 
Differences in VO2max between untrained and trained individuals is largely due to 
differences in maximal cardiac outputs, with higher VO2max values seen in trained individuals 
(Saltin et al. 1968). The higher cardiac outputs in trained compared with the untrained state are 
due to variations in stroke volume rather than variations in maximal heart rate (Ekblom et al. 1968). 
Less of the variation in VO2max is due to oxygen extraction by active skeletal muscle as little 
differences in oxygen extraction exist between trained and untrained individuals. Therefore, the 
large increases in VO2max which occur following aerobic endurance training are accompanied by 
increases in maximal cardiac output, with only small changes in A-VO2difference (Ekblom et al. 1968, 
Saltin et al. 1968, Saltin 1985). 
Available evidence suggests cardiac output is the primary limiter of VO2max in healthy 
individuals. During single leg knee extensor exercise the oxygen uptake of the knee extensors is 
2-3 times greater than knee extensor oxygen consumption during whole body maximal exercise 
(Saltin et al. 1976). During whole body exercise, working skeletal muscle has the capacity for 
increasing blood flow and oxygen consumption beyond the capacity of the heart (i.e. cardiac 






rather than the ability of the mitochondria to consume oxygen. Taken together, this data further 
indicates maximal cardiac output is the principle factor limiting VO2max in healthy individuals.  
Mitochondrial Adaptations 
Following endurance training a ~2-fold increase in mitochondrial enzyme activity is 
associated with only a ~30% increase in VO2max (Saltin et al. 1977). Rather, the increases in 
mitochondrial enzymes following training results in increases fat oxidation and decreases lactate 
production, for a given work rate, as opposed to improvements in VO2max (Holloszy et al. 1984). 
This is consistent with the theory that VO2max is limited by oxygen delivery (i.e. cardiac output) 
rather than oxygen utilization (i.e. mitochondrial adaptations). Further, the mitochondrial 
adaptations following endurance training have larger effects on endurance performance rather than 
VO2max, as athletes with similar VO2max values can vary up to two-fold in mitochondrial enzymes 
(Coyle et al. 1991). Mitochondrial adaptations and their relationship to endurance performance 
and submaximal exercise will be discussed in detail later in this review.  
Differences in VO2max between Cycling and Running 
 In recreationally active individuals VO2max on a cycle ergometer is ~10% lower than the 
VO2max achieved during treadmill running (Astrand et al. 1961, Withers et al. 1981, Mikesell et al. 
1984). It is generally accepted that the lower VO2max while cycling compared to running is due to 
less active muscle mass while cycling. Importantly, the reduced muscle mass recruitment while 
cycling likely results in a reduced cardiac output leading to lower VO2max  (Faulkner et al. 1971, 
Reybrouck et al. 1975). However, research investigating whether differences in VO2max between 
cycling and running are a result of reduced cardiac output or A-VO2difference have found mixed 






When comparing VO2max between treadmill running and cycling, among well-trained 
runners and cyclists it appears that training significantly influences the maximal capacity achieved 
with each test (Millet et al. 2009). Trained runners tend to have higher VO2max values while 
treadmill running compared to cycling, while trained cyclists can achieve VO2max values while 
cycling approaching or equaling those while treadmill running (Millet et al. 2009). Therefore, that 
ability of well-trained cyclists to reach high VO2max values while cycling has been attributed to 
their ability to recruit large muscle mass while cycling (Tanaka et al. 1987, Tanaka 1994). 
Additionally, in individuals with VO2max values that are lower on a cycle ergometer compared to 
treadmill running increasing the maximal values of cardiac output and/or A-VO2difference per se are 
not necessary for improvements in the VO2max while cycling. Rather, the ‘narrowing of the gap’ 
between cycling VO2max and treadmill VO2max, can be achieved through increases in muscle mass 
recruitment leading to increases in peak cardiac output while cycling.  
Endurance Performance 
 Endurance performance can be predicted by VO2max among individuals with heterogeneous 
VO2max values (Bassett et al. 2000, Joyner et al. 2008). However, individuals with homogenous 
VO2max values restricts the range of VO2max values and therefore the ability for VO2max to predict 
endurance performance (Coyle et al. 1988, Coyle et al. 1991). Rather, among athletes with similar 
VO2max the ‘performance VO2,’ or highest steady state of oxygen consumption that can be 
maintained for the duration of the endurance event, is the primary predictor of performance (Coyle 
et al. 1988). 
Oxidative Capacity and Lactate Threshold 
As exercise intensity increases blood lactate concentration progressively increases as 






to drive metabolic reactions in the cell to meet the demand of the exercising muscle. The increase 
in ADP concentration increases glycolysis and carbohydrate oxidation leading to accumulation of 
pyruvate and NADH, and subsequently and increase in lactate production/accumulation (Holloszy 
et al. 1984). Improving skeletal muscle oxidative capacity through endurance training delays the 
production and subsequent accumulation of lactate for a given submaximal work rate leading to 
increases in lactate threshold (Ivy et al. 1980, Holloszy et al. 1984). Therefore, increases in lactate 
threshold are accomplished primarily through the increased oxidative capacity of skeletal muscle 
(Ivy et al. 1980).  
A muscle’s oxidative capacity and it’s absolute and relative lactate thresholds are highly 
correlated (Ivy et al. 1980). Improved oxidative capacity in response to chronic endurance training 
is due to increases in mitochondria number, size, and enzyme activity in response to chronic 
endurance exercise (Holloszy 1967, Holloszy 1973, Ivy et al. 1980). These mitochondrial 
adaptations lead to increased pyruvate and fat oxidation at both relative and absolute work rates 
eliciting reduced carbohydrate oxidation in the trained state (Holloszy 1973, Holloszy et al. 1976, 
Holloszy et al. 1984).  
The absolute oxygen requirements for a given submaximal work rate may be similar 
between trained and untrained individuals, but there can be more than a two-fold difference in 
muscle oxidative capacity. Thus, to maintain the same rate of oxygen utilization, the oxidative 
work done per mitochondria is less in trained individuals. Consequently, lower ADP concentration, 
higher ATP, and higher phosphocreatine concentrations are present in trained muscle at the same 
absolute work rates (Karlsson et al. 1972). As a result of the higher ATP/ADP ratio skeletal muscle 
glycolysis is less activated, allowing well-trained athletes to exercise at higher relative work rates 






1984). Additionally, research examining the adaptations to detraining have shown parallel 
decreases in oxidative enzyme capacity and LTVO2, further supporting the role of skeletal muscle 
oxidative capacity in determining LTVO2 (Coyle et al. 1985).  
Due to the tight coupling of oxidative capacity and LTVO2 researchers have suggested that 
skeletal muscle fiber type may determine differences in LTVO2 of endurance athletes. In untrained 
individuals, the oxidative capacity of Type I muscle fibers is nearly double that of Type II 
suggesting fiber type composition may play a role in determining LTVO2 in an untrained population 
(Chi et al. 1983). In fact, long distance runners tend to have a greater percent Type I fiber compared 
with sprinters (Gollnick et al. 1972). However, the oxidative capacity of Type I & Type II fibers 
are similar in well-trained endurance athletes suggesting fiber type percentage plays little to no 
role in determining LTVO2 in this population (Figure 11)(Chi et al. 1983).  
 
 
Figure 11. Oxidative capacity comparisons of Type I and Type II fibers in well-trained 
endurance athletes (Chi et al. 1983).  
 In summary, the two primary physiological adaptations to endurance training are increases 
in the oxygen delivery to and oxidative capacity of the skeletal muscle leading to improvements 
















































of athletes, but less predictive in a group of well-trained athletes that present with similar maximal 
oxygen consumption (Coyle et al. 1991). Furthermore, LTVO2 is coupled to skeletal muscle 
oxidative capacity as evidenced by parallel decreases in oxidative enzyme capacity and LTVO2 
following detraining (Coyle et al. 1985). Although improvements in oxidative capacity explain a 
large percentage of adaptations to endurance training, muscle recruitment, active muscle mass, and 
mode of exercise appear also to play a role in determining and endurance athletes LTVO2. 
Motor Unit Recruitment and Lactate Threshold 
Available evidence suggests that the appearance of lactate in the blood occurs in 
conjunction with a progressive recruitment of larger motor units (i.e. motor units with greater 
glycolytic capacity). Compelling evidence for this phenomenon is demonstrated by a non-linear 
increase in integrated EMG signal corresponding to the point of blood lactate threshold in cycling 
and running (Nagata et al. 1981, Taylor et al. 1994). It has been hypothesized that increased 
recruitment and/or increased firing of fast glycolytic muscle fibers leads to increases in integrated 
EMG signals. A progressive recruitment in this fiber type would lead to an increased lactate 
production for a given work rate due to the lower oxidative capacity, greater glycolytic capacity, 
and reduced mitochondrial density of the fast glycolytic fibers compared with slow oxidative fibers 
in untrained subjects (Gollnick et al. 1972). Since trained athletes have similar oxidative capacity 
in both fiber types it is unlikely that a progressive recruitment of Type II fibers leads to increased 
production of lactate, as prior research has shown Type II fibers are recruited even at low exercise 
intensities and their selective recruitment does not lead to accumulation of lactate (Ivy et al. 1987). 
Furthermore, with sufficient stimulus isolated preparations (without fast glycolytic fibers)  show a 
clear lactate threshold (Connett et al. 1986), suggesting the increased iEMG may be a consequence, 






the relative intensity of contraction and activation timing, it is unable to determine the amount of 
muscle used or the physiological stress placed on the working muscle. Therefore, using EMG data 
in conjunction with markers of physiological stress might allow for a more comprehensive 
understanding of muscle recruitment and lactate threshold. 
Muscle Mass Utilization and Lactate Threshold 
Much like the way in which increasing the mitochondria content allows for reduced 
oxidative work per mitochondria, the distribution of power to a greater percentage of muscle mass 
should, in theory, increase the number of active mitochondria performing oxidative metabolism. 
This, in turn, would reduce the oxygen demand per mitochondria, decrease reliance on 
glycogenolysis, and lower overall lactate production during submaximal exercise (Coyle et al. 
1988).  
In support of this hypothesis, it’s been found that well-trained cyclists with high LTVO2 use 
approximately 1.8kg more muscle mass during cycling compared with low LTVO2 cyclists despite 
having similar VO2max. The muscle mass used (kg) explained approximately 20% of the variance 
in the LTVO2 (Coyle et al. 1988, Coyle 1995). The authors attributed the increased LTVO2 to the 
improved ability to “spread the work” to a greater amount of muscle mass noting the greater 







Previous research has compared lactate response between exercise involving varying 
amounts of muscle mass (Davis et al. 1976, Neary et al. 1986, Richter et al. 1988, Savard et al. 
1989). Lactate concentration is higher for a given work rate in 1-leg vs 2-leg cycling (Neary et al. 
1986) (Figure 12), which is partially explained by the usage of more muscle mass (Richter et al. 
1988). However, studies have shown similar LT%VO2 between 1-leg and 2-leg cycling suggesting 
active muscle mass plays little role in determining lactate threshold  (Stamford et al. 1978). Rather, 
the mode of exercise is likely a more relevant factor in determining LTVO2 (Davis et al. 1976).  
When comparing arm cycling, leg cycling, and treadmill running LT%VO2 has been shown to occur 
46%, 63%, and 58% respectively (Davis et al. 1976). In addition, well-trained cyclists exhibit 
lower LTVO2 when running on level ground compared to cycling, suggesting that running is a 
learned skill (Mazzeo et al. 1989, Bouckaert et al. 1990) and uses different muscles than cycling 
(Costill et al. 1971, Costill et al. 1974, Costill et al. 1976). However, well-trained cyclists running 
on a 10% incline demonstrate a comparable LTVO2 to that seen while cycling (Coyle et al. 1988) 
due to the similarities in muscle groups used during uphill running and cycling (Costill et al. 1974).   
The distribution of muscle mass contributing to power accomplished should be viewed in 
a separate context to the electromyographic examination of muscle activity. EMG has been used 






to examine the extent of motor unit recruitment during progressive increases in endurance exercise 
intensity and its relationship to blood lactate threshold; however, EMG fails to quantify the volume 
of muscle mass activated. Additionally, the increase in EMG associated with lactate threshold 
could be a result of the decreased pH which reduces force production of individual motor units, 
signaling increased motor unit recruitment to compensate for the reduced force (Nagata et al. 
1981).  
 Muscle Utilization Patterns During Exercise 
Exercise intensity, training status, and fiber type all play a role in determining glycogen 
utilization of the working muscle. However, due to the invasive nature of muscle glycogen 
assessment via muscle biopsies few studies have examined differences between muscle groups 
during exhaustive exercise. Those studies that have examined glycogen usage between muscles 
have found that glycogen depletion is related to the involvement of the particular muscle in 
performing work (Costill et al. 1971, Costill et al. 1971, Costill et al. 1974).  
Glycogen usage occurs at all exercise intensities and increases progressively as the 
intensity of exercise increases. Moderate intensity exercise (i.e. ~65% of VO2max) performed to 
exhaustion (~2-3 hours) can markedly reduce muscle glycogen. However, high intensity exercise 
(I.e. 90% of VO2max), which can typically only be performed for 30-60 minutes, also shows 
reductions in glycogen equal to that observed with long duration, moderate intensity exercise. 
Additionally, in regards to glycogen depletion, fiber types respond differently to exercise intensity 
and duration. Type I fibers are used throughout all exercise intensities and demonstrate reduced 
glycogen levels during exercise of moderate and high intensity (Gollnick et al. 1973, Gollnick et 
al. 1973, Gollnick et al. 1974). However, Type II fibers appear to lose glycogen only during 






Gollnick et al. 1973). Additionally, as exercise intensity increases above 90% VO2max Type II will 
reduce their glycogen content as much as, or more than, Type I fibers (Gollnick et al. 1974); this 
suggests that Type II are recruited during exhaustive, moderate intensity exercise and short periods 
of high intensity exercise.               
Variations in glycogen depletion are not limited to differences in exercise intensity, 
exercise duration, or fiber type. Glycogen depletion varies between active muscles which 
contribute different amounts of work to the exercise task. It was once thought that distance running 
to exhaustion did not result in complete glycogen depletion, as significant decrements in muscle 
glycogen levels of the vastus lateralis were not seen with endurance running (Costill et al. 1971, 
Costill et al. 1971); whereas cycling elicited large decreases in muscle glycogen at the same 
relative exercise intensity in the vastus lateralis  (Coyle et al. 1988). However, the studies 
examining runners assumed sampling from the vastus lateralis was appropriate due to the large 
reductions seen in cycling. When directly comparing glycogen use of the vastus lateralis during 
level and uphill running the glycogen depletion of the vastus lateralis during uphill running is 
elevated compared to level running suggesting total work performed by the vastus lateralis during 
level running is reduced (Costill et al. 1974). Therefore, studies using both cycling and running 
protocols to determine VO2max and LTVO2 should have the athletes run uphill to utilize similar 
muscles recruited during cycling. This uphill protocol has been used as an indicator of cycling 
skill, as low LTVO2 while cycling and high LTVO2 while uphill running indicate that those athletes 
have the capacity for a higher cycling LT, yet something is preventing a high LTVO2 while cycling 
(Coyle et al. 1988). Although direct determination of muscle glycogen via muscle biopsy provides 






researchers have used a non-invasive technique to determine oxygenation status of working muscle 
which provides an indication of the physiological stress of the muscle while exercising.  
Muscle Oxygenation During Cycling 
Near-infrared spectroscopy (NIRS) is a non-invasive method used to assess oxygenation 
status of working skeletal muscle. The chromophores of O2Hb and HHb have different optical 
properties of absorbing near-infrared light and can be detected with NIRS. The initial amplitude 
of light from the NIRS transmitter is attenuated by the HHb within tissue and the resultant 
amplitude is influenced by the absorption coefficient, concentration of the tissue, and distance, in 
accordance with the Beer-Lambert law. After being detected by the receiver, the index of the 
regional deoxygenation status is converted to Hb, allowing for the determination of the absolute 
concentration of oxygenated hemoglobin (O2Hb) and deoxygenated hemoglobin (HHb). Further, 
percent saturation (%Sat) is calculated by the ratio of O2Hb and the total Hb concentration 
(THb)=O2Hb + HHb.  
Concentrations of oxygenated (O2Hb) and deoxygenated (HHb) hemoglobin reflect the 
balance between O2 delivery and O2 consumption at the muscle level. NIRS has been used 
previously to determine the relative physiological stress placed (i.e. ∆ in HHb) on the muscle in 
response to changes in work rate (Skovereng et al. 2016) and cadence (Boone et al. 2015, 
Skovereng et al. 2016) during cycling.  
Moreover, NIRS has previously been used to detect the relationship between local 
physiological stress (i.e. HHb) and muscle activation (i.e. iEMG). Despite a linear increase in 
iEMG with increasing work rates HHB plateaus at high work rates suggesting changes in HHb are 






at the local level (Chin et al. 2010). In this context, NIRS can be used as an indicator of 
‘physiological stress’ at the muscle level. 
BIOMECHANICS OF CYCLING 
Muscle Activity While Cycling 
Surface electromyography (EMG) has been used to measures changes in muscle activation 
during cycling in response to changes in saddle height (Ericson et al. 1985), cadence (Ryan et al. 
1992, Marsh et al. 1995, Neptune et al. 1997, MacIntosh et al. 2000, Baum et al. 2003), work rate 
(Ericson 1986, Ryan et al. 1992, MacIntosh et al. 2000), and cycling skill level (Chapman et al. 
2006, Chapman et al. 2008, Chapman et al. 2009).During steady state cycling, muscle activation 
occurs in a predictable, cyclical fashion reflective of the movement itself, with activation and 
deactivation of lower extremity muscles occurring in specific regions of the crank cycle. By 
determining the crank location at top dead center (TDC) and bottom dead center (BDC) EMG 
profiles can be obtained as a function of time expressed in a percentage of the total duration of the 
crank cycle. Knee extensors (e.g. vastus lateralis (VL), vastus medialis (VM), and rectus femoris 
(RF)) are first activated close to top dead center (e.g. ~0°/TDC of crank cycle). Hip joint extensors 
(e.g. gluteus maximus (Gmax)) activate later in the crank cycle (e.g. 90° of crank cycle) (Hug et 
al. 2009). A majority of the mechanical energy produced during the down stroke (~86%) is 
accomplished primarily from the gluteus maximus and the vastii muscle groups (Neptune et al. 
1997, Raasch et al. 1997, Neptune et al. 2000). However, only 55% of the energy produced by the 
gluteus maximus and vastii are directly delivered to the crank, rather 45% of the energy is delivered 
to the limbs (Raasch et al. 1997, Neptune et al. 2000). A combination of plantar flexor and knee 
flexor activation occurs towards the bottom of the down stroke (e.g. 180°/BDC of crank cycle) 






towards the acceleration of the crank (Gregor et al. 1991, Neptune et al. 1997, Raasch et al. 1997, 
Hug et al. 2009).  
Activation timing appears to be little influenced by changes in power output (Jorge et al. 
1986). However, pedaling rate appears to have a large influence on activation timing of lower 
extremity muscles. As pedaling rate increases a general shift in peak activity to earlier in the crank 
cycle occurs (Marsh et al. 1995), with onset and offset timing appearing earlier in the Gmax, BF, 
RF, and VM (Neptune et al. 1997). Although activation timing provides useful information as to 
when muscle is active while cycling, EMG is less informative regarding the relative intensity of 
muscle activation. The intensity of muscle activation during pedaling is typically quantified by 
taking the root mean square (RMS)(Dorel et al. 2009) or integrated EMG (iEMG) (Ericson et al. 
1985, Takaishi et al. 1998) of the raw EMG data and normalizing the values to maximum value to 
account for between subject differences in raw EMG values (Hug et al. 2008, Hug et al. 2009).  
Increases in work rate (i.e. increased resistance by ergometer) elicit dramatic changes in 
EMG activity of select lower limb muscles while cycling (Ericson 1986, MacIntosh et al. 2000, 
Hug et al. 2009). Constant-load exercise performed at different intensities while controlling for 
cadence and fatigue allows for accurate comparison of changes in muscle activity across work 
rates. Large increases in muscle activity of the primary muscles used while cycling (i.e. gluteus 
maximus, vastus lateralis, rectus femoris, vastus medialis, and biceps femoris) were found when 
work rate was progressively increased from 120-240W. Similarly, increasing work rate elicits 
large increases in gluteus maximus activity as well as increases in total lower extremity joint 








 Figure 13. Gluteus maximus EMG activity with changes in cadence and work rate 
(MacIntosh et al. 2000). 
 
Figure 14. Changes in total lower extremity muscle activity in response to changes in cadence 
and work rate. Lines represent power outputs of 100,200,300, & 400 watts from 
bottom to top, respectively  (MacIntosh et al. 2000). 
Muscle activity is not only influenced by the mechanical load, but the interaction of 
cadence and work rate while cycling as well (Marsh et al. 1995, MacIntosh et al. 2000). There 
have been large discrepancies in the literature regarding the EMG response to increased cadence 






changes while cycling are influenced by the power output at which the subject is cycling,  which 
could help explain the discrepancies in the effects of cadence on muscle activation seen in previous 
studies (MacIntosh et al. 2000). When cycling at relatively low power outputs, increases in cadence 
and muscle activation for most lower extremity muscles are linearly related (Ericson et al. 1985); 
however, at higher work rates (300-400W) increasing cadence decreases activation of the VL and 
Gmax (Lucia et al. 2004), as well as total lower extremity muscle activation (MacIntosh et al. 
2000). Therefore, it has been hypothesized a minimal muscle activation for a given work rate 
occurs and can be influenced by cadence.  
Joint Contribution While Cycling 
External work rate increases elicit increases in the absolute joint power of the hip, knee, 
and ankle (Elmer et al. 2011, Skovereng et al. 2016). However, the relative contribution of the hip, 
knee, and ankle to total lower extremity power have differing responses to increases in work rate  
(Elmer et al. 2011, Skovereng et al. 2016, Aasvold 2017). Relative hip joint contribution has been 
shown to increase (Skovereng et al. 2016, Aasvold 2017) or remain constant (Elmer et al. 2011) 
with increases in work rate. Relative knee extensor contribution decreases as the external work 
rate increases (Elmer et al. 2011, Skovereng et al. 2016), and the relative ankle contribution 
remains constant with changes in work rate despite increases in absolute ankle power with 
increasing work rates (Elmer et al. 2011, Skovereng et al. 2016, Aasvold 2017). The largest 
contributors to power generation during cycling comes from the muscles of the hip and knee joints 
(Raasch et al. 1997, Neptune et al. 2000, Korff et al. 2009, Martin et al. 2009, Skovereng et al. 
2016). While the total joint power generated from the hip and knee extensors increases linearly 






relative knee contribution decreases with increasing work rate in trained cyclists (Skovereng et al. 
2016).  
Cadence has varying effects on relative joint contribution during cycling and is largely 
dependent on the work rate selected to assess cadence. Prior research has found decreases in the 
hip joint specific power and increases in knee joint-specific power with increased cadences in 
recreational cyclists (Skovereng et al. 2016), which is in agreement with research in which both 
professional and recreational cyclists were compared (Aasvold 2017). However, others have found 
increased absolute and relative joint contribution from both the hip and knee joints when 
combining high cadences with maximal work rates (McDaniel et al. 2014) or no difference in 
absolute or relative hip or knee contribution with increased cadence (Bini et al. 2010). The 
discrepancies between studies are likely due to the work rates utilized: with high cycling cadence, 
hip joint specific power is decreased with low work rates and increased with high work rates 
(McDaniel et al. 2014, Skovereng et al. 2016). The decrease in the hip joint power at low work 
rates is in line with EMG data of the gluteus maximus: with high cycling cadence, gluteus maximus 
activity is decreased with low work rates and increased with high work rates (MacIntosh et al. 
2000). Therefore, to determine the independent effect of cycling experience or work rate on 
relative joint contribution during submaximal cycling researchers should control for cadence to 
minimize the effects on relative joint contribution.  
Joint Contribution and Cycling Experience 
Determining changes in the relative joint contribution in response to changes in work rate 
or cadence play an important role in identifying how the body accommodates changes in cycling 
task demands; however, comparing individuals’ relative joint contribution may provide insight in 






determine relative joint contribution between groups of individuals have focused on ‘cycling skill’ 
typically defined as an individual who is an experienced or novice cyclists or by comparing cyclists 
to triathletes (Hoshikawa 2007, Bini et al. 2014). While cycling at a constant work rate, 
experienced cyclists have a lower relative contribution from the hip and higher relative knee 
contribution compared with recreationally active individuals (Hoshikawa 2007). However, the 
work rate chosen by Hosikawa 2007 was 200W, which is a relatively high work rate for the 
recreationally active subjects and a relatively low work rate for experienced cyclists. Therefore, 
differences in relative joint contribution could be due to experienced cyclists generating the 
necessary power by utilizing primarily the knee extensors, while recreational active individuals 
would rely more on both the hip and knee joints to produced power since it is closer to their 
maximal intensity and relative hip and knee joint contribution increase with increases in work rate 
(Skovereng et al. 2016).  
Studies which have examined differences in relative joint contribution between cyclists 
and triathletes have found no difference in hip contribution or knee contribution between groups 
at higher work rates; closer to what would be experienced in a race (i.e. ~275 Watts) (Bini et al. 
2014). Recently, researchers have compared differences in relative joint contribution between 
professional (i.e. Continental/World Tour) cyclists with recreational riders with prior cycling 
experience while exercising at similar relative work rates (i.e. 55, 85, and 100% LTwatts) (Aasvold 
2017). The professional riders had higher relative hip and lower relative knee joint contribution at 
all work rates compared to the recreational riders, which suggests well-trained riders develop a 
strategy consistent with increasing hip contribution and decreasing knee contribution as they 
become more skilled (Aasvold 2017). Due to the large differences in athletic ability between 






recreational cyclists (~275 W) were likely a result of differences in maximal capacities of oxygen 
delivery and/or consumption rather than differences in a joint contribution (Aasvold 2017).  
 
Future Directions 
Prior research comparing subjects based on ‘cycling skill’ have done so with binary 
definitions of skill (i.e. cyclists or non-cyclists), years of cycling experience (i.e. 
competitive/professional vs novice/recreational), or competitive athlete type (i.e. cyclist vs 
triathlete). When comparing individuals  based on ‘skill’, subject populations can have large 
differences in VO2max and/or LTVO2 capabilities (Aasvold 2017) or researchers have often failed to 
report VO2max, LTVO2, or both (Hoshikawa 2007, Bini et al. 2014). To date, no study has 
systemically controlled for both VO2max and varied LTVO2 of well-trained cyclists while 
determining relative joint power contribution. Controlling for these factors would allow for relative 
joint contribution to be compared at similar absolute and relative work rates, minimizing the 
confounding effects of work rate on relative joint contribution. This would allow researchers to 
compare joint power differences in athletes with similar VO2max capabilities but who vary on 
LTVO2 while cycling to determine if higher or lower LTVO2 are associated with a specific cycling 
strategy (i.e. do high LTVO2 cyclists have a higher relative hip contribution compared to low LTVO2 
cyclists, similar to the differences found between elite and recreational cyclists(Aasvold 2017) and 
in agreement with hypotheses put forward by others (Coyle et al. 1988, Bassett et al. 2000, Millet 
et al. 2009)?). Although joint power calculated through inverse dynamics has often been used 
interchangeably to describe biomechanics associated with muscular power, these joint power 
calculations are independent of the mechanical energy expenditure of working muscles during 






1998, Kautz et al. 2002). Therefore, electromyography and/or near-infrared spectroscopy can be 
used in conjunction with joint power calculations to determine the relative joint contribution during 
submaximal cycling and the effects on muscle/oxygenation and metabolic stress. 
 

















During exercise the participants breathed through a two-way non-rebreathing valve (Hans 
Rudolph, Kansas City, MO). Ventilation was measured via an inspiratory pneumotachometer 
attached to the two-way valve (Hans Rudolph, Kansas City, MO). Expired gas samples were taken 
from a mixing chamber which was directly connected via capillary tubing to oxygen and carbon 
dioxide analyzers (Applied Electrochemistry, Models S-3A/I and CD-3A, respectively). MOXUS 
metabolic software (Applied Electrochemistry) was then used to continuously analyze VO2, VCO2, 
and RER throughout the exercise trials.  
Near-Infrared Spectroscopy 
Near-infrared spectroscopy (OxiplexTS, ISS, Champaign, IL) was used to measure 
oxygenated hemoglobin [O2Hb] and deoxygenated hemoglobin [HHb] in the vastus lateralis. NIRS 
uses the feature that the chromophores of O2Hb and HHb have different optical properties of 
absorbing near-infrared (wave length: 690 nm, 830 nm). This enables NIRS to measure the 
absolute concentrations of O2Hb and HHb in µM at real-time in noninvasive manner (Ryan et al. 
2012, Boone et al. 2015, Skovereng et al. 2016).  
Before every test, the NIRS was calibrated after 30 minutes of warm-up. Figure 15. shows 
the description of the probe designed for skeletal muscle measurements and this probe was used 
for this study. The acquisition frequency of 2 Hz was used for this study. The NIRS data was 








Figure 15. OxiplexTS NIRS Probe. 
Blood Lactate Concentration 
This protocol requires 30 min of continuous exercise at submaximal intensities (5 min at 
each stage of approximately 40, 50, 60, 70, 80, 90% of maximal oxygen consumption). The lactate 
threshold was determined from analysis of a series of blood samples obtained, between min. 4-5 
in each stage. Blood samples were immediately deproteinized by placing it in 8% perchloric acid 
and lactic acid levels were later measured on the supernatant. Enzymatic analysis was used to 
determine blood lactate concentration based on methods of Farrell et al. (Farrell et al. 1979, Coyle 
et al. 1988). The lactate threshold was defined as the exercise intensity that elicits a 1mM increase 
above baseline in blood lactate concentration (Coyle et al. 1988, Coyle et al. 1991).  
Blood lactate concentration was determine using the following procedures and enzymatic 
reactions: 
Part 1: Supplies, solutions, etc.  
Glassware  
1. Polypropylene 12x75mm test tube Qty: 2 (per blood sample)  
2. Eppendorf 1.5mL tube Qty: ((X+3)*2)  
  
Solutions and Reagents  
1. NAD (Sigma N-7004)  
2. LDH (Sigma L-3916)  
3. Hydrazine (Sigma H-9507)  
4. Glycine (Fisher G-46)  






6. Perchloric Acid (Fisher A-229 70%)  
PCA: to get 10%, take 71.42mL of 70% stock, bring up to 500mL with dH2O  
Glycine-Hydrazine Buffer for 1000mL  
0.33M glycine25.02g  
0.27M hydrazine23.98mL  
Mix and bring up to 1000mL with dH20, pH to 9.2  
Page Break  
Part 2: Sample preparation  
Step 1: Reagent Cocktail Preparation  
1. Prepare reagent cocktail- for each sample or tube  
a. 1 mL of glycine-hydrazine buffer  
b. 0.83mg of NAD  
c. 5U of LDH, if use 1000U/ml stock, need 5uL  
2. If you have X blood samples:  
a. ((X+3)*2+1)*(above recipe)  
b. Need the samples, one blank, two standards, all in duplicate, plus one extra so you have 
enough buffer for all of your samples  
  
Step 2: Blood Deproteinization  
  
1. Protective gloves, glasses, and lab coat should be used when handling blood.  
2. Exactly 0.5mL of whole blood should be immediately mixed with 1.5mL 8%PCA  
3. Vortex the tube to fully deproteinize the sample.  
4. Centrifuge at 4°C for at least 15 minutes at 3000 RPM  
5. Transfer the clear supernatant to an appropriately labeled tube.  
Lactate is stable in supernatant is stable for at least one week at 2-6°C, longer if frozen.  
 
Step 3: Supernatant/Reagent Mixture  
1. Add 1mL of reagent cocktail (see Part 2, Step 1 above)  
2. Add 50uL of 10% PCA to the Eppendorf 1.5Ml tubes for blank.  
3. Add 50uL of two lactic acid standards to std1 and std2 eppendorf 1.5mL tubes.  
4. Add 50uL of sample supernatant to sample 1 to sample N eppendorf 1.5mL tubes.  
5. Vortex each eppendorf tube  
6. Incubate tubes at 37°C for 45 minutes in shaking water bath at 60 RPM.  
 
Part 3: Sample analysis  
Step 1: Spectrophotometer & Calculations  
1. Warm the spectrophotometer for 30 minutes, read the sample at 340nM  
a. Instrument: Spectrophotometer Beckman DU-600  
b. Method: A:\LAT  
c. Read average time: 0.5s  
d. Fixed wavelength: 340nM  
e. Factor 10.13  
2. Calculations  
a. Lactate standard 40mg/100mL, 400 
b. mg/L, or 4.44mM (Sigma 826-10, now Trinity Biotech 82610)  
i. Low 10mg/100mL (1.11mM)  
ii. High 20mg/100mL(2.22mM)  






c. 1.05/0.05= cuvette d 
d.  
e. dilution (0.05mL blood in 1mL reagent cocktail)  
d.  
e.  
f. Standard concentration = Abs/6.22 x cuvette dilution= Abs x 3.38  
e. 3/1= blood dilution (0.5mL blood in 1.5mL of 10%PCA)  
f. Sample concentration= (Abs/6.22) x 1.05/0.05 x 3/1= Abs x 10.13mM  
Blood Lactate Concentration [La]=abs×10.13mM 
  
Electromyography 
Bagnoliä Desktop EMG system (Delsys INC., Natick, MA) will be used to determine 
muscle activity of the: gluteus maximus, rectus femoris, vastus lateralis, vastus medialis, biceps 
femoris, gastrocnemius, soleus, and tibialis anterior. Locations were determined based on 
recommendations of the Surface Electromyography for the Non-Invasive Assessment of Muscles 
(SENIAM) ((SENIAM). 2006). Skin sites were cleaned and shaved with an alcoholic prep wipe 
and disposable razor. Electrodes were then placed along the skin surface to run in parallel with the 
skeletal muscle fibers, and secured with double sided tape and athletic wrap. Raw EMG signals 
were smoothed using a fourth-order, band-pass Butterworth filter with a frequency range set 
between 20 and 500Hz. Onset and offset of EMG activity were determined when the signal with 
an amplitude above two standard deviations beyond the mean of the quiescent phase between EMG 
bursts (Diefenthaeler et al. 2012). All EMG data were visually inspected and data manually 
selected to determine periods of quiescence before and after EMG bursts. EMG data were 
normalized as the percentage of the highest value which occurred during testing. 
Joint Power Calculations 
Pedal Force 
Normal and tangential components of force applied to the pedal were collected using a 
custom-designed force pedal with two piezo electric force transducers (Kistler, model 9251AQ01) 






with a cutoff frequency of 10Hz (Coyle et al. 1991, Diefenthaeler et al. 2012). Data were paired to 
match the kinematic data obtained through motion analysis. Using the pedal angle obtained in the 
coordinate data, forces were transformed from the reference frame of the pedal into the inertial 
reference frame. Data were used for inverse dynamics calculations that will determine the joint 
moments/power from the hip, knee, and ankle (Hull et al. 1985, Skovereng et al. 2016, Skovereng 
et al. 2016). Data was processed using a custom MatLab (MathWorks Inc., Natick, MA, USA) 
program. 
Motion Analysis 
During this procedure, subjects will be exercising on a stationary cycle ergometer while 
wearing 3M reflective markers. The markers were secured to the subjects using double-sided tape 
and placed on 9 sites (acromion process, mid-axillary, greater trochanter, mid-femur, lateral 
epicondyle of knee, mid-shank, lateral malleolus, toe of shoe, and heel of shoe). The Vicon Nexus 
motion analysis system uses infrared technology to collect data on the position of the markers in a 
3-dimensional space and provides coordinates that were used for data processing and analysis 
(Vicon Motion Systems Ltd., Lake Forest, CA). Data were used for inverse dynamics calculations 
that will determine the joint moments/power from the hip, knee, and ankle (Hull et al. 1985, 
Neptune et al. 1995, Neptune et al. 1996, Skovereng et al. 2016, Skovereng et al. 2016). All data 
were processed using a custom MatLab (MathWorks Inc., Natick, MA, USA) program.  
Joint powers at the hip, knee, and ankle were derived using standard inverse dynamics 
techniques (Hull et al. 1985). Rigid segment models of the crank, foot, leg, and thigh were 
generated. Hip position was determined based on the location of the anterior superior iliac spine 
(Neptune et al. 1995). Linear and angular velocities and accelerations of the limb segments were 






proportions, center of mass locations, and radii of gyration will be estimated from anthropometric 
tables (de Leva 1996). Joint moments of the ankle, knee, and hip were calculated through use of 
angular accelerations of the segments, normal and tangential pedal forces, and acceleration of 
segmental center of gravity. Joint powers were then calculated by the product of joint angular 
velocities and joint moments.  
Joint reaction forces: 
 
Sum of Horizontal Forces, SFx= m.ax:  
Rxp = m.ax - Rxd ... 
(where p = proximal, d = distal joint, ay = acceleration of segment center of mass, CoM, in y 
direction; Note that d = force pedal when p = ankle) 
from Newton, Sum of Vertical Forces, SFy = m.ay:  
Ryp = m.ay + mg - Ryd ... 
Joint moment about segment CoM: 
Using motion co-ordinates: 
Mzp = Iza - Mzd - Rxp.(yp-yCoM) + Ryp.(xCoM-xp) + Rxd.(yCoM-yd) - Ryd.(xd-xCoM) ...  
where (xCoM, yCoM) are the co-ordinates of the center of mass of the segment, (xp, yp) the 

















Study 1 Individual Data: Low (LLT) and High (HLT) Lactate Threshold Cyclists Maximal 


















1 72.4 4.87 1.10 194 410 20 
2 60.0 4.00 1.08 171 335 18 
3 62.1 4.90 1.11 170 355 18 
4 68.1 4.50 1.11 181 325 17 
5 66.1 3.92 1.10 180 290 17 
6 62.1 4.21 1.09 188 295 18 
7 63.6 4.60 1.10 171 275 18 
8 64.9 4.42 1.11 180 325 18 
Mean 64.9 4.43 1.10 179 326 18 
HLT       
1 68.9 4.90 1.10 186 390 18 
2 61.3 5.30 1.11 185 313 18 
3 64.5 3.91 1.10 196 425 19 
4 65.4 4.61 1.10 190 375 18 
5 54.4 4.51 1.11 194 375 19 
6 52.9 4.46 1.14 190 360 18 
7 58.8 4.10 1.10 180 280 19 
8 56.4 4.90 1.09 198 350 18 








Study 1 Individual Data: Low (LLT) and High (HLT) Lactate Threshold Cyclists Maximal 















1 76.7 5.07 1.09 188 19 
2 61.4 4.09 1.09 168 18 
3 59.7 4.76 1.13 175 17 
4 69.9 4.69 1.10 180 17 
5 64.5 3.89 1.02 181 17 
6 64.6 4.40 1.09 189 17 
7 64.6 4.60 1.00 171 18 
8 65.7 4.50 1.09 180 18 
Mean 65.9 4.49 1.07 179 18 
HLT      
1 64.1 4.62 1.11 183 18 
2 60.2 5.05 1.11 177 18 
3 60.3 3.93 1.10 183 17 
4 60.0 4.19 1.10 173 19 
5 55.0 4.59 1.11 184 18 
6 52.9 4.46 1.15 192 19 
7 60.3 4.16 1.02 182 18 
8 56.4 4.78 0.98 197 19 









Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ oxygen 
consumption (L/min) during cycling lactate threshold testing  
  LLT Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 1.77 2.16 1.69 2.00 1.70 1.46 1.67 1.81 1.70 
50 2.10 2.54 2.02 2.01 2.21 1.57 2.13 2.20 2.13 
60 2.62 3.14 2.39 2.57 2.60 2.60 2.46 2.60 2.60 
70 3.08 3.55 2.71 3.06 3.22 3.01 2.94 3.10 3.06 
80 3.55 4.04 3.23 3.75 3.60 3.10 3.48 3.60 3.54 
90 4.03 4.64 3.63 4.45 4.11 3.50 3.93 4.00 4.04 
  HLT Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 1.80 2.05 1.80 1.62 1.18 1.93 1.71 1.60 2.49 
50 2.22 2.42 2.22 1.93 1.90 2.31 2.15 1.99 2.86 
60 2.76 2.96 2.76 2.20 3.19 2.77 2.82 2.22 3.19 
70 3.21 3.42 3.21 2.70 3.68 3.23 3.35 2.70 3.42 
80 3.66 3.85 3.66 3.12 3.80 3.74 3.84 3.20 4.10 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ heart rate 
(bpm) during cycling lactate threshold testing 
 
  LLT Heart Rate (bpm) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 114 126 87 123 109 137 110 101 113 
50 121 136 102 142 118 148 120 110 125 
60 137 152 119 155 133 158 129 117 138 
70 152 164 132 164 155 172 153 126 152 
80 164 176 146 175 169 185 167 135 165 
90 174 186 156 190 179 191 175 145 175 
  HLT Heart Rate (bpm) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 114 109 111 114 105 118 118 100 138 
50 124 122 122 131 118 128 128 104 139 
60 138 137 137 141 130 141 141 130 150 
70 151 152 147 166 139 154 154 139 160 
80 165 161 161 178 150 168 168 164 174 









Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ respiratory 
exchange ratio during cycling lactate threshold testing 
 
  LLT Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.89 0.85 0.82 0.97 0.88 0.91 0.94 0.92 0.90 
50 0.92 0.90 0.87 0.99 0.90 0.93 0.96 0.92 0.92 
60 0.94 0.92 0.89 1.01 0.90 0.95 0.98 0.96 0.94 
70 0.95 0.96 0.92 1.04 0.93 0.93 0.98 0.99 0.96 
80 1.00 0.98 0.94 1.10 0.98 1.00 1.01 1.00 1.00 
90 1.02 1.03 0.95 1.02 1.00 1.02 1.10 1.02 1.02 
  HLT Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.86 0.92 0.88 0.88 0.76 0.87 0.87 0.85 0.85 
50 0.90 0.91 0.91 0.91 0.96 0.90 0.90 0.88 0.86 
60 0.92 0.90 0.91 0.92 1.06 0.93 0.93 0.89 0.85 
70 0.95 0.93 0.92 0.94 1.07 0.97 0.97 0.92 0.87 
80 0.98 0.94 0.93 0.98 1.12 1.00 1.00 0.97 0.93 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ work rate 
(Watts) during cycling lactate threshold testing 
 
  LLT Work Rate (Watts) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 117 135 100 135 120 100 110 115 120 
50 153 175 135 175 155 130 145 150 155 
60 186 215 170 215 190 160 175 180 185 
70 221 255 200 250 230 190 210 215 220 
80 256 295 230 290 265 220 245 250 255 
90 291 335 260 330 300 250 275 285 290 
  HLT Work Rate (Watts) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 120 130 145 100 110 120 120 110 120 
50 155 170 190 135 145 155 155 140 150 
60 191 210 230 165 175 195 195 170 190 
70 228 250 275 200 210 230 230 210 220 
80 265 290 320 230 245 265 265 250 260 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ rating of 
perceived exertion (RPE) during cycling lactate threshold testing 
 
  LLT Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 9 9 9 8 9 11 7 10 9 
50 11 11 10 10 11 13 11 12 11 
60 13 13 12 12 13 16 13 14 13 
70 15 15 14 13 15 17 15 15 15 
80 17 17 16 17 17 18 17 16 17 
90 18 18 18 18 18 19 19 18 18 
  HLT Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 8 10 7 9 9 7 7 7 9 
50 10 12 11 12 10 9 9 9 11 
60 12 13 13 14 11 11 11 9 12 
70 14 14 14 16 13 13 13 12 14 
80 16 17 16 18 14 16 16 13 16 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ blood 
lactate concentration (mmoL) during cycling lactate threshold testing 
 
  LLT Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 1.07 1.0 0.4 1.1 0.9 1.3 0.7 2.1 1.1 
50 1.28 1.0 0.4 1.1 1.1 1.7 0.8 2.9 1.3 
60 2.06 1.2 0.5 2.1 1.1 1.4 2.3 5.8 2.1 
70 2.50 2.1 0.7 2.7 1.5 2.8 2.5 5.5 2.5 
80 4.40 3.8 1.5 4.6 2.4 3.8 5.1 9.6 4.4 
90 6.30 6.6 3.0 7.1 2.9 7.5 5.6 10.5 6.2 
  HLT Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.78 0.5 0.6 1.1 0.7 0.5 0.5 1.2 1.2 
50 0.81 0.6 0.7 1.3 0.6 0.7 0.7 1.1 0.8 
60 1.01 0.9 0.7 0.8 0.6 1.6 1.6 0.9 1.0 
70 1.35 1.5 0.8 0.8 0.7 2.2 2.2 1.7 0.9 
80 2.10 2.4 1.5 1.1 1.4 3.3 3.3 2.1 1.7 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ oxygen 
consumption (L/min) during uphill running lactate threshold testing 
 
  LLT Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 1.64 2.02 1.40 1.53 1.58 1.45 1.80 1.64 1.63 
50 2.01 2.80 1.80 2.03 1.83 1.57 2.10 1.90 2.00 
60 2.80 3.33 2.70 2.43 2.73 2.50 2.60 2.96 2.75 
70 3.41 3.94 3.50 3.75 3.40 3.01 3.10 3.17 3.41 
80 3.79 4.61 3.70 4.15 3.65 3.09 3.70 3.68 3.80 
90 4.12 4.90 4.10 4.36 3.96 3.50 3.90 4.20 4.13 
  HLT Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 1.63 1.42 2.00 1.20 1.90 1.64 1.86 1.29 1.70 
50 1.98 1.65 2.58 1.60 2.50 2.18 1.82 1.42 2.10 
60 2.86 2.39 4.01 2.70 3.20 3.32 2.23 1.99 3.00 
70 3.43 3.12 4.61 3.20 3.50 3.61 3.24 2.53 3.60 
80 3.95 3.79 5.34 3.95 3.80 3.76 3.65 2.99 4.30 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ heart rate 
(bpm) during uphill running lactate threshold testing 
 




1 2 3 4 5 6 7 8 
40 107 138 82 112 93 137 94 102 108 
50 119 146 102 135 109 141 102 106 120 
60 142 164 130 145 136 165 132 127 143 
70 158 176 150 163 149 176 148 148 159 
80 170 187 162 168 161 182 170 160 170 
90 177 193 171 173 169 190 180 173 178 




1 2 3 4 5 6 7 8 
40 103 88 110 106 92 117 110 97 100 
50 114 98 121 123 112 126 113 100 115 
60 142 123 151 176 154 157 130 123 121 
70 161 145 160 193 169 166 153 147 156 
80 173 163 176 193 172 176 165 167 170 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ respiratory 
exchange ratio (RER) during uphill running lactate threshold testing 
 
  LLT Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.85 0.90 0.81 0.86 0.85 0.88 0.86 0.85 0.86 
50 0.91 0.95 0.86 0.95 0.90 0.90 0.91 0.90 0.91 
60 0.94 0.96 0.87 0.98 0.92 0.98 0.94 0.96 0.94 
70 0.96 0.98 0.91 1.02 0.93 0.93 0.95 0.97 0.95 
80 0.97 1.03 0.93 0.99 0.94 0.99 0.98 0.98 0.98 
90 1.03 1.10 1.01 1.02 0.98 1.04 1.02 1.02 1.02 
  HLT Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.82 0.88 0.93 0.85 0.82 0.75 0.83 0.75 0.78 
50 0.88 0.88 0.87 0.93 0.88 0.89 0.91 0.80 0.85 
60 0.93 0.91 0.95 0.97 0.93 0.94 0.92 0.88 0.91 
70 0.93 0.92 0.94 0.99 0.93 0.96 0.93 0.88 0.89 
80 0.97 0.95 0.98 0.98 0.97 1.02 0.97 0.90 0.96 







Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ rating of 
perceived exertion (RPE) during uphill running lactate threshold testing 
 
  LLT Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 7 6 7 7 7 10 7 7 7 
50 9 9 9 9 9 13 7 9 9 
60 12 12 11 12 11 15 11 12 12 
70 13 14 13 14 12 16 12 13 13 
80 15 16 15 15 13 17 13 15 15 
90 17 19 17 17 14 18 17 17 17 
  HLT Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 8 7 10 8 9 7 11 8 9 
50 10 8 12 10 11 12 13 10 11 
60 11 11 14 15 13 13 13 11 13 
70 13 12 15 18 15 15 15 13 14 
80 15 14 17 18 17 18 16 15 18 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ blood 
lactate concentration (mmoL) during uphill running lactate threshold testing 
 
  LLT Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.6 0.4 0.3 0.6 0.6 0.8 0.1 1.5 0.6 
50 0.7 0.5 0.4 0.7 0.5 0.7 0.2 2.3 0.8 
60 1.1 0.7 0.5 1.2 0.8 0.9 0.6 3.2 1.1 
70 1.8 1.5 0.8 3.6 1.0 2.0 0.6 3.4 1.8 
80 2.5 2.9 1.5 4.4 1.3 2.4 1.2 4.3 2.6 
90 4.1 4.9 2.6 5.5 1.9 4.7 2.1 7.5 4.2 
  HLT Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
40 0.6 0.9 0.5 0.6 0.4 0.2 0.1 1.1 0.6 
50 0.7 0.9 0.5 0.8 1.2 0.5 0.1 1.2 0.6 
60 1.2 1.2 0.9 0.7 2.7 1.3 0.4 1.3 1.2 
70 1.9 1.2 1.4 1.4 4.4 2.3 0.8 1.3 2.6 
80 2.8 1.7 2.9 2.1 4.6 3.6 1.2 1.4 4.8 








Study 1 Individual Data: Low (LLT) and high (HLT) total hemoglobin concentration (µM) 
during submaximal biomechanical testing 
 
  LLT Total Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 100.1 118.5 112.4 36.2 88.9 117.5 132.6 82.6 98.4 
60 104.1 118.5 120.4 40.1 91.4 117.5 144.8 82.6 102.2 
70 111.8 116.2 113.5 42.7 97.6 162.4 152.3 96.8 111.6 
80 109.4 121.3 97.7 43.6 100.7 167.2 144.9 98.9 110.6 
90 106.4 125.4 97.7 36.7 103.9 168.3 114.5 101 106.8 
  HLT Total Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 65.3 66.9 80.1 98.7 40.0 59.1 47.2 76.72 53.4 
60 69.4 66.9 78 102.5 40.1 66.8 47.2 94.9 58.4 
70 75.5 69 85.4 104.9 39.8 76.2 55.6 110.5 62.4 
80 78.1 77.9 84.5 106.9 43.6 78.0 60.5 109.1 64.3 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ oxygenated 
hemoglobin concentration (µM) during submaximal biomechanical testing 
 
  LLT Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 72.6 86.3 87.4 20.4 59.8 85.6 108.1 47.8 70.8 
60 71.5 86.3 92.7 22.4 61.0 85.6 118.4 47.8 73.5 
70 79.8 81.8 80.2 25.8 65.5 132.0 126.7 64.4 82.3 
80 78.1 87.3 61.6 25.6 66.2 137.1 117.6 64.9 80.0 
90 72.7 90.9 61.6 18.8 69.5 139.3 71.4 65.9 73.9 
  HLT Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 41.3 38.6 54.1 66.4 18.9 38.1 23.6 60.0 30.8 
60 43.5 38.6 53.3 62.5 18.9 43.6 23.6 72.5 34.7 
70 48.6 38.4 56.6 64.7 19.2 52.6 33.0 87.7 37.2 
80 50.5 42.8 56.2 67.0 22.2 54.0 36.6 86.3 39.0 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ 
deoxygenated hemoglobin concentration (µM) during submaximal biomechanical testing 
 
  LLT Deoxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 27.0 32.2 25.0 15.8 29.1 32.0 24.5 34.8 27.6 
60 28.1 32.2 27.7 17.7 30.4 32.1 26.4 34.8 28.7 
70 28.8 34.4 33.3 16.9 32.1 30.4 25.6 32.4 29.3 
80 29.9 34.0 36.2 18.0 34.5 30.1 27.2 33.9 30.6 
90 31.9 34.5 36.3 17.9 34.4 29.1 43.1 35.1 32.9 
  HLT Deoxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 23.9 28.3 26.0 32.3 21.1 20.9 23.5 16.7 22.6 
60 25.9 28.3 24.8 39.9 21.1 23.2 23.5 22.4 23.7 
70 26.8 30.5 28.7 40.2 20.6 23.5 22.6 22.8 25.2 
80 27.6 35.1 28.2 39.9 21.4 24.0 23.9 22.8 25.3 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ percent 
saturation during submaximal biomechanical testing 
 
  LLT %Saturation 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 69.4 72.8 77.7 56.3 67.2 72.8 81.5 57.9 69.5 
60 69.3 72.8 76.8 55.8 66.7 72.8 81.7 57.9 69.2 
70 71.2 70.3 70.6 60.4 67.1 81.2 83.1 66.5 71.3 
80 69.7 71.8 63.0 58.8 65.7 81.9 81.2 65.7 69.7 
90 65.9 72.4 63.0 51.2 66.9 82.7 60.3 65.2 66.0 
  HLT % Saturation 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
Rest 60.8 57.7 67.6 67.2 47.3 60.8 50.1 78.2 57.6 
60 60.2 57.7 69.2 61.0 47.3 60.2 50.1 76.4 59.4 
70 61.5 55.7 66.3 61.7 48.2 61.5 59.4 79.4 59.6 
80 62.2 54.9 66.6 62.6 50.9 62.2 60.4 79.1 60.7 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ vastus 
lateralis activation (%Activation) during submaximal biomechanical testing 
 
  LLT Vastus Lateralis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 36.8 45.4 32.7 30.6 33.6 44.4 33.6 43.1 31.3 
70 35.9 44.4 35.6 31.7 35.2 33.2 35.2 40.3 32.1 
80 45.7 52.8 37.6 37.9 36.8 70.7 36.8 59.3 33.8 
90 44.6 57.0 41.2 31.1 38.5 ----- 38.5 76.5 29.5 
  HLT Vastus Lateralis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 37.4 41.2 26.7 39.9 43.7 43.1 35.6 42.1 27.1 
70 39.5 42.4 31.1 44.3 42.3 40.9 38.8 46.8 29.7 
80 41.4 39.8 28.6 48.7 40.1 48.3 41.9 51.6 32.4 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ vastus 
medialis activation (%Activation) during submaximal biomechanical testing 
  LLT Vastus Medialis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 50.3 28.7 24.9 28.8 70.3 75.9 70.3 74.4 29.0 
70 52.0 31.9 22.8 31.7 62.9 95.3 62.9 81.0 27.5 
80 41.6 33.6 29.4 33.2 55.5 41.0 55.5 52.9 31.6 
90 40.9 44.1 35.3 30.3 48.1 39.0 48.1 48.1 34.7 
  HLT Vastus Medialis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 29.6 29.2 30.8 32.6 26.2 ----- 23.2 34.6 30.8 
70 32.5 32.6 33.5 36.7 26.2 ----- 25.3 39.1 33.9 
80 33.3 28.2 35.1 40.9 20.6 ----- 27.4 43.6 37.0 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ rectus 
femoris activation (%Activation) during submaximal biomechanical testing 
  LLT Rectus Femoris Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 24.2 27.4 22.5 26.6 22.8 24.1 22.8 26.5 21.6 
70 23.0 28.5 22.4 23.2 21.4 22.2 21.4 25.9 19.2 
80 26.8 31.1 33.2 38.9 20.0 23.6 20.0 35.6 11.8 
90 32.2 46.0 34.6 24.9 18.6 ----- 18.6 71.5 11.1 
  HLT Rectus Femoris Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 29.3 20.1 17.2 27.7 60.7 37.5 26.7 28.6 15.9 
70 32.7 22.7 17.8 29.6 66.8 35.3 27.9 30.7 30.7 
80 30.5 23.3 18.1 31.5 40.3 36.4 29.1 32.8 32.8 








Study 1 Individual Data; Low (LLT) and high (HLT) lactate threshold cyclists’ biceps 
femoris activation (%Activation) during submaximal biomechanical testing 
 
  LLT Biceps Femoris Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 35.2 26.6 23.2 ----- 42.8 39.4 42.8 44.3 27.3 
70 36.7 30.2 28.1 ----- 42.2 39.8 42.2 43.3 30.9 
80 35.9 34.5 25.0 ----- 41.6 36.0 41.6 42.5 30.2 
90 39.2 45.2 34.9 ----- 40.9 33.3 40.9 44.0 35.1 
  HLT Biceps Femoris Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 40.9 27.8 47.4 34.5 46.1 55.8 32.6 34.7 48.5 
70 41.7 24.7 51.6 34.9 42.7 59.8 34.4 35.1 50.5 
80 41.8 37.4 51.9 35.2 44.2 41.0 36.3 35.5 52.7 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ gluteus 
maximus activation (%Activation) during submaximal biomechanical testing 
 
  LLT Gluteus Maximus Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 49.0 36.9 47.3 ----- 46.9 58.1 ----- 56.0 ----- 
70 55.9 42.2 54.2 ----- 59.3 61.2 ----- 62.8 ----- 
80 66.3 77.7 64.0 ----- 50.0 64.3 ----- 75.3 ----- 
90 69.8 74.7 69.0 ----- 64.8 67.4 ----- 73.2 ----- 
  HLT Gluteus Maximus Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 43.6 24.0 41.6 23.7 55.5 49.2 55.5 ----- ----- 
70 49.2 39.2 46.9 25.6 53.3 63.4 53.3 ----- ----- 
80 53.7 46.3 50.1 26.9 51.0 75.6 51.0 ----- ----- 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ tibialis 
anterior activation (%Activation) during submaximal biomechanical testing 
 
  LLT Tibialis Anterior Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 33.7 45.3 24.6 68.2 8.9 43.8 8.9 56.7 13.5 
70 23.1 4.4 21.6 57 11.7 30 11.7 41.8 6.7 
80 34.8 29.8 17.7 100 14.6 28.1 14.6 67.1 6.3 
90 36.5 31.9 36.1 62.6 17.4 51.4 17.4 54.3 20.7 
  HLT Tibialis Anterior Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 54.6 68.1 61 40.1 93.6 47.8 25.8 41 59.8 
70 48.4 46.2 65.3 41.8 51.5 54.1 30.0 42.8 55.1 
80 40.1 46.2 30.3 43.6 21.7 49.6 34.2 44.7 50.2 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ gastroc 
medialis activation (%Activation) during submaximal biomechanical testing 
 
  LLT Gastroc Medialis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 29.4 29.2 53.6 33.2 11.7 34.9 11.7 44.9 15.7 
70 26.6 24.7 42.0 34.0 14.3 29.2 14.3 37.4 17.1 
80 27.6 28.6 43.0 35.9 16.9 23.1 16.9 37.9 18.5 
90 27.2 23.8 37.6 33.6 19.5 28.5 19.5 34.6 20.8 
  HLT Gastroc Medialis Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 36.7 28.0 36.0 22.4 55.3 55.2 35.0 23.7 38.3 
70 35.8 30.6 37.5 25.1 46.3 47.4 36.2 26.6 36.5 
80 36.1 32.4 41.1 27.8 41.8 43.5 37.5 29.6 35.2 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ soleus 
activation (%Activation) during submaximal biomechanical testing 
 
  LLT Soleus Activation (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 40.9 38.6 51.9 52.8 33.3 34.7 33.3 49.9 33.0 
70 40.4 36.7 51.9 49.4 35.2 33.1 35.2 48.4 33.4 
80 44.6 39.3 60.5 58.2 37.2 33.9 37.2 56.1 34.5 
90 42.3 35.9 49.3 51.1 39.1 39.6 39.1 48.6 37.1 
  HLT Soleus Activation (5) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 52.6 51.3 90.1 35.3 62.5 56.3 34.6 38.0 ----- 
70 54.2 58.6 70.1 40.8 42.8 58.8 39.3 44.0 79.3 
80 51.5 50.4 57.3 46.4 47.4 58.5 44.0 50.0 57.8 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ normalized 
hip joint specific power (W/kg) during submaximal biomechanical testing 
 
  LLT Normalized Hip Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 1.09 0.79 1.15 1.64 1.28 1.07 0.89 1.09 0.87 
70 1.15 0.93 1.34 1.44 1.26 1.15 1.11 1.08 0.86 
80 1.30 1.31 1.14 1.60 1.59 1.22 1.33 1.12 0.85 
90 1.34 1.00 1.10 1.76 2.05 1.29 1.55 1.10 0.84 
  HLT Normalized Hip Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 1.16 1.44 1.05 0.59 1.27 1.07 1.39 1.44 1.03 
70 1.25 1.47 1.07 1.13 1.28 1.08 1.47 1.44 1.07 
80 1.38 1.50 1.09 1.66 1.37 1.10 1.56 1.64 1.14 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ normalized 
knee joint specific power (W/kg) during submaximal biomechanical testing 
 
  LLT Normalized Knee Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 1.31 1.29 1.38 1.64 1.24 1.32 1.39 1.08 1.10 
70 1.38 1.42 1.42 1.69 1.30 1.48 1.56 1.07 1.07 
80 1.49 1.58 1.31 1.87 1.57 1.64 1.73 1.15 1.04 
90 1.58 1.58 1.27 2.05 1.91 1.80 1.90 1.14 1.01 
  HLT Normalized Knee Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 1.42 1.41 1.21 1.44 1.54 1.23 1.43 1.95 1.13 
70 1.42 1.37 1.25 1.48 1.60 1.27 1.47 1.71 1.21 
80 1.45 1.33 1.28 1.36 1.63 1.31 1.52 1.91 1.24 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ normalized 
ankle joint specific power (W/kg) during submaximal biomechanical testing 
 
  LLT Normalized Ankle Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 0.27 0.30 0.26 0.18 0.06 0.46 0.36 0.37 0.20 
70 0.26 0.15 0.44 0.12 0.05 0.25 0.38 0.40 0.30 
80 0.27 0.13 0.42 0.21 0.17 0.05 0.39 0.42 0.40 
90 0.35 0.33 0.47 0.30 0.09 0.07 0.41 0.61 0.50 
  HLT Normalized Ankle Joint Specific Power (W/kg) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 0.16 0.19 0.08 0.27 0.16 0.09 0.31 0.08 0.07 
70 0.17 0.08 0.10 0.46 0.14 0.10 0.31 0.08 0.06 
80 0.18 0.08 0.11 0.44 0.16 0.11 0.31 0.12 0.09 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ relative hip 
contribution (% contribution) during submaximal biomechanical testing 
 
  LLT Relative Hip Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 40.7 33.1 41.1 47.4 49.6 37.7 33.8 42.8 40.0 
70 41.1 37.2 41.8 44.4 48.4 39.8 36.5 42.4 38.5 
80 41.6 43.2 39.7 43.5 47.7 41.9 38.5 41.6 37.0 
90 40.1 34.6 38.8 42.8 50.6 39.7 40.1 38.5 35.7 
  HLT Relative Hip Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 42.2 47.5 44.7 25.6 42.9 44.9 44.4 41.6 46.2 
70 44.2 50.4 44.1 36.7 42.4 44.4 45.3 44.7 45.7 
80 45.9 51.5 43.6 48.0 43.5 43.8 46.0 44.7 46.2 








Study 1 Individual Data: Low (LLT) and high (HLT) lactate threshold cyclists’ relative 
knee contribution (% contribution) during submaximal biomechanical testing 
 
  LLT Relative Knee Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 48.9 54.2 49.5 47.4 48.0 46.3 52.6 42.7 50.8 
70 49.4 56.7 44.4 51.9 49.7 51.4 51.2 42.0 48.0 
80 48.8 52.4 45.5 50.7 47.3 56.4 50.1 42.8 45.4 
90 47.9 54.2 44.7 49.8 47.2 55.5 49.3 40.0 43.0 
  HLT Relative Knee Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 52.0 46.3 51.6 62.5 51.8 51.6 45.7 56.0 50.8 
70 50.2 46.8 51.8 48.3 52.9 51.7 45.3 53.0 51.7 
80 48.4 45.7 51.9 39.2 51.5 51.8 44.8 52.2 50.1 








Study 1 Individual Data:  Low (LLT) and high (HLT) lactate threshold cyclists’ relative 
ankle contribution (% contribution) during submaximal biomechanical testing 
 
  LLT Relative Ankle Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 10.9 12.7 9.4 5.3 2.4 16.0 13.7 14.5 9.2 
70 9.5 6.1 13.8 3.8 1.9 8.7 12.4 15.6 13.5 
80 9.5 4.4 14.8 5.8 5.0 1.7 11.4 15.7 17.5 
90 11.6 11.2 16.4 7.3 2.2 2.2 10.6 21.5 21.3 
  HLT Relative Ankle Contribution (%) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 
60 5.7 6.2 3.7 11.9 5.3 3.5 9.8 2.4 2.9 
70 5.6 2.8 4.1 15.0 4.7 3.9 9.5 2.3 2.5 
80 5.7 2.7 4.5 12.7 5.0 4.3 9.2 3.2 3.7 
















Study 2 Individual Data: Control and training group baseline treadmill maximal oxygen 












1 4.29 1.04 194 17 
2 3.45 1.00 202 18 
3 4.08 1.10 192 17 
4 4.26 1.08 181 17 
5 3.41 1.09 188 19 
6 2.96 1.04 189 16 
7 2.17 1.15 199 19 
8 2.75 0.98 183 20 
9 5.30 1.10 182 18 
10 2.49 1.12 204 18 
Mean 3.52 1.07 191 18 
Training     
1 1.95 1.00 181 16 
2 3.69 1.07 190 17 
3 3.02 1.12 195 19 
4 1.76 1.13 182 17 
5 4.07 1.11 188 18 
6 3.25 1.18 190 17 
7 4.46 1.13 210 18 
8 4.66 1.20 179 19 
9 3.12 1.07 198 17 
10 4.44 1.10 167 16 







Study 2 Individual Data: Control and training group baseline cycling peak oxygen 















1 3.55 1.10 260 180 16 
2 2.38 0.91 155 174 17 
3 4.03 1.04 280 182 17 
4 3.69 1.10 235 180 17 
5 3.28 1.08 245 193 18 
6 2.48 1.08 190 178 17 
7 2.04 1.12 145 188 18 
8 1.98 1.17 180 181 20 
9 4.21 1.10 315 180 16 
10 2.11 1.10 160 182 19 
Mean 2.98 1.08 217 189 18 
Training      
1 1.82 1.04 130 180 17 
2 3.21 1.07 240 184 18 
3 2.54 1.00 180 175 17 
4 3.47 1.09 250 172 18 
5 1.84 1.09 150 179 18 
6 3.13 1.11 240 172 20 
7 4.32 1.13 285 190 20 
8 4.12 1.17 265 175 17 
9 3.15 1.01 225 198 18 
10 3.97 1.05 310 160 19 









Study 2 Individual Data: Control and training group post-intervention/training cycling 















1 3.52 1.06 260 179 17 
2 2.36 0.95 175 179 18 
3 3.91 0.99 280 183 20 
4 3.69 1.10 235 180 17 
5 3.28 1.09 245 192 18 
6 2.40 1.08 190 183 17 
7 2.10 1.06 150 182 17 
8 2.07 1.14 185 184 20 
9 4.28 1.07 355 182 19 
10 2.15 1.12 160 183 19 
Mean 2.98 1.07 224 183 18 
Training      
1 1.86 1.08 130 178 17 
2 3.41 1.03 270 183 18 
3 2.92 1.06 200 183 18 
4 3.99 1.08 280 186 19 
5 1.90 1.10 160 179 16 
6 3.40 1.06 260 176 20 
7 4.26 1.04 315 188 19 
8 4.13 1.15 300 176 19 
9 3.39 1.00 225 198 19 
10 3.96 1.04 275 161 19 








Study 2 Individual Data: Baseline control and training group oxygen consumption (L/min) 
during cycling lactate threshold testing 
 
  Control Group Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.52 2.12 1.57 1.92 1.79 1.16 1.17 0.93 0.97 2.58 1.01 
50 1.80 2.41 1.78 2.28 2.32 1.38 1.33 0.99 1.25 3.05 1.21 
60 2.07 2.76 2.09 2.65 2.64 1.66 1.56 1.08 1.48 3.41 1.40 
70 2.40 3.10 2.25 3.24 3.32 1.96 1.78 1.25 1.78 3.88 1.48 
80 2.64 3.42 2.51 3.50 3.75 2.11 1.98 1.17 1.91 4.30 1.73 
 
  Training Group Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.43 1.15 1.45 1.14 1.62 0.76 1.38 1.83 2.08 1.31 1.59 
50 1.70 1.27 1.74 1.40 1.87 0.92 1.71 2.09 2.57 1.49 1.91 
60 1.95 1.33 2.08 1.63 2.18 1.02 2.00 2.37 2.95 1.67 2.22 
70 2.31 1.50 2.38 1.90 2.62 1.07 2.29 2.80 3.52 2.24 2.74 








Study 2 Individual Data: Post-intervention/training control and training group oxygen 
consumption (L/min) during cycling lactate threshold testing  
 
  Control Group Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.51 2.12 1.55 1.85 1.79 1.16 1.15 1.01 0.99 2.43 1.02 
50 1.76 2.41 1.77 2.13 2.32 1.38 1.37 1.07 1.19 2.79 1.19 
60 2.03 2.76 2.05 2.50 2.64 1.66 1.56 1.16 1.42 3.19 1.37 
70 2.35 3.10 2.30 2.90 3.32 1.96 1.82 1.21 1.62 3.75 1.54 
80 2.62 3.42 2.55 3.35 3.75 2.11 2.02 1.32 1.84 3.95 1.88 
 
  Training Group Oxygen Consumption (L/min) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.41 1.01 1.15 1.15 1.45 0.83 1.45 1.67 2.25 1.34 1.81 
50 1.66 1.11 1.27 1.37 1.78 1.02 1.75 1.94 2.62 1.54 2.15 
60 1.87 1.23 1.33 1.62 2.09 1.05 1.96 2.27 3.07 1.76 2.33 
70 2.18 1.37 1.5 1.83 2.55 1.22 2.29 2.65 3.65 1.94 2.84 








Study 2 Individual Data: Baseline control and training group respiratory exchange ratio 
during cycling lactate threshold testing 
 
  Control Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 0.93 0.97 0.84 0.93 0.99 0.85 0.89 0.95 0.90 1.03 0.94 
50 0.95 0.98 0.89 0.97 0.97 0.90 0.92 0.97 0.94 1.00 0.96 
60 0.97 1.02 0.89 0.97 1.03 0.93 0.96 0.97 0.94 1.03 0.97 
70 0.98 1.06 0.91 0.96 1.03 0.90 0.97 0.95 0.98 1.07 1.00 
80 1.01 1.08 0.94 1.03 1.05 0.94 1.01 0.96 0.99 1.07 1.02 
 
  Training Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 0.96 0.92 0.95 0.86 0.94 1.01 1.05 0.98 1.02 0.92 0.94 
50 0.97 0.95 0.96 0.89 0.96 1.02 1.01 1.03 1.00 0.91 0.95 
60 0.98 0.96 0.97 0.91 0.98 1.03 0.98 1.06 1.06 0.94 0.95 
70 1.00 0.99 0.98 0.93 1.01 1.04 0.99 1.03 1.12 0.91 1.00 








Study 2 Individual Data: Post-intervention/training control and training group respiratory 
exchange ratio during cycling lactate threshold testing 
 
  Control Group Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 0.93 0.97 0.89 0.92 0.99 0.85 0.89 0.94 0.90 0.97 1.01 
50 0.96 0.98 0.94 0.96 0.97 0.90 0.93 0.95 0.93 0.95 1.06 
60 0.98 1.02 0.94 0.97 1.03 0.93 0.97 0.95 0.96 1.00 1.05 
70 0.99 1.06 0.95 0.98 1.03 0.90 0.98 0.95 0.97 1.02 1.05 
80 1.01 1.08 0.98 1.00 1.05 0.94 1.01 0.95 1.01 1.05 1.02 
 
  Training Group Respiratory Exchange Ratio 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 0.94 0.91 0.95 0.91 0.98 0.83 0.96 0.95 1.03 0.97 0.92 
50 0.97 0.94 0.96 0.94 1.00 0.88 0.98 1.00 1.05 0.98 0.95 
60 0.99 1.00 0.97 0.96 1.03 0.95 0.98 1.04 1.07 1.00 0.95 
70 1.00 1.04 0.98 0.98 1.05 0.95 0.94 1.01 1.07 1.03 0.98 








Study 2 Individual Data: Baseline control and training group heart rate (bpm) during 
cycling lactate threshold testing 
 
  Control Group Heart Rate (bpm) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 123 127 139 127 118 100 114 128 118 144 117 
50 137 152 149 134 134 120 122 131 136 158 138 
60 150 166 159 142 148 140 142 140 150 171 145 
70 163 181 173 152 162 158 153 151 165 181 157 
80 175 200 183 166 177 164 167 155 170 195 169 
 
  Training Group Heart Rate (bpm) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 116 136 107 107 105 100 108 114 131 146 105 
50 132 151 136 113 121 113 136 131 144 154 119 
60 145 157 152 123 145 130 146 150 159 161 125 
70 158 168 164 142 158 139 160 165 171 174 137 








Study 2 Individual Data: Post-intervention/training control and training group heart rate 
(bpm) during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 119 128 138 118 118 100 106 123 107 132 120 
50 136 148 160 130 134 120 129 131 123 149 133 
60 149 164 168 146 148 140 145 138 139 162 144 
70 163 179 179 159 162 158 164 143 156 175 157 
80 175 197 194 173 177 164 184 148 166 180 168 
 




1 2 3 4 5 6 7 8 9 10 
40 113 117 117 108 102 93 102 107 130 135 118 
50 127 125 127 119 121 108 125 128 148 148 125 
60 141 137 150 134 139 120 139 151 160 155 129 
70 154 155 158 145 157 132 151 161 170 167 141 








Study 2 Individual Data: Baseline control and training group rating of perceived exertion 
during cycling lactate threshold testing 
 
  Control Group Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 10 9 9 11 11 13 9 11 11 9 9 
50 12 11 11 13 13 15 12 11 13 10 11 
60 14 12 14 14 15 17 15 11 15 11 12 
70 16 15 17 15 18 18 17 13 17 15 14 
80 18 17 17 17 20 20 20 14 19 16 17 
 
  Training Group Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 9 11 8 7 13 12 12 9 8 7 7 
50 11 11 11 9 15 12 13 12 11 11 9 
60 13 12 13 11 15 13 14 14 14 11 11 
70 15 13 15 13 16 13 16 16 19 12 12 








Study 2 Individual Data: Post-intervention/training control and training group rating of 
perceived exertion during cycling lactate threshold testing 
 
  Control Group Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 10 7 10 11 11 13 9 10 9 9 8 
50 12 10 12 12 13 15 11 10 11 11 12 
60 14 12 14 13 15 17 13 11 13 13 14 
70 16 15 17 15 18 18 15 12 15 15 16 
80 18 18 19 17 20 20 17 13 17 19 18 
 
  Training Group Rating of Perceived Exertion 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 10 11 7 8 13 12 12 11 8 7 7 
50 11 11 9 11 14 12 13 12 11 8 8 
60 13 13 12 13 15 12 13 13 14 11 11 
70 15 14 15 15 17 13 15 15 19 12 12 








Study 2 Individual Data: Baseline control and training group blood lactate concentration 
(mmoL) during cycling lactate threshold testing 
 
  Control Group Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.3 1.4 1.4 0.9 1.6 1.0 0.9 2.2 1.3 0.8 1.2 
50 1.7 1.8 1.4 1.7 1.7 1.1 2.0 1.9 1.4 1.7 1.8 
60 2.6 3.9 2.5 2.4 3.6 1.3 2.6 1.9 1.9 2.5 3.5 
70 3.2 4.8 3.3 3.7 5.0 1.4 3.5 2.3 2.6 2.8 2.4 
80 5.0 7.9 4.4 4.5 7.4 2.5 6.0 2.1 5.3 3.7 5.7 
 
  Training Group Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.6 2.9 2.1 1.3 1.4 1.2 1.0 1.4 1.2 1.8 1.3 
50 2.1 3.4 3.4 1.1 1.8 2.2 2.3 1.3 1.5 2.1 1.6 
60 2.8 4.9 4.5 1.8 2.0 2.5 3.4 2.8 1.6 2.5 2.2 
70 3.4 5.6 4.9 2.5 3.6 2.3 3.4 3.8 2.3 3.0 2.8 








Study 2 Individual Data: Post-intervention/training control and training group blood 
lactate concentration (mmoL) during cycling lactate threshold testing 
 
  Control Group Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.1 0.8 0.7 0.8 1.6 1.0 1.4 1.3 1.3 0.8 1.2 
50 1.4 1.5 1.0 0.9 1.7 1.0 1.5 1.3 1.4 1.7 1.8 
60 2.3 3.2 1.5 1.2 3.5 1.3 2.3 1.9 1.9 2.5 3.5 
70 3.1 5.1 3.1 2.8 5.1 1.6 3.4 2.0 2.6 2.8 2.4 
80 5.2 10.5 4.5 5.6 7.3 2.8 4.4 2.4 5.3 3.7 5.7 
 
  Training Group Blood Lactate Concentration (mmoL) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 1.7 2.1 1.1 2.0 1.5 1.0 2.3 1.1 1.3 2.2 2.0 
50 2.0 2.2 2.4 1.9 2.1 1.0 2.8 1.6 1.2 2.3 2.2 
60 2.4 3.3 3.2 1.4 2.9 0.9 1.8 2.8 1.9 2.9 2.5 
70 3.7 4.5 5.5 3.7 3.3 1.5 4.3 3.0 3.3 3.8 4.2 








Study 2 Individual Data: Baseline control and training group total hemoglobin 
concentration (µM) during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 56.3 87.5 59.6 93.4 93.6 35.1 52.0 25.2 43.7 43.0 30.0 
50 59.5 91.7 62.5 96.1 102.7 35.6 54.4 26.2 45.6 47.2 32.6 
60 61.7 96.0 64.1 100.4 104.9 37.2 56.5 26.4 50.1 46.7 34.2 
70 62.7 95.4 63.8 108.0 106.5 38.5 57.0 27.2 51.5 45.0 34.5 
80 65.3 99.6 66.0 111.5 112.2 43.6 59.2 27.7 51.6 46.9 34.3 
 




1 2 3 4 5 6 7 8 9 10 
40 61.5 40.7 81.4 36.6 82.1 36.6 81.2 90.6 43.0 17.5 105.1 
50 63.4 43.9 85.6 37.0 84.9 37.3 82.2 95.8 47.2 19.3 100.5 
60 63.6 43.9 86.7 38.9 85.7 37.8 84.5 97.1 46.7 19.2 96.1 
70 64.0 45.7 85.6 37.2 89.7 39.1 84.8 98.1 45.0 20.5 94.6 








Study 2 Individual Data: Post-intervention/training control and training group total 
hemoglobin concentration (µM) during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 53.9 83.6 59.6 84.0 93.6 35.1 40.3 33.4 41.2 38.1 30.8 
50 57.1 91.2 62.5 88.4 102.7 35.6 43.2 35.6 42.0 37.9 32.1 
60 58.6 93.2 64.1 93.5 104.9 37.2 43.5 36.0 43.9 37.9 31.5 
70 59.3 94.5 63.8 96.1 106.5 38.5 41.3 37.5 45.6 39.4 30.2 
80 61.8 99.3 66.0 99.2 112.2 43.6 42.9 37.9 46.3 40.2 30.1 
 




1 2 3 4 5 6 7 8 9 10 
40 57.2 32.2 60.3 34.8 80.2 40.1 86.0 92.0 61.7 17.0 68.1 
50 59.9 36.4 63.6 34.9 83.0 44.7 89.1 97.5 62.4 19.6 68.2 
60 61.7 36.8 66.1 35.2 85.9 44.3 88.4 101.5 66.5 22.0 69.9 
70 62.8 33.8 68.2 34.7 88.9 44.9 89.3 108.0 67.1 22.8 69.8 








Study 2 Individual Data: Baseline control and training group oxygenated hemoglobin 
concentration (µM) during cycling lactate threshold testing 
 
  Control Group Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 37.4 58.4 36.3 58.2 62.1 21.6 35.0 18.7 31.5 29.3 22.4 
50 38.9 59.5 37.9 54.1 67.5 22.3 38.5 19.7 33.5 31.1 24.8 
60 39.2 59.3 39.2 54.1 62.9 23.5 39.0 19.8 37.1 31.5 25.7 
70 40.8 56.8 39.2 58.5 75.8 24.8 38.7 20.4 37.9 29.8 26.0 
80 41.6 57.2 40.7 56.4 76.1 30.3 40.8 20.7 37.5 30.9 25.6 
 
  Training Group Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 39.6 26.8 53.4 23.1 47.8 25.6 49.4 61.3 29.3 13.0 66.1 
50 39.7 30.4 53.8 24.8 44.7 27.1 47.4 63.0 31.1 14.6 60.5 
60 39.1 30.4 55.8 26.9 44.0 27.7 43.0 61.7 31.5 14.7 55.7 
70 38.1 31.2 53.9 24.6 45.0 28.2 39.3 59.6 29.8 15.6 53.8 








Study 2 Individual Data: Post-intervention/training control and training group oxygenated 
hemoglobin concentration (µM) during cycling lactate threshold testing 
 
  Control Group Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 35.6 51.9 36.3 52.5 62.1 21.6 29.5 23.5 30.8 26.5 21.2 
50 37.5 55.4 37.9 53.2 67.6 22.5 30.9 25.2 30.9 28.1 23.6 
60 37.4 54.5 39.2 54.9 62.9 23.4 31.3 25.5 32.0 27.9 22.4 
70 38.8 55.2 39.2 53.8 75.9 24.9 29.2 26.9 33.2 29.0 20.7 
80 39.8 56.5 40.7 53.8 76.2 30.3 30.1 28.0 33.1 29.3 20.0 
 
  Training Group Oxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 37.7 21.5 42.6 22.9 48.8 28.5 51.4 61.6 41.3 11.9 46.4 
50 39.3 25.8 44.8 23.7 49.9 32.6 49.7 66.6 39.9 14.7 45.6 
60 39.6 26.7 45.4 23.3 51.6 32.6 44.8 66.8 41.8 16.6 46.4 
70 39.7 24.8 48.7 23.4 49.2 33.6 42.6 72.1 41.0 16.5 45.1 








Study 2 Individual Data: Baseline control and training group deoxygenated hemoglobin 
concentration (µM) during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 18.9 29.1 23.3 35.2 31.4 13.5 17.0 6.5 12.2 13.7 7.7 
50 20.5 32.2 24.5 42.0 35.1 13.1 15.9 6.5 12.1 16.1 7.8 
60 22.5 36.7 24.9 46.3 42.0 13.8 17.5 6.6 13.1 15.2 8.5 
70 21.9 38.6 24.5 49.6 30.7 13.6 18.2 6.7 13.6 15.2 8.4 
80 23.7 42.5 25.3 55.1 36.0 13.3 18.5 7.0 14.1 16.0 8.7 
 




1 2 3 4 5 6 7 8 9 10 
40 21.9 13.8 28.0 13.5 34.3 11.0 31.8 29.3 13.7 4.5 39.0 
50 23.6 13.5 31.8 12.2 40.3 10.2 34.8 32.8 16.1 4.7 40.0 
60 24.5 13.5 31.0 12.0 41.7 10.0 41.5 35.4 15.2 4.5 40.4 
70 25.9 14.5 31.7 12.6 44.7 10.9 45.5 38.5 15.2 4.8 40.8 








Study 2 Individual Data: Post-intervention/training control and training group 
deoxygenated hemoglobin concentration (µM) during cycling lactate threshold testing 
 
  Control Group Deoxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 18.4 31.7 23.3 31.5 31.4 13.5 10.8 9.9 10.4 11.5 9.6 
50 19.6 35.7 24.5 35.2 35.1 13.1 12.3 10.4 11.1 9.8 8.5 
60 21.2 38.7 24.9 38.5 42.0 13.8 12.1 10.5 11.9 10.0 9.1 
70 20.6 39.3 24.5 42.3 30.7 13.6 12.2 10.5 12.4 10.4 9.6 
80 21.9 42.6 25.3 45.5 36.0 13.3 12.5 10.0 13.2 10.9 10.0 
 
  Training Group Deoxygenated Hemoglobin Concentration (µM) 
Work Rate 
(%VO2max) 
Mean 1 2 3 4 5 6 7 8 9 10 
40 19.6 10.7 17.7 11.9 31.4 11.6 34.6 30.4 20.4 5.1 21.7 
50 20.6 10.6 18.7 11.2 33.1 12.2 39.4 30.9 22.5 4.9 22.6 
60 22.1 10.1 20.7 11.9 34.3 11.7 43.6 34.7 24.6 5.4 23.6 
70 23.0 8.9 19.5 11.4 39.6 11.3 46.7 35.9 26.1 6.2 24.7 








Study 2 Individual Data: Baseline control and training group percent saturation (%) 
during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 67.4 66.7 60.9 62.3 66.4 61.6 67.3 74.1 72.1 68.2 74.5 
50 67.2 64.8 60.7 56.3 65.7 63.3 70.8 75.2 73.4 65.9 76.1 
60 66.0 61.7 61.2 53.9 59.9 63.0 69.0 75.0 73.9 67.4 75.1 
70 66.9 59.5 61.5 54.1 71.1 64.7 68.0 75.2 73.5 66.1 75.5 
80 66.5 59.5 61.7 49.9 67.9 69.5 68.9 74.7 72.7 65.7 74.7 
 




1 2 3 4 5 6 7 8 9 10 
40 65.6 65.1 65.6 63.2 58.2 69.9 60.8 67.6 68.2 74.2 62.8 
50 64.9 69.5 62.8 66.9 52.6 72.6 57.6 65.7 65.9 75.4 60.1 
60 64.4 69.3 64.3 69.2 51.2 73.5 50.8 63.4 67.4 76.7 57.9 
70 62.6 68.2 62.9 66.0 50.1 72.2 46.3 60.6 66.1 76.5 56.8 








Study 2 Individual Data: Post-intervention/training control and training group percent 
saturation (%) during cycling lactate threshold testing 
 




1 2 3 4 5 6 7 8 9 10 
40 67.0 62.1 60.9 62.5 66.4 61.6 73.2 70.3 74.7 69.7 68.7 
50 67.4 60.8 60.7 60.2 65.7 63.3 71.5 70.8 73.6 74.1 73.4 
60 66.2 58.4 61.2 58.7 59.9 63.0 72.1 70.8 72.8 73.6 71.1 
70 66.9 58.4 61.5 56.0 71.1 64.7 70.6 71.9 72.8 73.6 68.3 
80 66.4 56.5 61.7 54.1 67.8 69.5 70.0 73.7 71.5 72.9 66.6 
 




1 2 3 4 5 6 7 8 9 10 
40 66.7 66.8 70.6 65.9 60.8 71.1 59.7 66.9 66.9 69.9 68.1 
50 67.2 70.9 70.5 67.9 60.1 72.8 55.7 68.2 63.9 74.9 66.8 
60 66.2 72.5 68.7 66.3 60.0 73.5 50.6 65.7 63.0 75.5 66.3 
70 65.5 73.6 71.4 67.2 55.3 74.9 47.7 66.6 61.0 72.7 64.5 








Study 2 Individual Data: Training group mean peak power (W) across the five training 
days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 512 518 497 484 501 
2 787 881 911 848 900 
3 820 807 759 761 750 
4 1251 1216 1273 1337 1281 
5 565 596 562 627 650 
6 1213 1344 1212 1168 1158 
7 1115 1173 1114 1160 1116 
8 1802 1697 1823 1788 1799 
9 779 809 771 752 768 
10 993 1003 950 1009 1018 









Study 2 Individual Data: Training group mean revolutions per minute at peak power 
across the five training days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 120 109 121 109 113 
2 127 127 128 128 126 
3 130 131 131 124 126 
4 140 140 141 134 142 
5 108 112 121 110 127 
6 140 149 134 137 145 
7 127 140 134 132 133 
8 130 138 133 133 134 
9 103 110 102 100 100 
10 127 120 129 134 120 








Study 2 Individual Data: Training group mean relative peak power (W/kg) across the five 
training days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 8.8 8.9 8.5 8.3 8.6 
2 12.1 13.3 14.2 13.0 13.8 
3 12.6 12.4 11.7 11.7 11.4 
4 16.7 16.2 16.9 18.0 17.3 
5 9.9 9.6 9.0 10.1 10.5 
6 16.9 18.8 16.7 16.2 16.1 
7 15.1 15.9 15.1 15.7 15.1 
8 15.2 14.4 15.4 15.1 15.2 
9 10.9 11.3 10.8 10.5 10.8 
10 15.5 15.6 14.8 15.7 15.8 








Study 2 Individual Data: Training group average heart rate (bpm) during the training 
session across the five training days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 103 111 103 106 106 
2 80 93 94 95 96 
3 87 83 83 97 102 
4 100 91 111 101 101 
5 94 95 107 100 99 
6 99 110 103 98 103 
7 88 88 82 95 96 
8 98 95 93 93 95 
9 101 101 100 106 98 
10 83 91 77 81 83 









Study 2 Individual Data: Training group average peak heart rate (bpm) during the 
training session across the five training days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 130 136 129 131 131 
2 111 123 135 117 117 
3 124 112 107 125 128 
4 119 119 138 110 120 
5 120 119 121 127 127 
6 125 128 129 118 123 
7 115 116 111 121 129 
8 128 126 121 121 120 
9 128 128 128 132 128 
10 106 105 104 107 106 









Study 2 Individual Data: Training group average resting heart rate (bpm) during the 
training session across the five training days 
 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
1 94 93 89 91 91 
2 65 75 84 78 83 
3 58 67 67 75 81 
4 84 75 97 85 85 
5 78 72 93 78 91 
6 78 93 78 80 80 
7 61 59 54 60 62 
8 80 76 74 74 72 
9 74 74 72 81 69 
10 63 63 60 65 64 




















Consent for Participation in Research 
 




The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study. The person performing the research will 
answer any of your questions. Read the information below and ask any questions you might 
have before deciding whether or not to take part. If you decide to be involved in this study, this 
form will be used to record your consent. 
 
Purpose of the Study 
 
You have been asked to participate in a research study about the relationship between your 
aerobic fitness capability and endurance performance. The purpose of this study is measure your 
level of physical fitness for running or bicycling. These measures can be used to compare your 
individual attributes to those of previous endurance athletes who have been studied in the Human 
Performance Lab (HPL). We also want to determine if athletes who have been performing 
endurance training for a greater number of years have a higher maximal oxygen consumption 
(VO2max) than the athletes with fewer years of training. 
 
What will you be asked to do? 
 
If you agree to participate in this you will be asked to: 
 
1. Complete a health history questionnaire. 
2. Have your height and weight measured. 
3. Apply a heart rate monitor strap to your chest. 
4. Have your maximal oxygen consumption measured during cycling or running. 
5. Cool down for about 10 minutes before leaving the laboratory. 
This study will take one visit of approximately 45 minutes and will include approximately 
50 study participants. 
 
Overview of Procedures: 
 
Health History (~15min): Before you can be admitted to the study, you will be given a brief 
examination. This examination will include filling out a brief Health History Questionnaire, 






Maximal Oxygen Consumption (~30 min.): You will be asked to perform a maximal 
oxygen consumption test (VO2max), which will take between 6 – 12 minutes. The 
intensity of exercise will be increased every 1-2 min. until you are at your maximal 
effort level and cannot maintain the exercise speed. The sensation of effort and fatigue 
during the last 1-2 min will be comparable to a race. During the test, you will breathe 
into a mouthpiece, while wearing a nose clip that will collect and analyze the O2 and 
CO2 content of expired air. In addition, a heart rate monitor will be worn around the 
chest that will be used to monitor heart rate throughout the course of the study. From this 
data we can determine your VO2max. 
 
The maximal oxygen consumption protocol can be done either while running 
on a treadmill or while cycling on a stationary cycle ergometer. Both 
protocols will require similar incremental increases in exercise intensity, 
leading to fatigue in 6-12 min. 
 
Please initial below next to which test you will be performing today. 
 
     I have chosen to perform the maximal oxygen consumption test while riding 
a stationary cycle ergometer while the resistance increases progressively. 
 
     I have chosen to perform the maximal oxygen consumption test while running 
on a treadmill 
while progressively increasing treadmill speed and incline. 
 
 
Your participation may be photographed or videotaped during the course of this 
experiment. Any photographs and/or videotapes of your performance (without 
your name or likeness revealed) may be shown to educational audiences, such as 
conferences. 
 
What are the risks involved in this study? 
 
This maximal oxygen consumption test may involve risks that are currently 
unforeseeable. Possible risks associated with this study are: 
 
The fatigue test to measure VO2max will feel like a very short race or a single bout 
of intense interval training. There is a very small risk that you could experience a 
muscular injury, such as a muscle strain. It is possible, although very rare, that intense 
exercise such as performed in this study might cause a heart attack. During the test you 






short race or training session. During the tests, you may stop performing the task at 
any time for any reason if you feel you need to do so. 
 
What are the possible benefits of this study? 
 
You will receive no direct benefit from participating in this study; however, each 
subject completing the study will be provided with information about his or her 
VO2max, which is useful to running and bicycling training and performance. 
Do you have to 
participate? 
 
No, your participation is voluntary. You may decide not to participate at all or, if you 
start the study, you may withdraw at any time. Withdrawal or refusing to participate 
will not affect your relationship with The University of Texas at Austin (University) 
in anyway. 
 
If you would like to participate please fully read, sign, and return this form to the 
principal investigator of this study (Brian Leary). You will receive a copy of this form 
for your personal records. 
 
What are the potential Conflicts of Interest? 
 
Dr. Coyle holds equity in Sports Texas: Fitness, Training and Nutrition, Inc., a 
company that consults on the topics of physical training and monitoring athletic 
progress. The business interests of Sports Texas: Fitness, Training and Nutrition, 
Inc. overlap with this area of research. 
 
Will there be any compensation? 
 
You will not receive any type of payment participating in this study. 
 
What if you are injured because of the study? 
 
1. The University has no program or plan to provide treatment for research 
related injury or payment in the event of a medical problem. In the event of a 
research related injury, please contact the principal investigator. 
2. The University has no program or plan for continuing medical care 
and/or hospitalization for research-related injuries or for financial compensation. 
3. If injuries occur as a result of study activity, eligible University students 
may be treated at the usual level of care with the usual cost for services at the 






payment in the event of a medical problem. 
 
 
How will your privacy and confidentiality be protected if you participate in 
this research study? 
 
Each subject will be assigned a unique Subject ID code. This informed consent form 
and the Health History Questionnaire are the only places where any personal 
identifying information will be recorded. These forms will be stored in a locked file 
cabinet. In all other cases, your data will only be identifiable by your unique code. 
Only the director of the laboratory (Dr. Coyle) will have access to a master list that 
will link your identity to your code. 
Because you will be participating in this study and may do so along with other 
subjects in a small group, we will ask that you do not disclose names of participants 
in your group or any information that was discussed with other group members 
outside of the experimental session. 
If it becomes necessary for the Institutional Review Board to review the study 
records, information that can be linked to you will be protected to the extent 
permitted by law. Your research records will not be released without your 
consent unless required by law or a court order. The data resulting from your 
participation may be made available to other researchers in the future for research 
purposes not detailed within this consent form. In these cases, the data will 
contain no identifying information that could associate it with you, or with your 
participation in any study. 
 
If you choose to participate in this study, you may be photographed or video 
recorded. Any photographs or video recordings will be stored securely and only the 
research team will have access to the recordings. Recordings will be kept for 3 years 
after the research experiment has been completed and then erased. 
 
Whom to contact with questions about the study? 
 
Prior, during or after your participation you can contact the researcher Brian Leary at 
(512)471-8598 or send an email to briankleary@austin.utexas.edu for any questions 
or if you feel that you have been harmed. 
 
This study has been reviewed and approved by The University Institutional 
Review Board and the study number is 2014-08-0082. 
Whom to contact with questions concerning your rights as a research participant? 
 






you can contact, anonymously if you wish, the Institutional Review Board by 









You have been informed about this study’s purpose, procedures, possible benefits and 
risks, and you have received a copy of this form. You have been given the opportunity to 
ask questions before you sign, and you have been told that you can ask other questions at 
any time. You voluntarily agree to participate in this study. By signing this form, you are 




NOTE: Include the following if recording is optional: 
 
     I agree to be photographed/video recorded. 
 











As a representative of this study, I have explained the purpose, procedures, 



























Consent for Participation in Research 
 Title: Lactate Threshold While Cycling or Running 
Introduction 
 
The purpose of this form is to provide you information that may affect your decision 
as to whether or not to participate in this research study. The person performing the 
research will answer any of your questions. Read the information below and ask any 
questions you might have before deciding whether or not to take part. If you decide to 
be involved in this study, this form will be used to record your consent. 
 
Purpose of the Study 
 
You have been asked to participate in a research study about your level of physical 
fitness as measured by your blood lactic acid concentration during cycling or running. 
These measures can be used to compare your individual attributes to those of previous 
endurance athletes who have been studied in the HPL. 
 
What will you be asked to do? 
 
You will be asked to report to the Human Performance Laboratory at the University of 
Texas at Austin, located in Bellmont Hall, Room 820. You should wear a shirt, shorts, 
and tennis shoes. Gentlemen may be asked to perform shirtless. This visit will take 
about 45-60min. The experimental procedures are as follows: 
 
1. Complete a health history questionnaire 
2. Have your height and weight measured 
3. Allow the researcher to insert a Teflon catheter in your arm for blood 
draws 
4. Apply a heart rate monitor strap to your chest 
5. Wear a mouth piece to measure your volume of oxygen consumed 
6. Permit 7 blood draws to measure your blood lactate concentration 
7. Cycle or run on for 30 minutes as your intensity of exercise increases 
every 5 minutes 
8. After 30 minutes, a cool down of easy exercise will continue for 10 
minutes 
 
This study will take one visit of approximately 75 minutes and will include 
approximately 50 study participants. 
 
Health History Questionnaire (~15mins): Before you can be admitted to the study, 






Health History Questionnaire, and taking measurements of your height and weight. 
Only if you are apparently healthy with no prior history of disease or medical 
condition will you be permitted to participate in the study. Specific exclusion criteria 
include the following: history of heart disease or coronary artery disease, hypertension, 
lung or respiratory problems, persistent chest pain during and/or after exercise, fainting 
or loss of consciousness during exercise, and palpitations/arrhythmias during exercise. 
 
Blood Measurements: At the beginning of the lactate threshold testing session, a 1-1/2 
inch flexible Teflon catheter will be inserted, under sterile conditions, into a forearm vein 
and taped into place. Blood will be drawn from this catheter 7 times for each testing 
session (1 resting value and 1 for each of the 6 submaximal stages. 
These blood samples will be used to determine blood lactic acid concentration and then 
your lactate threshold. 
Lactate Threshold (~60 min): Once you are familiarized with the exercise equipment you 
will be asked to exercise for 30 min. During this time, the intensity of exercise will be 
increased every 5 min. The intensity of exercise during the 6 stages will be approximately 
40, 50, 60, 70, 80 and 90% of your maximal     oxygen consumption. This progressive 
exercise will feel like a 'warm-up' and should elicit only moderate fatigue during the last 
5-10 min. 
Before you start exercise and at the end of each of the 6 stages of exercise, a small 
sample of blood (1 milliliter or 
< 0.1 tablespoons) will be obtained from the venous catheter. Lactic acid levels in 
your blood and 'lactate threshold' will be determined, which is another predictor of 
performance ability. Your blood sample will be frozen, stored, and will be kept 
frozen for less than one month after your visit to the laboratory. 
During the test, you will breathe into a mouthpiece, while wearing a nose-clip, that 
will collect and analyze the O2 and CO2 content of expired air. From this we can 
determine your oxygen consumption and precisely determine how hard you are 
working. In addition, a heart rate monitor will be worn as a strap around your chest so 
we can also determine your lactate threshold and heart rate relationship. 
The lactate threshold protocol can be done either while running on a 
treadmill or while cycling on a stationary cycle ergometer. Both protocols 
will require the same level of exercise intensity. Please initial below next to 
which test you will be performing today. 
 
   I have chosen to perform the lactate threshold test while riding a 
stationary cycle ergometer. I understand that intensity will be determined 
based by increasing the resistance on the cycle ergometer based on my 







   I have chosen to perform the lactate threshold test while running on a 
treadmill. I understand that intensity will be adjusted by increasing treadmill 
speed and incline based on my individual level of fitness. 
 
 
Your participation may be photographed/video recorded. 
 
What are the risks involved in this study? 
 
None of the above procedures are expected to be unduly painful or uncomfortable 
in a healthy individual. There is a very small risk that you could experience a 
muscular injury, such as a muscle strain. It is possible, although very rare, that 
intense exercise such as performed in this study might cause a heart attack. A 
minimal amount of fatigue may occur during the test, the amount of fatigue 
typically experienced is similar to what you would encounter during a short race or 
training session. You will be asked to use a mouthpiece to measure oxygen 
consumption, this may provide slight discomfort but feels similar to a mouth guard 
commonly used in sporting activities. During the tests, you may stop performing 
the task at any time for any reason if you feel you need to do so. 
Approximately one tablespoon of blood will be obtained via draws from the 
venous catheter. You may experience some mild pain and irritation during the 
catheter insertion procedure and the catheter sometimes is uncomfortable, 
although rarely, during exercise. There is also a very slight risk of infection, 
bruising, excessive bleeding, pain, fainting/light headedness, and blood clotting. 
To minimize this risk, only sterile and/or disposable equipment will be used and 
the skin where the catheter is inserted will be swabbed with rubbing alcohol both 
before and immediately after the procedure. Additionally, you will be asked to be 
well hydrated and eat a light meal before you arrive to perform the lactate 
threshold test to minimize risk of fainting. 
 
What are the possible benefits of this study? 
 
You will receive no direct benefits from participating in this research study. 
However, after completing the study you will be provided with information 
useful to training and performance, including your lactate threshold. 
Do you have to participate? 
 
No, your participation is voluntary. You may decide not to participate at all or, if 
you start the study, you may withdraw at any time. Withdrawal or refusing to 
participate will not affect your relationship with The University of Texas at 







If you would like to participate please read and sign the consent form and return to 
the study investigator. You will receive a copy of this form for your personal records. 
 
Will there be any compensation? 
 
You will not receive any type of payment participating in this study. 
 
What if you are injured because of the study? 
 
1. The University has no program or plan to provide treatment for research 
related injury or payment in the event of a medical problem. In the event 
of a research related injury, please contact the principal investigator. 
2. The University has no program or plan for continuing medical care 
and/or hospitalization for research- related injuries or for financial 
compensation. 
3. If injuries occur as a result of study activity, eligible University students 
may be treated at the usual level of care with the usual cost for services at 
the Student Health Center, but the University has no program or plan to 
provide payment in the event of a medical problem. 
 
 
How will your privacy and confidentiality be protected if you participate in this 
research study? 
 
Each subject will be assigned a unique Subject ID code. This informed consent 
form and the Health History Questionnaire are the only places where any personal 
identifying information will be recorded. These forms will be stored in a locked 
file cabinet. In all other cases, your data will only be identifiable by your unique 
code. Only the director of the laboratory (Dr. Coyle) will have access to a master 
list that will link your identity to your code. The identifiable information collected 
will be deleted one year after the completion of the research study. 
Because you will be participating in this study and may do so along with other 
subjects in a small group, we will ask that you do not disclose names of 
participants in your group or any information that was discussed with other group 
members outside of the experimental session. 
Authorized persons from The University of Texas at Austin and the Institutional 
Review Board have the legal right to review your research records and will 
protect the confidentiality of those records to the extent permitted by law. 
Otherwise, your research records will not be released without your consent 






published or presented at scientific meetings, your identity will not be disclosed. 
If it becomes necessary for the Institutional Review Board to review the study 
records, information that can be linked to you will be protected to the extent 
permitted by law. Your research records will not be released without your 
consent unless required by law or a court order. The data resulting from your 
participation may be made available to other researchers in the future for 
research purposes not detailed within this consent form. In these cases, the data 
will contain no identifying information that could associate it with you, or with 
your participation in any study. 
 
If you choose to participate in this study, you may be photographed/video 
recorded. Any photographs or video recordings will be stored securely and 
only the research team will have access to the recordings. These photographs 
and video recordings will be used for instructional purposes with permission 
from the subject. Recordings will be kept for 3 yrs. past the date of study 
completion and then erased. 
 
Whom to contact with questions about the study? 
 
Prior, during or after your participation you can contact the researcher Brian Leary 
at (512)471-8598 or send an email to briankleary@austin.utexas.edu for any 
questions or if you feel that you have been harmed. 
 
This study has been reviewed and approved by The University Institutional Review 
Board and the study number is 
2014-08-0083. 
 
Whom to contact with questions concerning your rights as a research 
participant? 
For questions about your rights or any dissatisfaction with any part of this study, you 
can contact, anonymously if you wish, the Institutional Review Board by phone at 








You have been informed about this study’s purpose, procedures, possible benefits and 






opportunity to ask questions before you sign, and you have been told that you can ask 
other questions at any time. You voluntarily agree to participate in this study. By 
signing this form, you are not waiving any of your legal rights. 
 
     I agree to be photographed or video recorded for instructional purposes. 
 










As a representative of this study, I have explained the purpose, procedures, 

















Consent for Participation in Research 
 
Title: Biomechanical Differences in Cycling. 
 
Introduction 
The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study. The person performing the research will 
answer any of your questions. Read the information below and ask any questions you might 
have before deciding whether or not to take part. If you decide to be involved in this study, 
this form will be used to record your consent. 
 
Purpose of the Study 
You have been asked to participate in a research study about the biomechanical differences in 
cycling that occur between various type of endurance athletes. The purpose of this study is to 
measure your aerobic fitness and cycling biomechanical strategy. These measures can be used 
to compare your individual attributes to those of other endurance athletes who have been 
studied in the Human Performance Lab (HPL).  
 
What will you be asked to do? 
If you agree to participate in this study, you will be asked to: 
• Complete a health history questionnaire.  
• Have your height and weight measured.  
• Have your maximal oxygen consumption measured while cycling. 
• Have your cycling strategy analyzed while cycling. 
 
This study will take three visits of approximately 60 minutes and will include 
approximately 50 study participants.  
 
Overview of Procedures: 
 
Visit # 1: Health History and Maximal Oxygen Consumption 
• Health History Questionnaire (~15minutes): Before you can be admitted to the study, you 
will be given a brief examination. This examination will include filling out a brief Health 
History Questionnaire, and taking measurements of your height and weight.  
 
• Maximal Oxygen Consumption (~30 min.): You will be asked to perform a maximal 
oxygen consumption test (VO2max), which will take between 6 – 12 minutes. The intensity of 
exercise will be increased every 1-2 min. until you are at your maximal effort level and 
cannot maintain the exercise speed. The sensation of effort and fatigue during the last 1-2 
min will be comparable to a race. During the test, you will breathe into a mouthpiece, while 
wearing a nose clip that will collect and analyze the O2 and CO2 content of expired air. In 
addition, a heart rate monitor will be worn around the chest that will be used to monitor 









Visit #2&3: Biomechanical Assessment and Near Infrared Spectroscopy (Visit 2 will 
serve as a familiarization for the biomechanical protocol. Visit 3 will be a repeat of the 
procedures followed during Visit 2). 
• Subject Preparation (~30minutes):  
o Before beginning the exercise protocol, you will need to be prepped for the 
biomechanical assessment. During this time, we will mark your skin site at 
the appropriate location for electrode placement that will be used to 
determine how hard your muscles are working. Your skin will be cleaned 
with an alcohol pad and shaved with a razor to provide a more accurate 
measurement of muscle activity. Electrodes will be placed on your skin over 
your muscles of the lower extremity and secured with double sided tape and 
athletic wrap. Reflective markers will be secured to your upper and lower 
extremity so the motion analysis software can detect where you are at in the 
lab. Shoes will be provided for you that care custom designed for our pedals, 
and you will wear these for the duration of the test.  
o A probe will be placed over your thigh muscle emits near-infrared light and 
calculate the oxygen concentration within the muscle in a non-invasive 
manner. The probe will be secured to the skin with double sided tape and 
wrapped with athletic wrap.  
 
• Biomechanical Exercise Protocol (~30minutes):   
o You will be asked to ride at a submaximal effort at 3 different workloads for 
5 minutes. A warm-up period of 5 minutes will be given so you can become 
accustom with the bicycle. After the warm-up period, you will exercise at 
either 200 watts, 300 watts, and 80% of your VO2max for 5 minutes at each 
workload; the order of testing will be randomized. After you have completed 
the testing session a 10-minute cool-down will have provided. From this 
data, we can determine your bicycling biomechanics.  
 
 
Your participation may be video recorded. Any photographs and/or videotapes of your 
performance (without your name or likeness revealed) may be shown to educational audiences, 
such as conferences.  
 
What are the risks involved in this study? 
 
This maximal oxygen consumption test may involve risks that are currently unforeseeable. 
Possible risks associated with this study are: 
 
The fatigue test to measure VO2max will feel like a very short race or a single bout of intense 
interval training. There is a very small risk that you could experience a muscular injury, such 
as a muscle strain. It is possible, although very rare, that intense exercise such as performed in 
this study might cause a heart attack. During the test, you will have the sensation of fatigue, this 






the tests, you may stop performing the task at any time for any reason if you feel you need to 
do so.  
 
What are the possible benefits of this study? 
 
You will receive no direct benefit from participating in this study; however, each subject 
completing the study will be provided with information about his or her VO2max, which is 
useful to running and bicycling training and performance. 
 
Do you have to participate? 
No, your participation is voluntary. You may decide not to participate at all or, if you start the 
study, you may withdraw at any time. Withdrawal or refusing to participate will not affect 
your relationship with The University of Texas at Austin (University) in anyway.  
 
If you would like to participate please fully read, sign, and return this form to the principal 




Will there be any compensation? 
 
You will not receive any type of payment participating in this study.  
 
What if you are injured because of the study?  
 
1. The University has no program or plan to provide treatment for research related injury or 
payment in the event of a medical problem. In the event of a research related injury, 
please contact the principal investigator. 
2. The University has no program or plan for continuing medical care and/or hospitalization 
for research-related injuries or for financial compensation. 
3. If injuries occur as a result of study activity, eligible University students may be treated at 
the usual level of care with the usual cost for services at the Student Health Center, but 
the University has no program or plan to provide payment in the event of a medical 
problem. 
 
How will your privacy and confidentiality be protected if you participate in this research 
study? 
Each subject will be assigned a unique Subject ID code. This informed consent form and the 
Health History Questionnaire are the only places where any personal identifying information 
will be recorded. These forms will be stored in a locked file cabinet. In all other cases, your data 
will only be identifiable by your unique code. Only the director of the laboratory (Dr. Coyle) 






Because you will be participating in this study and may do so along with other subjects in a 
small group, we will ask that you do not disclose names of participants in your group or any 
information that was discussed with other group members outside of the experimental session.  
If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. Your 
research records will not be released without your consent unless required by law or a court 
order. The data resulting from your participation may be made available to other researchers 
in the future for research purposes not detailed within this consent form. In these cases, the 
data will contain no identifying information that could associate it with you, or with your 
participation in any study. 
If you choose to participate in this study, you may be photographed or video recorded. Any 
photographs or video recordings will be stored securely and only the research team will have 
access to the recordings. Recordings will be kept for 3 years after the research experiment has 
been completed and then erased.  
 
What are the potential Conflicts of Interest? 
 
Dr. Coyle holds equity in Sports Texas: Fitness, Training and Nutrition, Inc., a company that 
consults on the topics of physical training and monitoring athletic progress. The business 
interests of Sports Texas: Fitness, Training and Nutrition, Inc. overlap with this area of 
research. 
 
Whom to contact with questions about the study?  
 
Prior, during or after your participation you can contact the researcher Brian Leary at (512)471-
8598 or send an email to briankleary@austin.utexas.edu for any questions or if you feel that 
you have been harmed.  
This study has been reviewed and approved by The University Institutional Review Board and the 
study number is [STUDY NUMBER]. 
 
 
Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you can contact, 




 If you agree to participate to a member of the research team. 
 
Signature   
You have been informed about this study’s purpose, procedures, possible benefits and risks, and 
you have received a copy of this form. You have been given the opportunity to ask questions 
before you sign, and you have been told that you can ask other questions at any time. You 
voluntarily agree to participate in this study. By signing this form, you are not waiving any of 







______   I agree to video recorded. 
______   I do not want to be video recorded. 
 
_________________________________ 
Printed Name  
 
_________________________________    _________________ 
Signature Date 
 
As a representative of this study, I have explained the purpose, procedures, benefits, and the risks 
involved in this research study. 
 
_________________________________      
Print Name of Person obtaining consent      
 
 
_________________________________    _________________  








Consent for Participation in Research 
 
Title: Lactate Threshold Following Short-Term Training 
 
Introduction 
The purpose of this form is to provide you information that may affect your decision 
as to whether or not to participate in this research study.  The person performing the 
research will answer any of your questions.  Read the information below and ask any 
questions you might have before deciding whether or not to take part. If you decide to 
be involved in this study, this form will be used to record your consent. 
Purpose of the Study 
You have been asked to participate in a research study about change in lactate threshold 
following a short-term cycling training program. These measures can be used to 
compare your individual attributes to those of other endurance athletes who have been 
studied in the Human Performance Lab (HPL).   
 
What will you be asked to do? 
You will be asked to report to the Human Performance Laboratory at the University of 
Texas at Austin, located in Bellmont Hall, Room 820. You should wear a shirt, shorts, 
and tennis shoes. Gentlemen may be asked to perform shirtless. The testing sessions 
will span over 10 days, each visit will take between 30 to 120 minutes (details below). 
The experimental procedures are as follows (see Figure 1 below for graphical 
overview): 
Overview of Procedures: 
 
Figure 1. Study Overview 
Day # 1: Health History and Treadmill Maximal Oxygen Consumption (~60 
minutes) 
• Health History Questionnaire (~15minutes): Before you can be admitted to the 
study, you will be given a brief examination. This examination will include filling 
Training Group: Inertial-Load Training
Control Group: No Training Intervention






out a brief Health History Questionnaire, and taking measurements of your height 
and weight.  
 
• Treadmill Maximal Oxygen Consumption (~30 min.): You will be asked to perform 
a maximal oxygen consumption test (VO2max), which will take between 8 – 12 
minutes. The intensity of exercise will be increased every 1-2 min. until you are at 
your maximal effort level and cannot maintain the exercise speed. The sensation of 
effort and fatigue during the last 1-2 min will be comparable to a race. During the 
test, you will breathe into a mouthpiece, while wearing a nose clip that will collect 
and analyze the O2 and CO2 content of expired air.  In addition, a heart rate monitor 
will be worn around the chest that will be used to monitor heart rate throughout the 
course of the study. From this data, we can determine your treadmill VO2max.  
 
Day #2: Rest Day: This day will serve as a rest day, you will be asked to refrain from 
vigorous exercise on this day and maintain your normal diet pattern. 
 
Day #3 & 10: Lactate Threshold, Near Infrared Spectroscopy (NIRS), and Cycling 
Peak Oxygen Consumption (~120 minutes total) 
• Subject Preparation (~30minutes):  
o Before you start a venous catheter will be inserted into your arm, and 
will be used to collect a resting blood measurement as well as exercising 
blood measurements. 
o Before beginning the exercise protocol, you will need to be prepped for 
near-infrared spectroscopy assessment. We will mark and clean a skin 
site over one of the muscle of your thigh, and then shave with a razor 
and rub with an alcohol wipe. Shoes will be provided for you that are 
custom designed for our pedals, and you will wear these for the duration 
of the test.  
o A probe will be placed over your thigh muscle emits near-infrared light 
and calculate the oxygen concentration within the muscle in a non-
invasive manner. The probe will be secured to the skin with double sided 
tape and wrapped with athletic wrap.  
o After completion of the submaximal protocol subjects will have the 
venous catheter removed and the NIRS device taken off before the rest 
period starts. 
 
• Submaximal Exercise Protocol (~30minutes):   
o You will be asked to exercise for 30 minutes. During this time, the 
intensity of exercise will be increased every 5 min. The intensity of 
exercise during the 6 stages will be approximately 40,50,60,70,80& 






test will feel like a ‘warm-up’ and should elicit only moderate fatigue 
during the last 5-10min.  
o During the final minute of each stage a small amount (1 milliliter or <0.1 
tablespoons) of blood will be obtained from the venous catheter. Lactic 
acid levels in your blood and ‘lactate threshold’ will be determined.  
o During this test, you will breathe into a mouthpiece, while wearing a 
nose-clip, that will collect and analyze oxygen and carbon dioxide 
content of expired air.  
o Following the submaximal protocol you will be give 30 minutes to rest. 
After completion of the submaximal test the venous catheter and NIRS 
probe will be removed. 
 
• Cycling Peak Exercise Protocol (~8-12 minutes): 
o You will be asked to perform a maximal oxygen consumption test 
(VO2max), which will take between 8 – 12 minutes. The intensity of 
exercise will be increased every 1-2 min. until you are at your maximal 
effort level and cannot maintain the exercise speed. The sensation of 
effort and fatigue during the last 1-2 min will be comparable to a race. 
During the test, you will breathe into a mouthpiece, while wearing a 
noseclip that will collect and analyze the O2 and CO2 content of expired 
air.  In addition, a heart rate monitor will be worn around the chest that 
will be used to monitor heart rate throughout the course of the study. From 
this data, we can determine your cycling VO2peak. 
 
Days #5-9: Control or Training Intervention (~30minutes):  
If you are assigned to the Control group you will be asked to maintain your normal diet 
and exercise regimen throughout Days 5-9. If you are assigned to the Training group you 
will be asked to come to the laboratory on Days 5-9 to perform the training protocol below.  
 
• Warm-Up (15 minutes): You will perform 5 minutes of active warm-up (i.e. 
squats and stretching). Immediately following the 5 minute of active warm-
up you will ride a cycle ergometer for 5 minutes at 100 watts with a cadence 
of 100-120rpms. Five minutes of rest will be given after the warm-up and 
after you will perform the training protocol. 
• Inertial-Load Training: You will perform 10 ‘maximal’ sprints lasting ~4 
seconds on the cycle ergometer. You will be asked to pedal as hard and fast 
as possible for the 4 seconds. After each repetition, you will be give 2 
minutes of rest.  
 
 
Health History Questionnaire: Before you can be admitted to the study, you will be 






History Questionnaire, and taking measurements of your height and weight. Only if 
you are apparently healthy with no prior history of disease or medical condition will 
you be permitted to participate in the study. Specific exclusion criteria include the 
following: history of heart disease or coronary artery disease, hypertension, lung or 
respiratory problems, persistent chest pain during and/or after exercise, fainting or loss 
of consciousness during exercise, and palpitations/arrhythmias during exercise.  
Blood Measurements:  At the beginning of the lactate threshold testing session, a 1-1/2 
inch flexible Teflon catheter will be inserted, under sterile conditions, into a forearm vein 
and taped into place. Blood will be drawn from this catheter 7 times for each testing 
session (1 resting value and 1 for each of the 6 submaximal stages.  These blood samples 
will be used to determine blood lactic acid concentration and then your lactate threshold.  
Lactate Threshold: Once you are familiarized with the exercise equipment you will be 
asked to exercise for 30 min.  During this time, the intensity of exercise will be increased 
every 5 min.  The intensity of exercise during the 6 stages will be approximately 40, 50, 
60, 70, 80 and 90% of your maximal oxygen consumption.  This progressive exercise 
will feel like a 'warm-up' and should elicit only moderate fatigue during the last 5-10 min. 
Before you start exercise and at the end of each of the 6 stages of exercise, a small sample 
of blood (1 milliliter or  < 0.1 tablespoons) will be obtained from the venous catheter. 
Lactic acid levels in your blood and 'lactate threshold' will be determined, which is 
another predictor of performance ability. Your blood sample will be frozen, stored, and 
will be kept frozen for less than one month after your visit to the laboratory. 
During the test, you will breathe into a mouthpiece, while wearing a nose-clip, that will 
collect and analyze the O2 and CO2 content of expired air.  From this we can determine 
your oxygen consumption and precisely determine how hard you are working. In 
addition, a heart rate monitor will be worn as a strap around your chest so we can also 
determine your lactate threshold and heart rate relationship. 
 
Your participation may be photographed/video recorded.    
What are the risks involved in this study? 
None of the above procedures are expected to be unduly painful or uncomfortable in a 
healthy individual. There is a very small risk that you could experience a muscular 
injury, such as a muscle strain. It is possible, although very rare, that intense exercise 
such as performed in this study might cause a heart attack. A minimal amount of fatigue 
may occur during the test, the amount of fatigue typically experienced is similar to what 
you would encounter during a short race or training session. You will be asked to use a 
mouthpiece to measure oxygen consumption, this may provide slight discomfort but feels 
similar to a mouth guard commonly used in sporting activities. During the tests, you may 
stop performing the task at any time for any reason if you feel you need to do so.   
Approximately one tablespoon of blood will be obtained via draws from the venous 






insertion procedure and the catheter sometimes is uncomfortable, although rarely, 
during exercise.  There is also a very slight risk of infection, bruising, excessive 
bleeding, pain, fainting/light headedness, and blood clotting. To minimize this risk, 
only sterile and/or disposable equipment will be used and the skin where the catheter 
is inserted will be swabbed with rubbing alcohol both before and immediately after the 
procedure. Additionally, you will be asked to be well hydrated and eat a light meal 
before you arrive to perform the lactate threshold test to minimize risk of fainting. To 
further minimize the risk of fainting you will be asked to lie in a supine position while 
the venous catheter is inserted. 
What are the possible benefits of this study? 
You will receive no direct benefits from participating in this research study. However, 
after completing the study you will be provided with information useful to training and 
performance, including your VO2max and lactate threshold. 
Do you have to participate? 
No, your participation is voluntary. You may decide not to participate at all or, if you 
start the study, you may withdraw at any time.  Withdrawal or refusing to participate 
will not affect your relationship with The University of Texas at Austin (University) in 
anyway.  
If you would like to participate please read and sign the consent form and return to the 
study investigator.  You will receive a copy of this form for your personal records. 
Will there be any compensation? 
You will not receive any type of payment participating in this study.  
What if you are injured because of the study?   
4. The University has no program or plan to provide treatment for research related 
injury or payment in the event of a medical problem.  In the event of a research 
related injury, please contact the principal investigator. 
5. The University has no program or plan for continuing medical care and/or 
hospitalization for research-related injuries or for financial compensation.  
6. If injuries occur as a result of study activity, eligible University students may be 
treated at the usual level of care with the usual cost for services at the Student 
Health Center, but the University has no program or plan to provide payment in the 
event of a medical problem. 
 
How will your privacy and confidentiality be protected if you participate in this 
research study? 
Each subject will be assigned a unique Subject ID code.  This informed consent form and 
the Health History Questionnaire are the only places where any personal identifying 
information will be recorded.  These forms will be stored in a locked file cabinet.  In all 
other cases, your data will only be identifiable by your unique code.  Only the director of 
the laboratory (Dr. Coyle) will have access to a master list that will link your identity to 
your code. The identifiable information collected will be deleted one year after the 






Because you will be participating in this study and may do so along with other subjects 
in a small group, we will ask that you do not disclose names of participants in your group 
or any information that was discussed with other group members outside of the 
experimental session.  
Authorized persons from The University of Texas at Austin and the Institutional Review 
Board have the legal right to review your research records and will protect the 
confidentiality of those records to the extent permitted by law.  Otherwise, your research 
records will not be released without your consent unless required by law or a court order. 
If the results of this research are published or presented at scientific meetings, your 
identity will not be disclosed.   
If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. 
Your research records will not be released without your consent unless required by law 
or a court order. The data resulting from your participation may be made available to 
other researchers in the future for research purposes not detailed within this consent 
form. In these cases, the data will contain no identifying information that could 
associate it with you, or with your participation in any study. 
If you choose to participate in this study, you may be photographed/video recorded.  
Any photographs or video recordings will be stored securely and only the research 
team will have access to the recordings.  These photographs and video recordings will 
be used for instructional purposes with permission from the subject. Recordings will 
be kept for 3 yrs. past the date of study completion and then erased.  
Whom to contact with questions about the study?   
Prior, during or after your participation you can contact the researcher Brian Leary at 
(512)471-8598 or send an email to briankleary@austin.utexas.edu for any questions or 
if you feel that you have been harmed.   
This study has been reviewed and approved by The University Institutional Review Board 
and the study number is 2014-08-0083. 
Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you can 
contact, anonymously if you wish, the Institutional Review Board by phone at (512) 471-
8871 or email at orsc@uts.cc.utexas.edu.  
Financial Conflict of Interest Disclosure 
The faculty advisor of the student researcher who is leading this study, Dr. Edward F. 
Coyle, holds equity in and consults on physical training and monitoring athletic progress 
for a company called Sports Texas: Fitness, Training, and Nutrition, Inc. The business 
interests of this company overlap with the topic of this study. 
Participation 
If you agree to participate please sign below and return to the principal investigator. 






You have been informed about this study’s purpose, procedures, possible benefits and 
risks, and you have received a copy of this form. You have been given the opportunity 
to ask questions before you sign, and you have been told that you can ask other questions 
at any time. You voluntarily agree to participate in this study.  By signing this form, you 
are not waiving any of your legal rights. 
______   I agree to be photographed or video recorded for instructional purposes. 
______   I do not want to be photographed or video recorded for instructional 
purposes. 
_________________________________ 
Printed Name  
_________________________________    _________________ 
Signature Date 
As a representative of this study, I have explained the purpose, procedures, benefits, and 
the risks involved in this research study. 
_________________________________      
Print Name of Person obtaining consent      
_________________________________    _________________  








Health History Questionnaire 
HUMAN PERFORMANCE LABORATORY – THE UNIVERSITY OF TEXAS 
IRB #: Subject ID: ____________ 
Date of Birth (mm/dd/yy) ____________________________ Age: 
________________________ 
MALE _____ FEMALE ____ 
Height ___________ Weight ___________ 
GENERAL HEALTH QUESTIONS 
1. Are you taking any of the following medications on a regular basis? Y / N 
(Psychotropics, Antihistamines, Asthma Meds, Aldomet, Clonidine, 
Anti-Depressants, Anti-Anxiety Meds) 
2. Are you taking any cardiovascular acting drugs? Y/N 
3. Any over-the-counter meds? Y / N 
If yes, explain: 
4. Do you have any disability or impairment that affects physical performance? Y / N 
5. Have you ever had any broken bones, surgery or injury to your lower extremities? Y / 
N 
If yes, explain: 
6. Have you had any significant medical problems within the last 10 years? Y / N 
If yes, explain: 
7. Do you have any drug and/or alcohol dependence? Y / N 
If yes, explain: 
8. Do you have any heart problems or coronary artery disease? Y / N 
If yes, explain. 
9. Do you have hypertension (high blood pressure)? Y / N 
If yes, explain. 






If yes, explain. 
11. Do you smoke? Y / N 
If yes, pattern. 
12. Do you use alcohol? Y / N 
If yes, pattern. 
13. Do you use caffeine (cola, coffee, etc…)? Y / N 
If yes, pattern. 
14. Do you have any allergies that require medication? Y / N 
If yes, explain. 
15. Do you experience difficulty swallowing medications or vitamins? Y / N 
If yes, explain. 
16. Do you take any dietary supplements aimed at increasing your exercise performance? 
Y / N 
If yes, what supplements so you normally take? 
17. Have you been diagnosed with an obstructive disease of the gastrointestinal tract 
including but not limited to esophageal stricture, diverticulous, inflammatory bowel 
disease (IBD), peptic ulcer disease, Crohn’s disease, ulcerative colitis, and previous 
gastro-esophageal surgery. Y / N 
HAVE YOU EVER HAD ANY SIGNIFICANT SYMPTOMS ASSOCIATED 
WITH EXERCISE? 
1. Easy fatigability or prolonged fatigue after exercise? Y / N 
If yes, explain. 
2. Persistent chest pain during and/or after exercise? Y / N 
If yes, explain. 
3. Fainting or loss of consciousness during exercise? Y / N 
If yes, explain. 
4. Palpitations (rapid, irregular, or skipped heartbeats) during exercise? Y / N 






PHYSICAL TRAINING HISTORY 
How many years have you been training? 
____________________________________________________ 
What type of physical training do you participate in? 
___________________________________________ 




















PLEASE GENERALLY DESCRIBE YOUR TRAINING PROGRAM DURING 
THE LAST 6 MONTHS 
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